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Abstract 
Current Lung function assessments in children can be clinically challenging and even 
inapplicable in preschool children, this is due to the test requirements of cooperation and 
understanding. Hence, there is a need for new techniques that can overcome these limitations. 
Structured Light Plethysmography (SLP) is a new non-invasive technique to measure tidal 
breathing by capturing the movement of the thoraco-abdominal wall. This technique requires 
minimal subject cooperation as it does not require the subject to perform any breathing 
manoeuvres but to sit still and breathe normally. The usefulness of SLP in adults has been 
shown in previous studies, specifically in detecting abnormal breathing patterns in adults 
diagnosed with Chronic Obstructive Pulmonary Disease (COPD). SLP is arguably a more 
suitable method for young children and infants. Therefore, the main aim of this study was to 
determine the reliability of SLP for lung function monitoring in paediatric population. The first 
part of this project aimed to investigate the use of SLP in assessing tidal breathing parameters 
in: (1) school-age children (7-16 years) with stable Asthma, (2) younger children (2-12 years) 
recovering from acute asthma/wheeze and (3) infants recovering from acute viral bronchiolitis 
(0-1 year). Whereas, the second part aimed to assess the robustness of the parameter estimation 
algorithm against interferences that might be introduced to the SLP signal during data 
acquisition. 
The results obtained from the studies conducted in this work illustrated the feasibility of SLP 
procedure in obtaining a reliable assessment of lung function in children aged 0 to 17 years. 
This is true for children presenting with normal lung function and lung function affected by 
stable asthma, acute asthma/wheeze and acute viral bronchiolitis. The method proved sensitive 
enough to detect differences in clinically important measures in healthy, asthmatic and 
recovering populations. This suggests that the potential use of SLP in monitoring asthma and 
bronchiolitisworth further investigation. However, more refinements in data analysis 
techniques are required. The robustness of the algorithm to possible interferences also needs to 
be further investigated before being introduced clinically.  
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1 Introduction 
Lung diseases are a prevalent group of long-term conditions and are one of the leading causes 
of emergency hospital admissions in adults and particularly in children. World Health 
Organisation (WHO) estimated that 65 million people were diagnosed with Chronic 
Obstructive Pulmonary Disease (COPD) by 2004 and that 3 million people died of COPD in 
2005 alone. According to Asthma-UK, 5.4 million people in the UK are diagnosed with asthma 
of which 1.1 million are children (1 in 11), and the rest 4.3 million are adults. According to 
Asthma UK (Asthma UK, 2018), someone has a dangerous asthma attack every 10 seconds, 
and three individuals die every single day in the UK because of an asthma attack. Two-thirds 
of these deaths are preventable (Asthma UK, 2018). 
Acute respiratory illnesses are the largest single cause of death in infants and children less than 
five years of age: intermittent problems with ‘’wheezy chest’’ in the first year of life occur in 
more than a third of all children. Asthma is the most common chronic disease during childhood 
which starts very early in life in the majority of cases, and it is under-diagnosed and under-
treated (World Health Organisation, 2013). 
Respiratory conditions such as asthma and COPD are typically identified by distressing 
symptoms, mainly breathlessness, chest pain, wheeze, dyspnoea and cough (Leach, 2008); 
those symptoms can markedly reduce the quality of a patient’s life (Weldam et al., 2014). 
Many respiratory diseases are not curable and are progressive, however accurate diagnosis and 
treatment can help in managing the symptoms and slowing the progression of the disease, thus 
improving quality of life.  
Lung function tests are examinations used to evaluate or give an interpretation of respiratory 
function (Quanjer, 2003). Most commonly used techniques require the patient to breathe 
through a mouthpiece, to provide a measurement of flow and volume. This requires the patient’s 
understanding and cooperation and can be challenging to perform and to obtain accurate 
measures in infants and preschool children (Williams et al., 2014) 
Pulmonary function testing (PFT) is a general term that covers a wide range of clinical tests to 
assess the respiratory status of a patient. A device employed in carrying out pulmonary function 
tests may broadly be classified as belonging to either one of two categories. In the first category, 
airflow is measured, and it is referred to as Pneumotachography. The second category is referred 
to as Plethysmography, and it involves the measurements of lung volume. 
Global lung function is assessed using a pulmonary function test (PFT), which offers essential 
information for diagnosing and monitoring lung disorders. The PFT data include: Functional 
Residual Capacity (FRC) which is the amount of air at the end of a normal quiet respiration, 
Forced Expiratory Volume (FEV1) which represents the amount of air measured during the 
first second of a forced exhalation, and Forced Vital Capacity (FVC) which is the maximum 
amount of air during the measurement of forced expiratory volume. 
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Various techniques have also been developed and validated which measure the chest wall 
movement (Respiratory Inductance Plethysmography). These techniques can provide useful 
information relating to ventilatory effort and can also provide an estimation of changes in 
volume. All of these techniques require physical contact with the patients, and the positioning 
of physical markers which can be encumbering and time-consuming (Stocks, 1996). 
A group of clinicians and scientists in Cambridge have developed a new technique, known as 
Structured Light Plethysmography (SLP), which is a non-contact light-based technique that 
measures the movement of the chest and abdominal wall during tidal breathing (Boer et al., 
2010). SLP provides valuable information about patients’ lung function (Ghezzi et al., 2017). 
In addition, SLP offers advantages over conventional lung function assessment, as it provides 
information about the regional changes in ventilation and also the relative contributions of 
different thoraco-abdominal regions in breathing across ages. The zero-contact environment 
minimises altered breathing mechanics, introduced from breathing into a measurement device. 
Thus, it allows more natural breathing patterns to be observed. One of the limitations of SLP is 
that an accurate data acquisition requires the patient to remain still and breathe quietly for a 
given period of time, which is sometimes difficult to achieve in young children (Almazaydeh 
et al., 2013). 
In order to overcome the limitations of traditional lung function assessment, SLP usage was 
investigated in this thesis as a possible alternative modality for lung function monitoring in 
paediatric population. This was done by firstly investigating the use of SLP in assessing tidal 
breathing in (1) school-age children (7-16 years) with stable Asthma, (2) younger children (2-
12 years) recovering from acute asthma/wheeze and (3) infants recovering from acute viral 
bronchiolitis (0-1 year). And secondly, by assessing the robustness of the parameter estimation 
algorithm against interferences that might be introduced to the SLP signal during data 
acquisition. 
In this thesis, Chapter 2 presents a literature review covering the anatomy and physiology of 
the respiratory system and its development. Natural physiology of breathing is also discussed 
with an introduction to respiratory diseases in childhood (mainly asthma/wheeze and Acute 
Viral Bronchiolitis). In addition, traditional measures of lung functions are illustrated. Specific 
aims of the thesis are articulated in chapter 3. Chapter 4 gives a technical overview of the 
working principle of SLP and defines core terminologies. Chapters 5,6 and 7 evaluate the use 
of SLP in monitoring lung function in healthy and sick children/infants. Chapter 8 investigates 
the effects of upper-body movements and coughs, as artefacts, on SLP signal and its estimated 
tidal breathing parameters. In addition, various signal processing and statistical techniques were 
applied to remove those artefacts. A general discussion of common themes is given in chapter 
9, and chapter 10 gives a final conclusion and recommendations.  
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2 Literature review  
2.1 Anatomy of respiratory system 
A constant supply of oxygen is required by the cells of the human body to stay alive (The Pt 
Group: Physical Therapy, 2015). The respiratory system acts in such a way that it provides the 
needed oxygen to the body as well as removes carbon dioxide, the accumulation of which is 
lethal. The process of moving gas into and out of the lungs (ventilation) and moving oxygen 
and carbon dioxide between air and blood (respiration) requires an elaborate organ system 
(Taylor, 2013; Beachey, 2018). 
 
Figure 2-1. Main respiratory system structures 
(Anatomy-medicine, 2018) 
 
The respiratory system is comprised of three major parts: the lungs, the muscles of respiration, 
and the airways (Figure 2-1). As the functional unit of the respiratory system, the lungs pass 
the oxygen into the body and remove the carbon dioxide. The muscles of respiration, including 
the intercostal muscles and the diaphragm, drive ventilation by pushing the air in and out of the 
lungs during breathing. The airway (the mouth, nose, pharynx, larynx, trachea, bronchi and 
bronchioles) passes air between the exterior of the body and the lungs (Taylor, 2013). These 
parts make up the conductive zone of the respiratory system wherein no gaseous exchange takes 
place, which only occurs in the alveoli and alveolar ducts as explained in the next section. 
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2.2 Respiratory system structure and function 
2.2.1 Nose and Nasal Cavity 
The nose and the nasal cavity together form the main respiratory system’s external opening, 
and they are the first section of the airway of the body, the respiratory tract which is responsible 
for the air movement. The nasal cavity, lined with mucus membrane and hairs, works as a 
filtering device, moisturising and warming air before it enters the lungs. The mucus and the hair 
help in the trapping of dust, pollen, mould and any other hazardous substances from the 
environment, preventing them from reaching the inner parts of the body. Air coming out of the 
body through the nose returns heat and moisture to the nasal cavity before it is finally exhaled 
to the environment (Taylor, 2013; Beachey, 2018). 
 
2.2.2 Mouth 
The secondary external opening for the respiratory tract is the mouth. Normal breathing occurs 
predominantly through the nasal cavity, and the mouth is mostly used as a supplement replacing 
the functions of the nasal cavity when the need arises. However, the disadvantages associated 
with breathing through the mouth include: 
a) The mouth cannot moisturise or warm the air entering the lungs as effectively as the 
nose, because the pathway of air entering the body through the mouth is shorter than the 
path of air that enters through the nose. 
b) The hairs and the sticky mucus, which are responsible for filtering the air that passes 
through the nasal cavity, are missing in the mouth (Taylor, 2013). 
 
2.2.3 Pharynx 
The Pharynx, commonly known as the throat, is made up of a muscular funnel extending from 
the posterior end of the nasal cavity and ends at the superior end of the Larynx and the 
Oesophagus. It is divided into three: The Oropharynx (located in the oral cavity’s posterior), 
the Nasopharynx (the largest region located in the posterior nasal cavity), and the 
Laryngopharynx. When inhaled from the nasal cavity, air passes into the Nasopharynx and then 
descends through the Oropharynx, but when inhaled through the mouth, air enters the Pharynx 
through the Oropharynx. The air that is inhaled descends right into the Laryngopharynx where 
Epiglottis, an elastic flap of cartilage, acts as a switch between the Oesophagus and the Trachea, 
diverts it into the Larynx’s opening (Taylor, 2013). This, a defence mechanism, ensures correct 
passage of air and food, avoiding choking (Beachey, 2018). 
 
2.2.4 Larynx 
The Larynx, commonly referred as the voice box, is the short length of the airway connecting 
the Trachea and the Laryngopharynx. It is positioned in the neck’s anterior portion, above the 
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trachea and below the hyoid bone and is a cylindrical structure, acting as a valve. The Larynx 
is comprised of several cartilage structures, hence its structural properties, and includes the 
Epiglottis. Just below the Epiglottis is the Thyroid cartilage, which is commonly known as 
Adam’s apple due to its enlarged size and visibility in male adults. The Thyroid offers 
protection to the vocal folds. The ring-shaped cricoid cartilage, which is located just below the 
thyroid cartilage, holds the larynx open and supports its posterior end. Other than the cartilage, 
the larynx also bears unique structures called the vocal folds, which are responsible for sounds. 
The tension, as well as the vibration speed of the vocal folds, can be changed so as the pitch 
that they produce (Taylor, 2013; Beachey, 2018). 
 
2.2.5 Trachea 
The Trachea, or windpipe, is a tube, 10-11 cm tube in length, and 1.5 - 2 centimetres in inner 
diameter. It is made up of C-shaped hyaline cartilage rings, lined with the Pseudostratified 
Ciliated Columnar Epithelium. The larynx is connected to the Bronchi by the Trachea which 
allows the passage of air into the Thorax through the neck. The Trachea, with the help of rings 
of cartilage that are contained in it, always remains open to air. The Oesophagus is allowed to 
expand into the space that is occupied by the trachea to accommodate the masses of food that 
are moving through the Oesophagus because the open end of the cartilage rings face posteriorly 
to the oesophagus (Taylor, 2013; Beachey, 2018). The Trachea ensure a clear airway passage 
of air to the lungs. Mucus, a defence mechanism, produced by the Epithelium lining the 
Trachea, helps to trap dust and other contaminants, preventing them from reaching the lung. On 
the surface of Epithelial cells, there are microscopic, slender, hair-like organelles. The mucus 
is moved toward the Pharynx superiorly where it can then be swallowed and finally digested in 
the Gastrointestinal tract (Taylor, 2013). 
 
2.2.6 Bronchi and Bronchioles 
Towards the end of the Trachea, there is a left and right division into branches called the primary 
bronchi. These bronchi enter each lung and branch off into relatively smaller secondary bronchi, 
carrying the air into the lobes of the left and right lungs. The secondary bronchus then split into 
smaller third bronchi in each lobe. The resulting tertiary bronchi further split into numerous 
bronchioles which then spread throughout the lungs. Each of the bronchioles then split into 
numerous smaller branches called terminal bronchioles whose diameters are less than one 
millimetre. Millions of tiny terminal bronchioles finally conduct air into the alveoli of the lungs. 
The structure of the airway’s wall also starts to change during the splitting of the airway into 
the tree-like branches of bronchi and bronchioles (Beachey, 2018). The primary function of 
both bronchi and bronchioles is to transmit air from the trachea into the lungs. The quantity of 
the air flowing into the lungs is regulated by the smooth muscle tissue found in the surrounding 
walls of the bronchi and the bronchioles (Taylor, 2013). 
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2.2.7 Lungs 
The pair of lungs, large and spongy, are found in the thorax just lateral to the heart and above 
the diaphragm. Each lung has a pleural membrane surrounding it to provide the space for the 
Lung to expand and a negative pressure space in relation to the exterior of the body. The 
negative pressure always allows for the passive filling of the Lungs with air as they relax. 
Because of the heart points to the left side of the body, the left and right lungs consequently 
have slightly different size and shape with the right lung being slightly bigger than the left lung.  
It is made up of three lobes while the left lung is made up of two lobes (Beachey, 2018). 
The lungs’ interior is made up of spongy tissues which contain many capillaries and numerous 
(around thirty million) tiny sacs called alveoli. These are cup-shaped structures, are surrounded 
by capillaries and are found at the end of the terminal bronchioles. The alveoli contain a thin 
simple and squamous epithelium lining that allows air entering the alveoli to be able to 
exchange its gases with the blood that is passing through the capillaries (Taylor, 2013). 
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2.3 Development of the respiratory system 
In this section, the development of the respiratory system is addressed, as this work has assessed 
breathing of infants (< two years) and children between 2 and 17 years of age. Human infants 
and mature adults have similar lungs in structure, but a difference in the number of airways and 
the components of airway walls (Greenough, 2003). There is a continuous development of the 
lung from birth until adolescence with its maximum in the first few months after birth. Newborn 
lungs have around 150 million alveoli. It was believed for a long time that alveolarisation stops 
by 7-8 years of age when this number almost quadruples (Angus and Thurlbeck, 1972; Langston 
et al., 1984; Malina, Bouchard and Bar-Or, 2004). Recent studies, though, suggested that 
alveolarisation continues after that age and during adolescence resulting in an increase in lung 
volume from 7 years to adulthood (Narayanan et al., 2012). 
The number of pulmonary capillaries surrounding the alveoli increases with age in childhood, 
increasing the gas exchange per unit of body mass (Zeltner et al., 1987; Greenough, 2003). 
Airways increase in size during childhood (Morgan et al., 1982; Zapletal, Samanek and Paul, 
1982), which result in a decrease in airways resistance with a linked rise in lung compliance 
(Stocks, 1999). 
The ribcage of a new-born is very compliant, consisting mainly of cartilage (Bryan and Wohl, 
2011). Ossification changes the structure of the ribcage into mineralised bone, which is a 
process that continues until 25 years of age (Glass et al., 2002). The high compliance of an 
infant chest wall decreases to almost one third in adulthood, because of both ossification and 
the increase of muscle mass (Papastamelos et al., 1995). 
In infants, the ribs are more horizontally oriented relative to the vertebra than in adults. The 
thoracic cage of an infant is triangular due to the shorter ribs length in the upper part of the rib 
cage, while it has a dome shape in an adult (Devlieger et al., 1991). This configuration causes 
flattening of the diaphragm in infants and children, which leads to a reduction in the load of 
lower rib cage on the abdominal content in diaphragm contraction (Devlieger et al., 1991), this 
means that the rib cage movement has a small contribution in tidal volume (Hershenson et al., 
1990). The raised orientation of the ribs changes with age, as the ribs tilt downward to reach 
the adult configuration by the age of ten years (Haddad, Abman and Chernick, 2002).  
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2.4 Natural physiology of breathing 
2.4.1 Pulmonary Ventilation 
Pulmonary ventilation is the process involving the movement of air in and out of the lungs to 
facilitate the exchange of gases. In order to achieve pulmonary ventilation, the respiratory 
system uses not only the negative pressure system but also the contraction of muscles 
(Ratnovsky, Elad and Halpern, 2008). In the negative pressure system, a negative pressure 
gradient is established between the alveoli and the external atmosphere. The lungs are sealed 
by the pleural membrane to maintain the pressure of the lungs slightly below the atmospheric 
pressure when the lungs are at rest. Consequently, the air is made to follow with the pressure 
gradient to passively fill the lungs which are at rest. The pressure within the lungs rises as the 
lungs fill with air until it matches the atmospheric pressure. More air can still be inhaled, albeit 
by the contraction of the diaphragm as well as the external intercostal muscles, leading to the 
increase in the volume of the thorax and resulting in the reduction of the pressure of the lungs 
below the atmospheric pressure once again (Taylor, 2013). 
In order to exhale air, the diaphragm and the external intercostal muscles relax, as the internal 
intercostal muscles contract leading to the reduction of the volume of the thorax and 
consequently increasing the pressure inside the thoracic cavity. The pressure gradient is 
reversed, leading to the exhalation of air which continues until the pressure inside the lungs and 
the pressure outside the body match (are equal). The elastic nature of the lungs then causes them 
to recoil back to their original volume, leading to the restoration of the negative pressure 
gradient which was present during the inhalation (Beachey, 2018). 
There are sets of muscles surrounding the lungs that have the ability to cause air from the lungs 
to be inhaled or exhaled. Diaphragm, a thin sheet of skeletal muscle which forms the bottom of 
the thorax, is the principal muscle of respiration that is found in the human body. During 
inhalation, the diaphragm contracts making it move a few inches lower into the abdominal 
cavity, thus expanding the space inside the thoracic cavity and, therefore, pull air into the lungs. 
By moving down, the thoracic cavity’s volume increases which drops the pressure inside the 
thoracic cavity with respect to the atmosphere, this difference in the pressure generates the flow 
of air (air rushes inside the lungs). The intercostal muscles further increase the volume of the 
thoracic cavity by moving the ribs forward and up (Taylor, 2013). 
The flow of air is directly proportional to the difference in the pressure between the thoracic 
cavity and the atmosphere, and inversely proportional to the airway resistance. 
On the other hand, when the diaphragm relaxes, air is allowed to flow back out of the lung 
leading to exhalation. When the diaphragm relaxes it moves up, and this decreases the volume 
of the thoracic cavity which increases the pressure inside and pushes the air out of the lungs. 
The relaxation of the intercostal muscles moves the ribs back and down which further reduces 
the volume (Taylor, 2013). 
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There are numerous small intercostal muscles between the ribs that assist the diaphragm with 
compressing and expanding the lungs. These muscles are generally divided into two groups: 
the internal intercostal muscles and the external intercostal muscles. The internal intercostal 
muscles which are the deeper lying sets of muscles act by depressing the ribs to help in the 
compression of the thoracic cavity which consequently forces the air from the lungs to be 
exhaled. The external intercostals, on the other hand, are found superficial to the internal 
intercostals, and they act to elevate the ribs, leading to the expansion of the volume of the 
thoracic cavity and consequently cause the air to be inhaled into the lungs (Beachey, 2018). 
Accessory muscles of the upper chest and neck contribute to different levels in the inspiration 
phase, whereas the abdominal muscles contribute in the expiration phase (MacBean, 2014). 
The contraction of abdominal muscles causes the abdominal wall to move inward, pushing the 
abdominal content and causing the diaphragm to move upward (Ratnovsky, Elad and Halpern, 
2008). The increase in both intra-abdominal and intra-thoracic pressures pushes the air out of 
the lungs. Abdominal muscles may also act as an accessory muscle set in the inspiratory phase, 
to further support the elastic recoil of the chest wall (Hamid, Shannon and Martin, 2005). 
 
2.4.2 External Respiration 
External respiration involves the exchange of gases between the air that fills the alveoli and 
blood in the capillaries that surround the walls of the alveoli. Air from the atmosphere entering 
the lungs has a higher partial pressure of oxygen and a relatively lower partial pressure of carbon 
dioxide than the blood found in the capillaries. This difference in partial pressure makes the 
gases diffuse passively from high to low pressure along their pressure gradient through the 
simple squamous epithelium lining of the alveoli. The net result of the external respiration, 
therefore, is the absorption of oxygen from the air into the blood and the expulsion of the carbon 
dioxide from the blood into the air. The oxygen is then transported to the tissues of the body 
while carbon dioxide is released out of the body during exhalation (Taylor, 2013). 
 
2.4.3 Internal Respiration 
Internal respiration involves the exchange of gases between the blood inside the capillaries and 
the body tissues. In the capillary, blood consists of higher partial pressure and a relatively lower 
pressure of carbon dioxide than the tissues it passes through. This means that the resulting 
partial pressure difference results in the diffusion of gases from high to low pressure along their 
pressure gradients, and this often happens through the endothelium lining of the capillaries. The 
net result of the internal respiration is, therefore, the diffusion of oxygen into the body tissues 
and the removal of carbon dioxide in the blood (Beachey, 2018). 
2.4.4 Transportation of Gases 
There are two major respiratory gases, they are, oxygen and carbon dioxide, and both of them 
are transported by blood through the body. Blood plasma is able to transport some of the 
dissolved oxygen and carbon dioxide, although a bigger percentage of the gases transported 
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within the blood are usually bonded to transport molecules. One of the most important transport 
molecules is the Hemoglobin that is found in the red blood cells that carry nearly ninety-nine 
percent (99%) of the oxygen in the blood. A small quantity of carbon dioxide can also be carried 
by the Hemoglobin from the tissues back to the lungs. The carbonic anhydrase enzyme always 
catalyses a reaction between water and the existing carbon dioxide to form carbonic acid 
whenever there is a high partial pressure of the carbon dioxide in tissues. Carbonic acid then 
dissociates to form hydrogen ion and bicarbonate ion. The low partial pressure of carbon 
dioxide in the lungs leads to the reverse reaction, and carbon dioxide is, therefore, liberated into 
the lungs to be exhaled (Taylor, 2013). 
 
2.4.5 Homeostatic Control of Respiration 
The body, under normal resting conditions, maintains a quiet breathing rate as well as depth 
which are referred to as Eupnoea (tidal breathing). Eupnoea is always maintained until there is 
a demand for oxygen by the body and the production of carbon dioxide rises as a result of 
greater exertion. The partial pressures of oxygen and carbon dioxide in the blood are monitored 
by autonomic chemoreceptors in the body which then send signals to the respiratory centre of 
the brain stem. The respiratory centre eventually adjusts the rate as well as the depth of 
breathing to return the blood to its usual levels of partial gas pressures (Beachey, 2018). 
 
2.5 Respiratory Disease in Childhood 
According to the British Thoracic Society statistics in 2006, respiratory disease is the most 
common reason for both acute and chronic illness in children in the United Kingdom, covering 
14% of all hospital consultant appointments and 42% of all inpatient admissions (BTS, 2006). 
Although most of the acute episodes of respiratory illness resolve spontaneously and do not 
have a long-lasting effect (Bush and Thomson, 2007), chronic disease place a significant burden 
on healthcare systems worldwide and causes significant morbidity and mortality. It is also well 
known that most of the burden of disease in later life has its origin in childhood (Piippo-
Savolainen et al., 2004; Pittman et al., 2011).  
 
2.5.1 Childhood Asthma 
Asthma is the most prevalent chronic ailment in childhood according to the World Health 
Organization, and the leading cause of morbidity among chronic diseases in this group 
(Pedersen et al., 2011). Asthma causes a significant burden on healthcare systems 
internationally, and the prevalence and incidence of asthma are growing worldwide (Bateman 
et al., 2008; Nunes, Pereira and Morais, 2017). 
Chronic inflammation of the airways and increasing activity of the smooth muscles surrounding 
them indicate asthma, causing the lining of the airways (epithelial) to swell and secrete more 
mucus. Consequently, the air becomes difficult to move in and out of the lungs. Asthma most 
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common symptoms are wheezing, coughing, shortness of breath and, in some cases, chest 
tightness. 
 
Figure 2-2. Normal Airway vs an airway with asthma 
(Nationwide Children’s Hospital, 2018). 
Asthma type, severity or frequency of symptoms have no standard definition (Papadopoulos et 
al., 2012), but among all definitions, many symptoms are in common mainly wheeze, cough, 
chest tightness and breathlessness, in addition to airflow obstruction and hyperresponsiveness 
(Monitoring, 2008; Pedersen et al., 2011; Turner et al., 2011). 
Clinical history obtained from the patient is used to confirm the diagnosis, lung function tests 
are then used to determine the severity of asthma, which could be used in school-age children. 
In younger children, clinical history provided by the parents is used to describe the symptoms 
which is a subjective method of information acquisition, this makes identification of the 
symptoms accurately hard to obtain in younger children, clinical observation is then used to 
confirm the diagnosis (Castro-Rodriguez, Rodriguez-Martinez and Custovic, 2012). 
An objective assessment of lung function is needed to identify airflow obstruction. Spirometer 
and peak expiratory flow are conventional techniques used in identifying airflow obstruction, 
its severity and response to treatments, but those techniques are used with children over five 
years of age (Spycher et al., 2008). Although there exist some guidelines suggesting the use of 
a spirometer to obtain objective measures from children below five (Pedersen et al., 2011; 
Turner et al., 2011), this age group is usually considered unsuitable for this test (Tidy, 2016).  
The history of wheeze episodes and the accompanying symptoms are considered as the basis 
for asthma diagnosis in children. Taking the family history of asthma into consideration further 
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support the possibility of the child having asthma. Various treatments are then tried to confirm 
the diagnosis, which may result in a late accurate-treatment for a child with asthma, and a non-
needed exposure of a treatment to a non-asthmatic child (Papadopoulos et al., 2012).  
 
2.5.2 Pre-school wheeze 
Pres-school wheeze is defined as whistling sounds happening in the inspiratory or expiratory 
parts of breathing due to increased work of breathing; it is also divided into two types: episodic 
viral and multiple trigger, depending on the symptoms and child’s history; identifying the type 
is then used to direct the treatment. The episodic viral type happens in the existence of a viral 
infection only, whereas the multiple trigger type is caused by triggers such as environmental 
allergies, tobacco smoke and exercise (Brand et al., 2008; Bush, Grigg and Saglani, 2014). One 
of the limitations of this classification is that there is not enough evidence that both types are 
pathologically different, this could be reasoned to the absence of an objective measure of 
pulmonary function in this young age group (Schultz et al., 2010; Castro-Rodriguez, 
Rodriguez-Martinez and Custovic, 2012).  
In this thesis ‘wheeze’ will refer to both types of pre-school wheeze. 
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2.5.3 Acute Viral Bronchiolitis (AVB) 
Acute Viral Bronchiolitis is an infection affecting the lower respiratory tract, which usually 
affects infants and young children (Green et al., 2016). AVB is common in winter and is usually 
caused by the respiratory syncytial virus (RSV) (Moodley et al., 2010). Almost 70% of all 
infants have had an RSV infection in their first year of life (Glezen et al., 1986), Although many 
bronchiolitis infections disappear without a treatment being necessary, symptoms can develop.  
Moreover, in 2-3% of primary infections, they result in admission to hospital for assessment 
and possibly for specific treatment (Deshpande and Northern, 2003; Hall et al., 2009). 
In England, hospital admissions of bronchiolitis have increased in the past three decades and 
are higher than estimates from similar industrialised countries. In 2011 259,044 infants less 
than 1 year of age were admitted to hospital because of bronchiolitis, which places a 
considerable strain on hospital resources especially during winter season. The high number of 
emergency admissions and the lack of universal preventive measures shines a light on the 
importance of controlling bronchiolitis (Green et al., 2016). There is also a reported relationship 
between early bronchiolitis in infancy and a higher chance of developing wheeze and asthma 
later in life (Sigurs et al., 2010; Blanken et al., 2013; Régnier and Huels, 2013).  
Coughing, wheezing and increased work of breathing are common symptoms of bronchiolitis, 
and there is insufficient evidence on the best treatment to use with infants with bronchiolitis, 
but providing patients with oxygen and fluids is the cornerstone of the therapy used currently. 
Conventionally, oxygen saturation is measured in AVB infants to monitor the progression of 
the condition and the response to treatment (NICE, 2015). 
Thoracoabdominal asynchrony (TAA) occurs in infants with acute and chronic lower airway 
obstruction such as bronchiolitis with the degree of asynchrony associated with the degree of 
the abnormality of pulmonary resistance and elastance (Rome et al., 1987; Allen et al., 1990). 
The quantification of TAA could be a promising approach in classifying the severity of the 
AVB. SLP could be used as an objective measure of the increased work of breathing and 
respiratory load even when a normal oxygen saturation levels exist (Allen et al., 1990). 
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2.5.4 Pathophysiological alterations in obstructive lung disease  
Obstructive lung diseases affect the respiratory system in different ways, but they have 
physiological features in common such as airway narrowing which occurs at different levels 
within the airway tree as a result of hyperactivity of smooth muscles or excessive secretion of 
mucous (Kim et al., 2007). In around 90% of asthma cases airway obstruction happens in large 
airways (internal diameter >2mm), which are above the 8th generation of the airways (Burgel 
et al., 2009; Thien, 2013), while in acute viral bronchiolitis (AVB) lower respiratory tract is 
mainly affected (Webb et al., 1985), obstruction in distal airways may cause their collapse in 
the expiratory phase of breathing, this can result in gas trapping or so-called hyperinflation, 
which is expressed as a high volume of air staying in the lungs at the end of breathing cycles. 
Gas trapping was also detected in acute exacerbation of respiratory conditions even with the 
absence of severe airflow obstruction (Muller, Bryan and Zamel, 1980). Hyperinflation 
introduces elastic load on the respiratory muscles, because of the excessive stretching of lung 
tissues caused by the increased residual lung volume (Moxham and Jolley, 2009). An increase 
in end-expiratory lung volume can result in a reduction in the mechanical advantage of the 
diaphragm which is referred to as the mechanical disadvantage of the diaphragm (Troyer, 1988; 
Decramer, 1997). 
The level of expiratory airflow obstruction in medium and severe airways obstruction might 
cause a change in respiratory pattern, as the expiratory will be driven by the active contraction 
of expiratory muscles rather than the elastic recoil of the lung and chest wall, causing an 
increased load on respiratory muscles (MacBean, 2014). 
There are various methods to quantify respiratory muscles load. Conventional lung function 
techniques could be used to assess only a specific side of the load on the respiratory system 
caused by a respiratory condition. Spirometry, for instance, is used to quantify the degree of 
airflow obstruction using forced expiratory manoeuvres, whereas body plethysmography is 
used to measure functional residual capacity in lung hyperinflation. These measures do not 
provide a full perception of disease pathology (MacBean, 2014). Measuring pressures created 
by the respiratory system to initiate ventilation is used to quantify respiratory load. Intrathoracic 
and intra-abdominal pressures are quantified using invasive techniques such as catheterisation. 
Inter-abdominal pressure is then subtracted from Intrathoracic pressure to quantify the pressure 
produced by the diaphragm. Load on the respiratory system is then estimated by taking the peak 
or the mean value of the diaphragmatic pressure during breathing (Gaultier and Gallego, 2005). 
The work of breathing is the time integral of the diaphragmatic pressure and could be quantified 
to estimate respiratory load. 
During tidal breathing in healthy people, changes in pressures produced by the respiratory 
muscles yield an efficient airflow (ventilation). In airways obstruction, this pressure - airflow 
relation is influenced because of gas trapping, which results in a positive resting intrathoracic 
pressure post-expiration. To account for this pressure changes are measured from the baseline 
when considering the peak value or the time integration of the pressure (MacBean, 2014). 
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2.6 Measures of the Lung Functions 
An accurate diagnosis and monitoring of respiratory disease is required for optimal 
management of the respiratory condition; this requires an accurate evaluation of lung functions. 
Early diagnosis and treatment in childhood are linked to an improved outcome in later life (Grol 
et al., 1999; Rasmussen et al., 2002; Davies and Alton, 2009). Most of the pharmacological 
treatments used in lung diseases have side effects. Therefore, an inaccurate treatment or an 
overtreatment should be prevented (Douglas et al., 2008). Chronic respiratory diseases place a 
significant burden on patients and their families, which further support the importance of 
making accurate treatment decisions. 
Conventional measures of pulmonary function such as spirometry require the patient to perform 
forced manoeuvres and are therefore unsuitable for use in younger age groups. Even in older 
age groups, a full understanding of the complex manoeuvres and cooperation are required. 
These tests also assess specific aspects of respiratory function and may, therefore, 
underestimate the full effect of the variety of pathophysiological changes. Distal airways 
collapse, airway narrowing and changes in respiratory pattern cause an increase in respiratory 
load and affect the capability of respiratory muscles to adapt to this increase (MacBean, 2014). 
Clinical assessment by a physician plays a vital role in diagnosing lung disease, especially in 
younger age groups where objective measures are difficult to obtain. The clinical assessment 
could be used to detect airflow obstruction, but it cannot be used to measure its severity (Shim 
and Williams, 1980; Russell et al., 1986). Acute exacerbations resulted from an inaccurate 
assessment of the severity of the obstruction (Baker et al., 2000; Davenport and Kifle, 2001), 
which further emphasises the need of a comprehensive, objective measure in order to provide 
an optimal management of the condition. 
  
2.6.1 Spirometry 
A spirometer is a device which is used to measure timed exhaled and inhaled volumes, which 
is then used to calculate the effectiveness and the speed with which the lungs can be filled and 
emptied. Spirometry is considered the gold standard in pulmonary function assessment (Johns 
and Pierce, 2007). 
Forced Vital Capacity (FVC), and the forced expired volume in one second (FEV1) are the 
main parameters looked at clinically (Figure 2-3). Some other parameters are looked at for 
research purposes but are not used clinically (MacBean, 2014). Measurement of flow can 
alternatively either be absolutely made or as a function of volume and, consequently, leading 
to Flow-volume curve as shown in Figure 2-4. The shape of Flow-volume loop is shown to be 
reproducible for subjects. However, the shape changes in the presence of a respiratory condition 
(Johns and Pierce, 2007).  
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Figure 2-3. Forced expired volume in one second (FEV1) and forced vital capacity (FVC), displayed 
on a spirometry output. 
 
Figure 2-4. Maximal expiratory and inspiratory flow-volume loop 
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Although Spirometry is considered the gold standard to identify and evaluate the severity of 
various lung diseases, it has a few restrictions. One of the main limitations appears in the young 
paediatric population, who are not able to cooperate enough to perform the assessment 
procedure. Obtaining reliable outputs is usually not possible below the age of five years, 
although a few authors have shown the possibility to perform spirometry in younger children, 
through proper training and encouragement (Crenesse et al., 2001), this is not always possible 
in clinical settings (Bush and Davies, 2005). 
For these reasons, national and international guidelines do not recommend spirometer as a tool 
to direct the treatment of children below five years of age (Flume et al., 2007; Douglas et al., 
2008; Pedersen et al., 2011). 
Respiratory conditions are usually accompanied by different symptoms such as breathlessness, 
cough and fatigue, which might influence patient’s ability to perform the forced manoeuvres 
required for the test (Cooper et al., 1990; Miller, Hankinson, et al., 2005). Furthermore, the 
normal variability of spirometry-test outcomes could reach up to 20%, which might even 
increase in the presence of airway obstruction (Cooper et al., 1990), such variability can affect 
the accuracy of the outcomes and the diagnostic decisions (Cotes, Chinn and Miller, 2009). 
Flow-Sensing Spirometers are among the range of new portable spirometers which have been 
developed over recent years due to advances in the electronics as well as the microprocessor 
technology Figure (2-5).  
 
Figure 2-5. A flow-based spirometer 
(Clinicalgate, 2015) 
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Generally, flow spirometers measure flow using a sensor as a primary signal, and then the 
volume is estimated by integrating the flow signal versus time (Johns and Pierce, 2007). 
The advantages of flow spirometers, that have led to their popularity, are that they are portable, 
easy to use and maintain (in terms of cleaning as well as disinfection), and that a wide range of 
ventilatory indices can be calculated automatically. In addition, flow spirometers can provide 
instant readings, store patient results with feedback on the data quality and can provide 
reference ranges expected for the patents (Johns and Pierce, 2007). 
Flow spirometers are associated with few limitations such as firstly, their regular calibration 
requirements, and appropriate correction to conditions of body temperature and pressure 
saturated (BTPS), which suggests that extra care should be taken when using them clinically. 
Secondly, their use is limited to adults who can understand the test procedure and be 
cooperative. 
 
2.6.2 Whole-Body Plethysmography  
The whole-body plethysmograph is made up of a rigid chamber, whose size and shape looks 
like an enclosed telephone booth, whereby the subject sits while breathing through a 
pneumotachograph. Pressure transducers, of different sensitivity, are arranged to measure the 
pressure across the pneumotachograph (flow). It also measures the difference in pressure across 
the wall of the plethysmograph as well as the pressure at the opening of the airway. Variations 
in alveolar pressure (PA) may be inferred from variations in plethysmograph pressure 
(Goldman, Smith and Ulmer, 2005), and this seems to be the main principle of the variable-
pressure plethysmograph. In the plethysmograph, a shutter mechanism is placed close to the 
mouth. To gain transient airway occlusion, this shutter should be closed.  Voluntary respiratory 
efforts are then carried out against the closed shutter, and at the same time, the estimation of 
the change in alveolar pressure (∆PA) is made by recording the resulting change in mouth 
pressure (∆Pm). The mouth pressure Pm (PA) is then plotted against simultaneous 
plethysmographic pressure variations during respiratory efforts against the closed shutter to 
measure the absolute thoracic gas volume (TGV) and airway resistance (Raw)(Goldman, Smith 
and Ulmer, 2005). 
Patients with obstructive lung diseases have a high airway resistance, which may cause air 
trapping in the lung at the end of expiration. Body plethysmograph is used to accurately quantify 
TGA and airways resistance, which can provide a precise description of the severity of the 
obstruction. 
One of the main drawbacks of whole-body plethysmograph is that subjects have to be seated in 
the sealed chamber for several minutes, and they are asked to perform some complex 
manoeuvres, which make it challenging for use in younger children (Vilozni et al., 2009).  
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2.6.3 Measurements of Chest Wall Movement  
Measurement of chest wall motion during tidal breathing may provide valuable information 
about respiratory function and mechanics (Adams et al., 1993). This includes many tradition 
and novel procedures and much research has gone into providing the pros and cons of these 
procedures.  Furthermore, different techniques measure different parameters of the lungs, here 
I focus on chest wall movement, and give practitioners the required information for the patients.  
I will describe some of these techniques, concluding with the reasons behind my choice in using 
SLP for further investigation. For each of the techniques, a comparison with between the 
method and SLP is made, noting the advantages SLP has on each of these methods.  This will 
provide a justification for choosing SLP in this thesis. 
 
2.6.3.1 Introduction 
Whether due to the pathology in the lungs, airways, chest wall or muscles, assessing chest wall 
motion is a basic and important constituent in managing the child with respiratory problems. 
Since the 1960s, clinical assessment has been supplemented with a plethora advanced and ever-
growing technological options for measuring chest wall motion, each with its pros and cons.  
Measurements of chest wall motion has its many advantages (Seddon, 2015).  These include:  
      1. Assess respiratory airflow and volume change, as a non-invasive alternative to 
measurement at the airway opening,  
      2. Monitor breathing over long periods of time, to help identify sleep-disordered breathing 
such as apnoea. 
     3. Identify and quantify patterns of abnormal chest wall movement and compare between 
certain breathing components or regions. 
Measuring chest wall motion can provide practitioners with valuable information that cannot 
be obtained using ordinary respiratory function techniques such as spirometry: it allows 
respiratory airflow to be measured in cases when it is impossible, it also provides information 
about the movement of different chest wall parts to produce that airflow (Seddon, 2015).  
The interest in measuring chest wall motion includes various and overlapping reasons.  Firstly, 
it is to enable the measurement of tidal volume and respiratory airflow pattern. Secondly it is 
to monitor breathing and identify central and obstructive sleeping problems over long periods 
of time. Thirdly, it enables the quantification of the degree of asynchrony between chest and 
abdominal respiratory motion as a possible measure of upper or lower airway obstruction. 
Fourthly, it enables the characterization of patterns of pathological chest wall movement in 
chest wall or neuromuscular disease.  Finally, it is to assess changes in end-expiratory lung 
volume (Seddon, 2015). The mathematical analysis of measuring chest wall motion was first 
achieved by Konno and Mead in which they demonstrated that it was possible to predict volume 
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changes (measured by spirometer) reasonably accurately in healthy adult subjects by measuring 
changes in the Anteroposterior (A-P) diameter of RC and AB (Konno and Mead, 1967). Since 
Konno and Mead's seminal article, a wide variety of measurement methods have been 
employed, classified in the following table. 
Table 2-1 Methods Used for chest wall motion measurements  
Methods use Methods measure 
Physical devices placed on 
the chest wall 
a) a) linear displacement along the AP axis (eg using 
magnetometers or accelerometers) 
b) b) changes in chest wall circumference, either physically 
(strain gauges) or by its effect on thoracic impedance 
(impedance pneumography) 
c) c) changes in cross-sectional area (respiratory inductive 
plethysmography) 
d) d) changes in volume (electromagnetic inductive 
plethysmography) 
External imaging devices a) Radiological techniques 
b) Optical techniques 
 
The basis of these techniques and their advantages and limitations will be reviewed and 
compared in this section. 
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2.6.3.2 Physical devices on the chest wall 
a) Linear displacement along the AP axis 
To measure an increase in AP diameter of RC and AB, linear displacement is quantified 
utilising a more sophisticated electronic versions in comparison to the Konno and Mead’s 
method. Here, the advantages include its increasing miniaturisation, the cheapness of device, 
use in other devices such as mobile phone, simple and portable, and the fact that it has been 
used extensively in research with adults as well as early young patients. However, as with many 
devices, they have disadvantages with the biggest being that there is a continuous assumption 
that changes in one dimension, at two points along the chest wall (usually nipple and umbilicus 
level), are a precise reflection of changes in the volume of a complex 3D structure. The 
relationship between linear displacement and volume change varies across subjects, even if 
healthy adults, and the methods become less reliable when there is a greater the degree of chest 
wall distortion (Heldt, 1988; Reich and McHenry, 1990; Russell and Helms, 1994). Linear 
measurement techniques are insufficient for estimating respiratory volumes in children. 
However, they are adequate for estimating respiratory rate.  An example of such a method,  
using three accelerometers has been shown in adults to precisely measure tPTEF/tE (Dehkordi 
et al., 2014). Other methods such as ultrasound signal transmission have been employed which 
are more sophisticated methods that measure the linear movement of different areas of the chest 
wall; this  can be placed on the chest wall to an external receiver, and this has been used 
successfully to assess differential chest wall movement in scoliosis (Kotani et al., 2002). Laser 
displacement sensors have also been used to measure RC and AB movement (Hargrove, 
Zemper and Jannausch, 2009). 
 
Figure 2-6 The device developed by Konno and Mead to measure chest and abdominal wall 
displacements 
 (Konno and Mead, 1967). 
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b) Measuring changes in chest wall circumference  
Strain gauges utilise changes in electrical conductance of fine bands which encircle the RC and 
AB. The expansion of the chest wall increases the circumference, stretching the band and 
increasing the resistance to a low electrical voltage (Adams et al., 1993). There is a similar 
technique which measures the delay between ultrasound emission and reception at opposite 
ends of two rubber tubes encircling RC and AB (Lafortuna and Passerini, 1995). This technique 
has been effective in measuring and estimating tidal volumes during exercise in healthy adults 
but has yet to show its use in children. Fibre optic respiratory plethysmography is another 
approach that utilises light transmission through fibre-optic bands to measure changes in 
curvature (Davis et al., 1999). Both of these techniques are more effective methods in predicting 
volume change than linear measurements. However, their limitations remain in the assumptions 
that not only the cross-sectional shape remains constant but also that the measurements at one 
level for RC and one for AB represent changes at all levels.  These limitations may be inaccurate 
in young infants, with either chest wall/neuromuscular disease or other severe respiratory 
disease. Although strain gauges have been used in some sleep monitoring systems, they have 
mainly been substituted by respiratory inductive plethysmography (RIP) (Figure). Through 
measuring the changes in electrical impedance, impedance pneumography examines changes 
in circumference of the chest wall to a very weak alternating current.  This is often transmitted 
between ECG electrodes and is with respect to intensive care units; widely used to give a 
respiratory trace on multi-channel monitors. However, its main use is for respiratory rate and 
apnoea, as it only assesses changes in partial circumference.  The other reason for this is because 
of the commonness in the random fluctuations in amplitude. Hence, It does not detect 
obstructive apnoea (Brouillette et al., 1987).  
 
c) Measuring changes in cross-sectional area (respiratory inductive plethysmography)  
Respiratory inductive plethysmography (RIP) uses sinusoidally-arranged wires.  These wires, 
carrying a low-voltage oscillating current, are incorporated in cloth bands which encircle the 
chest and abdomen approximately at nipple and umbilicus level Figure 2-7. The current in each 
segment of the band affects the current in other segments, having a rippled effect, best known 
as self-inductance. When the cross-sectional area enclosed by the band is changed, there is a 
change in self-inductance, causing the frequency to change too. These are demodulated to yield 
a voltage change which is proportional to the change in the cross-sectional area (Stocks, 1996). 
RIP has the potentiality to accurately estimate tidal volumes, in comparison with linear and 
circumference chest wall measurements (Adams et al., 1993). RIP advantages further include 
that it is able to calibrate fully using direct flow measurements at the airway opening, semi 
quantitaively using qualitative diagnostic calibration or uncalibrated (Sackner et al., 1989). 
However, the theory of the matter is not accurate when looking at how practical it is; fully 
calibrated RIP can theoretically be used to measure tidal and minute volumes non-invasively, 
while the need for calibration using flow at the airway opening practically makes this less 
beneficial, and calibration carried out in different conditions vary.  For example, the calibration 
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may be invalid when in quiet sleep in comparison to active sleep due to the changes in RC-AB 
relative contribution and chest wall distortion (Warren and Alderson, 1986). Nevertheless, both 
semi-calibrated and uncalibrated RIP has been extensively used in research and in clinical 
practice. Examples include: 
- In polysomnography to detect and differentiate central and obstructive apnoeas 
(Brouillette et al., 1987). 
- In acute and chronic respiratory disease to estimate thoracoabdominal asynchrony 
(TAA).  
To measure tidal flow timing parameters, uncalibrated RIP has also been used. An example is 
the time to peak tidal expiratory flow over total expiratory time (tPTEF/tE) (Stick et al., 1992). 
However, questions about the accuracy of these parameters compared to direct flow 
measurement at the airway opening remain (Jackson et al., 1995). 
 
D) Measuring changes in volume 
A relatively new technique, Electromagnetic inductive plethysmography (EIP) employs the 
following components: 
1) Two helical coils, with each carrying a weak electrical current, sewn into a single elasticated 
fabric garment; each surrounding the entire RC and AB components of the chest wall. 
 2) A magnetic moment detector. This is suspended horizontally above the cot or bed, producing 
a weak homogeneous magnetic field around the two coils (Figure).  
 
Figure 2-7 Respiratory inductance plethysmography, band are used to measure change in the cross-
sectional area enclosed by the bands  
(Stocks, 1996). 
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Figure 2-8 Electromagnetic inductive plethysmography. Upper shows a single coil representation of 
the device and lower shows a vest (containing the RC and B coils) placed on a new born infant  
(Seddon, 2015). 
The volumes changes contained within the two coils yield proportional changes in 
electromagnetic inductance of the system (Sartene et al., 1990). Using a calibration coil placed 
under the magnetic moment detector, the device can be calibrated off the patient. Mainly used 
for infants, EIP studies have involved healthy term newborns (Olden, Symes and Seddon, 2010; 
Petrus et al., 2015; Drakatos et al., 2016), preterm infants with lung disease (Williams et al., 
2011; Pickerd, Williams and Kotecha, 2013), and infants with lung disease (Olden, Symes and 
Seddon, 2010; Petrus et al., 2015).  These studies have shown that EIP can accurately be used 
to estimate tidal volume compared to flowmeter or pneumotach. With respect to tidal breathing 
parameters including tPTEF/tE, studies found a very close correspondence between EIP and 
airflow measurements . With respect to the measurment of TAA, RC and AB volume changes 
can be partitioned, and phase angle measurements have been reported in preterm infants.  
However, this technique has so far not been compared with TAA assessment using RIP. RIP 
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has the advantage over the other techniques that it allows a quantitative measurements of 
volume change without calibration on the child (e.g. with facemask and pneumotach). This is 
because the volume changes are measured over the whole chest wall, which makes this 
technique less susceptible to inaccuracy caused by the distortion of the chest wall, though this 
has not been practically proved. The need for a vest-type garment covering the whole torso 
remains a disadvantage, and this could be problematic in intensive care environments. 
 
2.6.3.3 Methods using external imaging devices  
a) Radiological techniques  
Magnetic resonance imaging (MRI), a widely used effective technique, has been used to 
examine detailed aspects of chest wall motion in adults or adolescents.  This has been used 
during: 
1) Slow deep or tidal breathing (Kondo et al., 2000; Kotani et al., 2004; Herrmann et al., 
2006; Tokuda et al., 2009). A study showed good correlation between changes in MRI 
cross-sectional area and in lung volume (Kondo et al., 2000), but tidal breathing has 
been more problematic (Tokuda et al., 2009). 
2) During breath-holds in deep breathing (Raichura et al., 2001; Chu et al., 2006).  
These techniques give comprehensive evidence about regional chest wall motion and have 
provided interesting data about the behaviour of the chest wall during breathing in pectus 
excavatum (Raichura et al., 2001; Herrmann et al., 2006) and scoliosis (Kotani et al., 2004).  
However, this technique is limited; as it requires prolonged periods in which young and sick 
children need to be inside a scanner, and with the need of cooperative, controlled breathing, and 
the difficulty with rapid respiratory rates and small volumes, the disadvantages of MRI has been 
noted. 
 
b) Optical techniques  
By capturing a dynamic sequence of video images of the anterior surface of the chest and 
abdomen, Optoelectronic plethysmography (OEP) uses complex signal processing to calculate 
the changes in the volume of the chest wall (Morgan, Gourlay and Denison, 1984; Ferrigno et 
al., 1994). To enable the signal processing, either a geometric pattern is projected onto the chest 
wall (Morgan, Gourlay and Denison, 1984), or markers are positioned on the chest wall 
(Ferrigno et al., 1994) Figure 2-9. Reasonable correspondence has been shown in adults with 
spirometric measurement of lung volume changes (Morgan, Gourlay and Denison, 1984), and 
more recently OEP and pneumotach measurements of tidal volume in stable neonates have 
shown good agreement (Dellaca et al., 2010). OEP has been used to investigate chest wall 
movement in tetraplegic adults (Morgan et al., 1985). An advantage of OEP is that it is a non-
invasive technique with considerable potential in young children. However, patients need to 
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remain still in order for measurements to be taken and this is at time problematic. Moreover, 
this technique is time-consuming and require equipped laboratories to perform the 
measurements. 
 
 
Figure 2-9 Optoelectronic plethysmography  
(Dellaca et al., 2010) 
 
 
2.7  Summary  
Childhood respiratory disorders place a significant burden on healthcare systems nationally and 
worldwide. Conventional objective measures of pulmonary functions allow accurate diagnosis 
and monitoring of respiratory disorders. Available techniques have some drawbacks such as 
inability to provide a complete image of the pathophysiological changes of lung disease, in 
addition to that, they are unsuitable for all ages and clinical conditions. 
After reviewing these methods, how they work, their advantages and disadvantages, it is 
important to note that what SLP does to make it more feasible in chest wall measurement is that 
it does not require any physical contact in comparison to the methods mentioned here, making 
it more patient-friendlier and easier for the practitioner to use. As an external imagining device, 
it is rather simple and does not require or need markers; instead, it can be used on the bed side 
in the supine position. Thus it was worthy for further investigation in children for my research. 
SLP is feasible in both healthy subjects and patients with COPD and was able to detect airway 
obstruction in the diseased group (Motamedi-Fakhr, Wilson and Iles, 2017). Further assessment 
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and validation of this technique in young children and infants is needed to assess its value and 
usefulness in paediatric patient groups. Although SLP requires the patient to be in a still 
position, which might be challenging in younger children, it could be, if feasible, used to 
provide an objective measure of pulmonary functions and valuable information about breathing 
mechanics.  
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3 Study Aims 
The purpose of this study is to evaluate the use of SLP in Paediatric respiratory disorders. For 
this purpose, I have constructed two main aims, each with specific objectives in order to achieve 
these aims.  These are: 
Aim 1:  To evaluate the use of SLP in clinical settings, demonstrating its feasibility and 
usefulness in various respiratory conditions at different ages.  
The first objective here is to assess the use of SLP in (1) identifying the existence of airways 
obstruction, and (2) detecting changes, after bronchodilation administration, in airways 
obstruction in children with stable asthma (7-16 years). SLP readings were confirmed by using 
the gold-standard measure (Spirometry). The second objective consisted of comparing SLP-
estimated parameters between (1) healthy and acute asthma/wheeze participants (2-12 years); 
(2) pre and post intervention for the Asthma group. Finally, the last objective aimed to assess 
the feasibility of utilising SLP with a younger population (< 2 years). This part consisted of 
comparing SLP-estimated parameters between: (1) healthy infants and infants with acute viral 
bronchiolitis (AVB); and (2) detecting changes, in the quantified parameters, between 
admission and discharge in the AVB group. 
 
Aim 2: To evaluate the robustness of SLP outcomes against introduced artefacts (upper body 
movements and coughs) that might interfere with its reading. 
The  first objective here is to find the optimal SLP-recording period. The second objective is to 
assess the effects of upper-body movements and coughs on SLP-estimated parameters. Finally, 
the last objective aimed to investigate the use of various signal processing and statistical 
techniques to remove upper-body movements and coughs from SLP signals. 
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4 Structured Light Plethysmography (SLP) 
4.1 Introduction 
Structured light plethysmography is a novel, non-contact technique developed by a group of 
clinicians and engineers to measure tidal breathing (Boer et al., 2010). SLP has shown potential 
clinical uses in various respiratory conditions, for example, it has been used to identify changes 
in chest wall motion in a group of patients with lung resection, a reduced chest wall contribution 
in the overall TA wall movement was observed on the operated side, with the amount of the 
reduction matching the size of the resection. Moreover, a higher thoraco-abdominal asynchrony 
(TAA) increase was identified in patients who had a lobectomy than in patients who had a 
resection (Elshafie et al., 2016). In another feasibility study, SLP has been shown sensitive 
enough to detect differences in tidal breathing patterns between patients with COPD (with a 
range of severities) and healthy individuals (Motamedi-Fakhr, Wilson and Iles, 2017). It is 
believed that respiratory conditions like COPD have an effect on tidal breathing parameters 
(Williams, Madgwick and Morris, 1998; Kostianev, Hristova and Iluchev, 1999; Morris et al., 
2004; Wilkens et al., 2010; Williams et al., 2014), SLP has identified breathing patterns 
differences, which assert its sensitivity in obstructive lung conditions. No evidence has shown 
the feasibility of SLP in young children with obstructive respiratory conditions. 
A study aimed to assess the agreement between tidal breathing parameters, measured 
simultaneously using PNT and SLP for 45 seconds, have shown that the fundamental 
parameters (will be explored later in the chapter) are in agreement. Moreover, the method has 
been proven to be repeatable, even though, SLP measures TA displacement and TA 
displacement-rate rather than flow or volume measurements in PNT (Motamedi‐Fakhr et al., 
2017). 
 
4.2 Tidal Breathing 
Tidal breathing refers to the state of inhalation and exhalation during breathing at rest; its 
patterns can reveal crucial physiological information about both the respiratory control and 
pulmonary mechanical function (Bates et al., 2000).  
In healthy individuals, tidal breathing is maintained within a normal range. Respiratory diseases 
such as asthma and COPD not only change the character, but can also lead to changes in a series 
of patterns of breathing (Olden, Symes and Seddon, 2010)  Thus, in patients with respiratory 
disorders, these alterations help clinicians to identify the underlying cause and establish care 
plans according to the disease.  
By analysing tidal breathing parameters, clinicians can assess the respiratory health status of 
the patient (Seppa, 2013), all of this shines the light onto the importance of investigating tidal 
breathing, especially with little children, who cannot cooperate and perform forced respiratory 
manoeuvres needed for conventional lung function testing.  
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4.2.1 Flow-based tidal breathing parameters 
Tidal breathing parameters are well explained by Stick et al. (1992) and Bates et al.(2000). Of 
flow-based parameters: peak tidal inspiratory flow (PTIF), peak tidal expiratory flow (PTEF), 
and times to reach those values (tPTIF and tPTEF). In addition, Parameters describing Flow-
volume loop’s shape such as: TEF50 (tidal expiratory flow at 50% of tidal volume), TIF50 
(tidal inspiratory flow at 50% of tidal volume) and the ratio between them TIF50/TEF50 which 
is also referred to as IE50 (Black et al., 2004). 
 
4.3 Structured Light Plethysmography - Thora3DiTM 
Thora3DiTM uses computer image and vision processing methodology to estimate tidal 
breathing parameters from the movement of the TA region; it does not require markers to be 
placed onto the body (Boer et al., 2010). Tidal breathing parameters measured using SLP have 
shown good agreement with the parameters measured simultaneously by Pneumotachography 
(Motamedi‐Fakhr et al., 2017). SLP works by having a grid pattern projected onto the TA 
region of a subject, while in a supine or seated position. 
 
 
 
Figure 4-1. A child undergoing an SLP assessment in a seated position 
(PneumaCare, 2013) 
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Figure 4-2. A child undergoing an SLP assessment in a supine position 
(PneumaCare, 2013). 
 
4.3.1 Thora3DiTM Working Principle 
4.3.1.1 Stereo Imaging 
Two cameras which are separated spatially to image a 3-D object are used in stereo imaging as 
shown in Figure 4-3 below. The two cameras are separated by a distance S, with the two optical 
axes in parallel which is the simplest case for the stereo imaging (Hossack, 2006). 
 
 
Figure 4-3. Basic Layout for a Parallel-optical axes Stereo Imaging system  
(Faugeras, 1993). 
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A different view of the same object (a cube in this case) can be obtained from the two cameras 
as shown in Figure 4-4. This will involve shifts in the vertical lines only to extract depth 
information. The system is comparable to a human visual system which involves two eyes 
separated by between 60 to 70 mm so when someone views a 3-D object; each eye will be able 
to see two slightly different views (Faugeras et al., 1993). 
 
 
Figure 4-4. Two stereo Images of a Cube 
(Faugeras et al., 1993) 
 
 
Figure 4-5. Parallel geometry system 
(Hossack, 2006) 
This figure shows a simple stereo imaging system where: 
- The two cameras are aligned with respect to their optical axes so that they are parallel 
to each other. 
- ‘S’ is the distance between both cameras’ optical axes. 
- x0 and x1 are the locations of the image of P on cameras 1 and 2 planes respectively. 
- u is the distance from the lens to the detector plane, and it is assumed to be the same for 
both cameras. 
  
Left Camera         Right Camera 
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Then from triangles similarities: 
 
𝑥1
𝑢
=
X1
𝑣
 Equation 4-1 
      
 
𝑥0
𝑢
=
X0
𝑣
 Equation 4-2 
 
And from the locations of the two images of P:         
 
𝑋1 =
𝑣𝑥1
𝑢
 Equation 4-3 
 
𝑋0 =
𝑣𝑥0
𝑢
 Equation 4-4 
 
Knowing that the optical axes of both cameras are parallel: 
 
𝑋1 = 𝑋0 + 𝑆 Equation 4-5 
 
by substitution we have: 
 
𝑥1 = 𝑥0 +
𝑢𝑆
𝑣
 Equation 4-6 
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Solving for v which is the length of the horizontal line from the point P to the two camera 
lenses: 
 
𝑣 =
𝑢𝑆
(𝑥1 − 𝑥0)
=
𝑢𝑆
∆𝑥
 Equation 4-7 
   
∆𝑥 : is the difference between the two images of P, (𝑥1 − 𝑥0). From the Gaussian lens formula, 
which gives the relation between the focal length of a lens (f), and the position of the object and 
image plans as:  
 
1
𝑓
=  
1
𝑢
+
1
𝑣
 Equation 4-8 
                   
However, in most systems, there is a distant object so that for a short focal length lens, 𝑣 ≫ 𝑢 
and we can assume that  𝑢 ≈ 𝑓, this means that the distance between the lens and detector is 
simply the focal length of the lens, then: 
 
𝑣 ≈
𝑓𝑆
∆𝑥
 Equation 4-9 
                 
And substituting 𝑧 = 𝑢 + 𝑣  from the figure above, we can get the equation representing the 
distance between the image plan and the object as: 
 
𝑧 = 𝑓 (1 +
𝑆
∆𝑥
) Equation 4-10 
              
So, knowing the focal lengths of both cameras and the separation distance between them, we 
can estimate the distance between the object and the image plane, by only calculating ∆𝑥, which 
is the difference between locations of the image of P in cameras 1 and 2. 
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Thora3Di uses the above principle to extract the corner features from the projected grid of light 
on the thoracoabdominal region to build a 3D- reconstruction of the projected area and track it 
over the recording period at a 30Hz frame rate.  
The point of intersection of the grid is defined as the corner shared by four squares. The entire 
grid consists of wgrid × hgrid of these points. 
 
Figure 4-6. Grids identification on a patient’s TA wall. 
 The grid pattern (left). The corners of the squares are ‘grid intersection points’, and there are wgrid×hgrid 
(23 × 28) of these. The grid pattern as projected onto a subject (centre), and after identifying grid 
intersection points (right) (Boer et al., 2010, p.3) 
The two cameras used to record the subject’s chest area are placed at different and known 
positions and angles. The intersection points of the grid pattern are tracked and then brought 
into correspondence. External and internal parameters of the two cameras as well as the 
projector from the subset of point correspondences are inferred by a self-calibration algorithm. 
The 3D-reconstruction of the chest wall is then done by the use of camera calibration. Unwanted 
parts (such as limbs) are then removed as the missing parts are filled. The reconstruction is then 
tracked and used to calculate the breathing trace over the recording period (Boer et al., 2010). 
SLP technology was developed at Cambridge University; it attempts to solve most of the 
drawbacks of the previous methods by introducing a zero-contact and non-invasive method for 
monitoring tidal breathing and extracting lung functions. 
 
4.3.2 Thora3DiTM tidal Breathing Parameters  
PneumaCare's Thora3Di™ enables doctors and surgeons to understand the patient's pulmonary 
function and also to view the effort in the regional segments by measuring the movement of the 
TA wall. Images which are required can be taken even with the patient lying on their bed. The 
machine has the advantage of showing the data of lung function in 3D format. The machine 
builds the 3D reconstruction of the thoraco-abdominal region and allows the division of that 
region in order to see the movements of each part with respect to the other part. 
Quantified tidal breathing parameters could be categorized into three different groups: 
parameters which describe the overall displacement of the thoraco-abdominal region, the ones 
which describe the displacement rate of it, and the parameters which describe the regional 
contribution and temporal movements of different thoraco-abdominal compartments.  
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4.3.2.1 SLP-estimated tidal breathing parameters derived from TA displacement with time 
signals 
The tidal breathing trace is computed by quantifying the averaged axial displacement of each 
intersection of the grid of light projected onto the TA wall. Timing indices such as inspiratory 
time (tI), expiratory time (tE), total breath time (tTot), the ratios between them tI/tE and tI/tTot 
and respiratory rate (RR) are estimated from this trace. These timing indices have shown good 
correlation with those measured using a Pneumotachography (Motamedi‐Fakhr et al., 2017). 
Figure 4-7 (A) shows how the indices are calculated. 
 
4.3.2.2  SLP-estimated tidal breathing parameters derived from TA displacement rate with 
time signals 
Although SLP does not measure flow or volume, SLP tidal breathing flow parameters are 
calculated in the same way as PNT flow-based parameters, where TA displacement is 
considered analogous to volume, and TA displacement rate analogous to flow, and is calculated 
by taking the first time derivative of the TA displacement trace. By plotting TA displacement 
vs. time the following parameters can be derived: peak tidal inspiratory flow (PTIFSLP), peak 
tidal expiratory flow (PTEFSLP), and time taken to reach these points (tPTIFSLP and tPTEFSLP) 
respectively Figure 4-7 (B). To correct for different respiratory rates, the latest parameters were 
normalised against total inspiratory and expiratory time (tPTIFSLP/tI and tPTEFSLP/tE). 
 
4.3.2.3 Parameters that describe the shape of the displacement loop 
The loop produced by plotting TA displacement against TA displacement rate is considered 
comparable with a conventional Flow-Volume loop (H. Hmeidi et al., 2017). 
Many parameters were used to describe the shape of both the inspiratory and the expiratory 
parts of this loop: tidal inspiratory TA displacement rate at 50% of inspiratory displacement 
(TIF50SLP), and tidal expiratory TA displacement rate at 50% of expiratory displacement 
(TEF50SLP) respectively Figure 4-7 (C).  
IE50SLP (inspiratory to expiratory TA displacement rate ratio), which is the ratio between 
TIF50SLP and TEF50SLP could also be calculated (Black et al., 2004). SLP validation study has 
shown a good agreement between IE50SLP and IE50 measured simultaneously by 
Pneumotachography (Motamedi‐Fakhr et al., 2017). 
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Figure 4-7. SLP-traces of tidal breathing and the derived parameters. 
(A)Timing indices. (B) TA displacement rate-derived parameters. (C) TA displacement rate with TA 
displacement-derived parameters (Hmeidi et al., 2017, p.3) 
 
4.3.2.4 SLP assessment of regional tidal breathing parameters 
The TA region could be split into different compartments such as Thorax/Abdomen, Left/Right 
or even quadrants: Upper Left (UL), Upper Right (UR), Lower Left (LL) and Lower Right 
(LR). 
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Figure 4-8. The anterior TA wall split into two sections, 
One representing the thorax and the other the abdomen. The axial displacements of the thorax and 
abdomen are averaged to produce the overall TA wall displacement (Motamedi-Fakhr, Wilson and 
Iles, 2017, p.3).(Motamedi-Fakhr, Wilson and Iles, 2017)(Motamedi-Fakhr, Wilson and Iles, 
2017)(Motamedi-Fakhr, Wilson and Iles, 2017)(Motamedi-Fakhr, Wilson and Iles, 2017)(Motamedi-
Fakhr, Wilson and Iles, 2017)(Motamedi-Fakhr, Wilson and Iles, 2017)(Motamedi-Fakhr, Wilson and 
Iles, 2017) 
The relative contributions of any compartment are calculated as a percentage of the total 
displacement. Figure 14 below shows total TA displacement and its thoracic and abdominal 
components for a single breath. To obtain the relative thoracic contribution for the shown 
breath, the peak of ribcage displacement (the dashed line b) is divided by the peak of TA 
displacement (dashed line a), similarly dividing peak abdominal displacement (dashed line c) 
by the peak of TA displacement (dashed line a) provide the relative abdominal contribution.   
 
Figure 4-9. Thoracic and abdominal components of one breath as calculated using SLP  
 
(Hmeidi et al., 2017, p.3). 
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Konno-Mead Loop 
Konno-Mead loop shows the relationship between Chest and Abdominal contributions in the 
overall movement. It shows the percentage of chest movements versus percentage abdomen 
movements or the percentage left movements versus percentage right movements (Warren, 
Horan and Robertson, 1997). 
Phase Angle 
The phase describes the time lag in movement between one TA region with respect to another. 
A phase lag of zero degrees means a full unison or synchrony between both the regions. If the 
movement of one region lags behind the movement of the other, then those regions are 
considered asynchronous.  
 
 
Figure 4-10. A representation of Konno and Mead method of quantifying thoracoabdominal asynchrony 
for a single breath. 
An example. From left to right the figures show -90°,-45°, 0°, 45°, and 90° phase shifts between the 
ribcage and abdomen signals. The direction of the Konno–Mead loop determines which signal is lagging 
behind or leading the other (Hmeidi et al., 2017, p.4). 
Phase is quantified by plotting the displacement of both regions against each other (Konno-
Mead Loop) and then calculating the magnitude of asynchrony using the shape of this plot 
(Konno and Mead, 1967). Phase usually represent only thoracoabdominal asynchrony (TAA). 
However, the asynchrony between left and right compartments could be assessed with SLP. 
Phase is quantified in degrees using the following equation: 
phase = TAA =  sin−1 (
m
s
) Equation 4-11 
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where: 𝑚 is the width of the Konno-Mead loop at 50% of ribcage displacement, and 𝑠 is the 
range of abdominal displacement Figure 4-11. 
 
 
Figure 4-11. A single breath representation using Konno-Mead approach. 
m is the width of the loop at 50% of ribcage displacement, and s is the range of the abdominal 
displacement (Hmeidi et al., 2017, p.4). 
SLP data is usually acquired for up to five minutes which allows the acquisition of many 
breaths. Previously mentioned parameters are calculated for every single breath, median value 
is calculated for each parameter to estimate its magnitude. Median is preferred over the mean 
because of its stability in the presence of outliers. 
 
4.3.2.5 Variability in SLP tidal breathing parameter 
Each tidal breathing parameter shows an amount of within-subject variability. SLP allows the 
quantification of this variability, as data is acquired for many successive breaths, each 
parameter is quantified for every single breath, then the variability is obtained over the recorded 
period. The interquartile range (IQR) was used for this purpose, because of its robustness in the 
presence of outliers unlike the standard deviation (H. Hmeidi et al., 2017).  
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4.3.3 Thora3DiTM Software and Data Analysis 
PneumaView-3D™ software (PneumaCare, Ltd.) allows the movement of the reconstructed 
TA surface to be viewed as a video. The assessment of the movement of this surface is an 
important step as it may identify subtle tracking errors that are not obvious in the TA 
displacement-time trace. 
These tracking errors can be due to excessive wrinkling of the white T-shirt or by a lack of 
contrast in the projected grid (which could be caused by unsuitable lighting in the room). This 
can cause either flickering or missing of some points in the reconstructed surface. 
Subject movement or coughing is another kind of artefact which might occur during the 
recording. A sudden movement of the reconstructed surface from its trajectory can be used to 
identify these artefacts and exclude them later from the analysis.  
Datasets are excluded from the analysis if >50% of their respiratory cycles were affected by 
one or more of the above artefacts. Accepted datasets are exported by the PneumaView3D 
software. The exported data included information on the overall TA wall movement, as well as 
regional movements. A breath detection algorithm was used, which was developed, based on 
the work explained by Bates et al. (2000) and Schmidt et al. (1998), by identifying the peaks 
and troughs of the signal using a zero-crossing of the first-time derivative of the overall 
displacement signal. Finally, for the cycle to be considered as a breath, its peak-to-peak 
amplitude should be > 25% of the median peak-to-peak amplitude of the entire breaths in the 
signal.  
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5  Tidal breathing parameters in healthy children 
and those with stable asthma 
 
 
 
 
 
 
 
 
 
The work reported in this chapter has been published in Physiological Reports ISSN 2051-
817X, with the title “Tidal breathing parameters measured using structured light 
plethysmography in healthy children and those with asthma before and after bronchodilator” 
by (Hmeidi et al., 2017). Permission was obtained from the publisher to reuse relevant aspects 
of this work in this thesis (i.e. figures, plots and tables). 
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5.1 Introduction 
Asthma is the most common chronic disease in childhood, and one of the main causes of 
morbidity among other chronic diseases in children (Pedersen et al., 2011). According to 
Asthma UK, one in every 11 children is diagnosed with asthma, and 185 people are hospitalised 
daily because of asthma attacks (most of those admissions are for children). Asthma causes a 
significant burden on the healthcare systems in the UK and worldwide (Bateman et al., 2008; 
Nunes, Pereira and Morais, 2017). Lung function assessment is required in order to diagnose 
asthma accurately and provide optimal management of the condition (Brusasco, Crapo and 
Viegi, 2005; Miller, Crapo, et al., 2005; National Heart Lung, Institute and others, 2007; 
Wijngaart, Roukema and Merkus, 2015). Spirometry is the technique used clinically to assess 
lung functions, but it is not suitable for all ages due to the nature of the test (Beydon et al., 
2007). In young children obtaining objective measures of airways obstruction might improve 
their care, thus investigating the use of new simpler techniques is essential. 
Tidal breathing measurements can provide valuable information about respiratory function and 
mechanics (Bates et al., 2000). On their own, many tidal breathing parameters have been shown 
the ability to diagnose several lung conditions (Bates et al., 2000). Tidal breathing reveals some 
important physiological indications relating to pulmonary mechanics and respiration control 
mechanism in healthy adults and infants. Moreover, airflow limitation and its degree have 
shown to affect tidal breathing patterns in both children and adults (Williams et al., 2014). 
Tidal breathing measurements are relatively simpler than other methods of assessing lung 
function in infants, which highlights the importance of analysing tidal breathing patterns (Stick, 
1996). Traditional techniques include the measurement of airflow signals using a mouthpiece 
or a facemask (i.e. Pneumotachography) or measurements of thoracoabdominal (TA) wall 
movement using bands placed around thorax and abdomen (i.e. respiratory inductive 
plethysmography [RIP-bands]) (Stick et al., 1992; Adams et al., 1993). Those techniques 
require direct contact with the patient, and the placement of the mouthpiece or the facemask in 
Pneumotachography can result in changing of tidal breathing pattern (Weissman et al., 1984; 
Laveneziana et al., 2015a), whereas in RIP slippage of the elastic band that contains the elastic 
coil during data collection could provide an erroneous reading (Caretti et al., 1994). 
Structured light plethysmography (SLP) allows a detailed assessment of tidal breathing patterns 
using a light-based technique in a zero-contact environment. Two digital cameras record the 
movement of a pattern of light projected onto the anterior TA wall. The average axial 
displacement of the grid over time is used to estimate tidal breathing parameters (Boer et al., 
2010). SLP recording requires the subject to sit still and breath, without the need to perform 
any forced breathing manoeuvres. Minimal patient cooperation was required to obtain an SLP 
scan in adults (Motamedi-Fakhr, Wilson and Iles, 2017), which make it suitable even for young 
children. 
Furthermore, using some distraction methods to reduce excessive patient movement, SLP scans 
could be successfully obtained from younger children down to 3 years of age (Hmeidi et al., 
2015). As a result, SLP might be a useful technique for children who cannot perform 
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conventional tests of respiratory function assessment such as spirometry. School-age children 
were investigated in this study because of their ability to perform spirometry, which is used as 
a reference to confirm the obstruction and the response to bronchodilator treatment. 
 
5.2 Study Aims 
In this study the use of SLP in assessing tidal breathing was evaluated in two groups: school-
age children with asthma and age-matched healthy children, then the findings were compared. 
The effect of bronchodilation on both tidal breathing parameters and spirometry was also 
assessed in the asthmatic group.  
 
5.3 Methods 
5.3.1 Study participants and design 
For this study, children visiting an outpatient clinic for a routine check who were found to have 
an airway obstruction were recruited. Airway obstruction was determined by abnormal 
spirometry, such that the forced expiratory volume in 1 second (FEV1) was less than 80% of 
the predicted value. Bronchodilator reversibility assessment was performed as a part of the 
clinical procedure in the outpatient clinic. Spirometry was repeated after the administration of 
bronchodilation (four puffs of 100 mg salbutamol using a metered dose inhaler via a large 
volume spacer) to assess the response to bronchodilation. Asthmatic children aged 7-16 were 
recruited, to ensure their ability to perform spirometry. A group of healthy children of matched 
ages and genders were recruited. Health is defined as no current or previous diagnosis of 
respiratory disease. 
Children with significant comorbidity or chest wall abnormality, obstructive sleep apnea or any 
other condition which could affect the study were excluded from the study. Furthermore, the 
body mass index was restricted to 40kg/m2. 
After consenting, asthmatic children were assessed twice using SLP; the first time once the 
obstruction was confirmed with the abnormal spirometry, and the second time after the 
administration of salbutamol and just before repeating spirometry. Healthy children were 
assessed only once using SLP. 
The study was approved by the UK Health Research Authority National Research Ethics 
Service (reference number 11/EE/00/37) and was performed at the Royal Stoke University 
Hospital (Stoke-on-Trent, UK) according to International Council for Harmonisation 
Guidelines for Good Clinical Practice. It is registered on ClinicalTrials.gov as part of a larger 
evaluation of SLP in individuals aged 2–80 years (NCT02543333). All children were enrolled 
between March 2014 and June 2015 (Hmeidi et al., 2017). 
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5.3.2  Study devices and procedures 
Tidal breathing trace was recorded using an SLP device for five minutes, and tidal breathing 
parameters were derived. The following procedure is followed: 
- Children were seated in a high-backed chair as far back in the seat as possible and were 
instructed to be as still as possible. 
- A close-fitting white T-shirt was provided by the study sponsor for them to wear during 
the procedure. Also a research nurse provided a distraction for the children during the 
scan so that they remained still, breathing as naturally as possible. 
- For each subject, the scanner head of the device was positioned at 1 - 1.2 meters from 
the chest wall, then its height and angle were adjusted by the researcher. These 
adjustments included fixing the optical axis perpendicularly to the chest wall and the 
midpoint of the grid located at the base of the child’s xiphisternum. 
- The grid pattern projected by SLP was altered to accommodate the size of each TA area 
and to cover an equidistant area above and below the xiphisternum from the clavicles 
to the anterior iliac crests.  
- The size of the grid was chosen to fit the chest size of the child among three different 
sizes with various numbers of squares (14x10, 12x8 or 10x6) contributing equally to the 
signal. 
- 30 Hz sampling rate was adequate to capture the dynamics of TA wall displacement. 
5.3.3 Parameters 
Tidal breathing parameters derived from both: TA displacement with time, as well as its 
derivative, displacement rate with time, were quantified. Other parameters that describe the 
shape of the displacement loop and regional the parameters were also calculated. Magnitudes 
and the within-subject variabilities of all these parameters were quantified, for more details 
about the parameters and the selection criteria see chapter 4. 
5.3.4 Statistical Analysis 
Power calculations were not carried out prior to the study because this study began as a pilot 
and no data regarding variability of SLP parameters were known beforehand.  
The median value (m) and the inter-quartile range IQR (v) were calculated for each parameter 
in each 5 min SLP assessment. To compare the data between healthy children and those with 
asthma (before administration of a bronchodilator), a Mann-Whitney 𝑈 test was used, 
comparing the SLP parameters and their variability. In addition, a Wilcoxon signed-rank test 
was used to evaluate the effect of a bronchodilator in children with asthma. Differences between 
the groups and the response to treatment in the asthma group were further assessed using the 
nonparametric common language effect size (CLES) for the parameters which showed a 
significant difference. CLES was used to assess the ability of the significant parameters to 
differentiate between health and asthma or to detect response to treatment. Finally, the 
correlation between IE50SLP and lung functions measured using a Spearman´s rank correlation 
Figure 5-3. 
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5.4 Results 
5.4.1 Study population 
The children who met the selection criteria and provided evaluable data were 30 asthmatics and 
41 healthy children. There were no differences between the asthmatic and the healthy groups 
in their age (10.7 ± 2.4 and 11.2 ± 3.2 years) respectively, height (145.0 ± 17.4 and 148.0 ± 
17.6 cm), or weight (41.4 ± 15.1 and 43.9 ± 17.5 Kg). Males in both groups were 17 (57%) and 
21 (51%), respectively. At baseline, there was a clear airway obstruction in the children with 
asthma (FEV1[% predicted] 68.4±12.5; FEV1/ forced vital capacity [FVC] 69.1±10%). 
For the SLP procedure, the success rate is defined as the number of subjects who provided 
valuable data divided by the total number of eligible subjects, for more details about the main 
criteria for this decision see chapter four. The success rate for each group was high: asthma 
30/32 [93.8%]; healthy: 41/48 [85.4%]. 
 
5.4.2 Spirometry 
Significant increases in spirometry measures were observed after the administration of 
bronchodilation, including FEV1, FVC and FEV1 (% predicted). FEV1/FVC (%) also 
increased significantly after bronchodilator but stayed abnormal (mean=76.1%), showing that 
airway obstruction was still present (Table 5-1). 
 
Table 5-1. Comparison of spirometry measures in children with asthma  
(N=41) before and after bronchodilator administration.  
 
FEV1 (L) 
mean ± SD 
FVC (L) 
mean ± SD 
FEV1/FVC 
(%) 
mean ± SD 
FEV1(% 
predicted) 
mean ± SD 
Prebronchodilator 1.62 ± 0.64 2.36 ± 0.89 69.1 ± 10 68.4 ± 12.5 
Postbronchodilator 1.93 ± 0.67 2.58 ± 0.94 76.1 ± 9.7 81.2 ± 11.2 
Significance* P < 0.0001 P < 0.01 P < 0.0001 P < 0.0001 
(FEV1, forced expiratory volume in 1sec; FVC, forced vital capacity; SD, standard deviation. 
Significance* tested using a paired t-test. 
 
5.4.3 Tidal breathing parameters’ magnitudes and within-subject variabilities 
Table 5-2 shows the differences between tidal breathing parameters measured with SLP 
between healthy children and children with asthma (Prebronchodilator). (*Significant with 
P<0.05, ** Significant with P<0.001). 
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Table 5-3 shows the differences in the parameters between pre and post-bronchodilator in the 
asthmatic group. 
Those tables show all median SLP-obtained parameters and their within-subject variability. In 
each SLP assessment, the median number of detected breaths in each SLP scan was 82-86 and 
did not change significantly in any of the performed comparisons.  
A significantly higher inspiratory to expiratory TA displacement-rate ratio (i.e. IE50) and its 
variability were observed in children with asthma (prebronchodilator) than in healthy children 
(mIE50SLP: 1.53 vs. 1.22, P< 0.001; vIE50SLP: 0.63 vs. 0.47, P<0.001) (Hmeidi et al., 2017) 
(Table 5-2, Figure 5-1). In asthmatic children after bronchodilation, both mIE50SLP and 
vIE50SLP decreased from 1.53 to 1.45 (P = 0.001) and 0.63 to 0.60 (P = 0.04) respectively 
(Comparison of tidal breathing parameters measured with SLP between healthy children and 
children with asthma (prebronchodilator) Figure 5-1). Esven though both values decreased after 
bronchodilation, they stayed higher than in the healthy group (1.45 vs. 1.22, P <0.001; 0.60 vs. 
0.47, P < 0.01) (*Significant with P<0.05, ** Significant with P<0.001). 
 
 
 
Table 5-3, Figure 5-1, showing that the obstruction was still present. 
Asthmatic children were divided into two subgroups; children who responded to 
bronchodilation (with a response defined as ≥ 12% increase in FEV1 predicted, n=16 
(Papadopoulos et al., 2012)), and children who did not respond to bronchodilation. In the 
responder subgroup, there was a significant difference in mIE50SLP before and after 
bronchodilation (P=0.038), while no significant change was observed in the non-responder 
group (P=0.24). 
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Figure 5-1. Box plots showing mIE50SLP(A) and vIE50SLP(B) in healthy children and those with asthma 
(pre- and postbronchodilator). 
The grey line indicates the median value, the rectangle spans the IQR, and the black whiskers indicate 
the minimum and maximum values (excluding the outliners indicated by the black circles). BD, 
bronchodilator; IE50SLP, thoracoabdominal (TA) inspiratory displacement rate at 50% of inspiratory 
displacement divided by TA expiratory displacement rate at 50% of expiratory displacement; IQR, 
interquartile range; m, median; v, variability (Hmeidi et al., 2016, p.7) . 
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Table 5-2. Comparison of tidal breathing parameters measured with SLP between healthy children and 
children with asthma (prebronchodilator).  
 
Healthy children 
(N = 41) 
Children with 
asthma 
(Prebronchodilator) 
(N = 30) 
 
Median IQR Median IQR z-stat 
Significance 
(MWU test) 
Timing indices and ratios 
mRR (brpm) 19.89 7.58 20.34 5.73 0.5 0.62 
vRR (brpm) 3.32 2.2 3.93 2.57 1.48 0.14 
mtI (sec) 1.33 0.46 1.18 0.2 -1.9 0.06 
vtI (sec) 0.27 0.17 0.24 0.14 -1.61 0.11 
mtE (sec) 1.63 0.64 1.7 0.47 0.43 0.67 
vtE (sec) 0.39 0.21 0.44 0.35 1.53 0.13 
mtTot (sec) 3.02 1.13 2.95 0.83 -0.49 0.62 
vtTot (sec) 0.53 0.32 0.56 0.44 0.72 0.47 
mtI/tE 0.82 0.16 0.69 0.1 -3.6 <0.001** 
vtI/tE 0.22 0.1 0.2 0.11 -0.36 0.72 
mtI/tTot 0.45 0.05 0.41 0.04 -3.61 <0.001** 
vtI/tTot 0.06 0.03 0.07 0.03 0.95 0.34 
Displacement with time-derived parameters 
mtPTEFSLP/tE 0.35 0.09 0.31 0.09 -1.81 0.07 
vtPTEFSLP/tE 0.18 0.1 0.21 0.11 2.22 0.03* 
mtPTIFSLP/tI 0.5 0.09 0.54 0.09 1.58 0.11 
vtPTIFSLP/tI 0.21 0.07 0.21 0.05 -0.08 0.94 
mIE50SLP 1.22 0.29 1.53 0.35 4.71 <0.001** 
vIE50SLP 0.47 0.18 0.63 0.32 4.45 <0.001** 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 41.96 20.04 39.18 11.3 -1.16 0.25 
vrCT(%) 7.62 6.52 9.53 8.03 1.01 0.31 
mHTA (deg.) 3.21 1.7 3.29 1.54 0.3 0.77 
vHTA (deg.) 3.76 2.55 3.96 2.28 0.79 0.43 
mTAA (deg.) 11.19 9.92 11.89 8.71 0.29 0.78 
vTAA (deg.) 10.55 9.67 12.67 9.48 0.77 0.44 
No. of Breaths         82 26.25 84 22 0.45 0.65 
(*Significant with P<0.05, ** Significant with P<0.001). 
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Table 5-3. Comparison of tidal breathing parameters measured with SLP in children with asthma before 
and after bronchodilator administration.  
 Children with 
asthma 
(Prebronchodilator) 
(N = 30) 
Children with 
asthma 
(Postbronchodilator) 
(N = 30) 
 
Median IQR Median IQR 
z-
stat 
Significance 
(Signed-
rank test) 
Timing indices and ratios 
mRR (brpm) 20.34 5.73 22.16 5.91 -0.93 0.35 
vRR (brpm) 3.93 2.57 4.62 2.34 -1.12 0.26 
mtI (sec) 1.18 0.2 1.13 0.3 -0.85 0.40 
vtI (sec) 0.24 0.14 0.23 0.1 -0.46 0.65 
mtE (sec) 1.7 0.47 1.6 0.43 -1.31 0.19 
vtE (sec) 0.44 0.35 0.43 0.21 -0.52 0.60 
mtTot (sec) 2.95 0.83 2.71 0.77 -1.2 0.23 
vtTot (sec) 0.56 0.44 0.6 0.28 -0.18 0.85 
mtI/tE 0.69 0.1 0.69 0.12 -0.92 0.36 
vtI/tE 0.2 0.11 0.21 0.09 -0.03 0.98 
mtI/tTot 0.41 0.04 0.41 0.04 -0.89 0.37 
vtI/tTot 0.07 0.03 0.07 0.03 -0.48 0.63 
Displacement with time-derived parameters 
mtPTEFSLP/tE 0.31 0.09 0.29 0.14 -0.57 0.57 
vtPTEFSLP/tE 0.21 0.11 0.19 0.12 -1.39 0.16 
mtPTIFSLP/tI 0.54 0.09 0.54 0.09 -0.66 0.51 
vtPTIFSLP/tI 0.21 0.05 0.19 0.09 -0.75 0.45 
mIE50SLP 1.53 0.35 1.45 0.24 -2.44 0.01* 
vIE50SLP 0.63 0.32 0.6 0.38 -2.05 0.04* 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 39.18 11.3 39.11 12.8 -0.34 0.73 
vrCT(%) 9.53 8.03 8.02 7.66 -1.61 0.11 
mHTA (deg.) 3.29 1.54 3.05 1.26 -1.8 0.07 
vHTA (deg.) 3.96 2.28 3.79 1.39 -1.24 0.21 
mTAA (deg.) 11.89 8.71 11.73 11.44 -0.05 0.96 
vTAA (deg.) 12.67 9.48 11.9 9.92 -1 0.32 
No. of Breaths         84 22 86 32 -0.34 0.73 
(*Significant with P<0.05). 
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There are other parameters which were different between children with asthma and healthy 
children, but they do not show a significant change after bronchodilation. Before 
bronchodilation, the ratios of inspiratory to expiratory time and inspiratory to total breath time 
were significantly lower in children with asthma (mtI/tE, P<0.001, mtI/tTot, P<0.001). The 
variability in the normalised time taken to reach peak tidal expiratory TA displacement rate was 
significantly higher (vtPTEFSLP/tE, P=0.03) (Table 5-2, Figure 5-2). After the administration 
of bronchodilation, both mtI/tE and mtI/tTot stayed significantly lower in the asthmatic group, 
whereas the difference in vtPTEFSLP/tE between both groups was no longer present (P=0.51) 
(Table 5-4). 
 
Table 5-4. Comparison of tidal parameters measured with SLP between healthy children and children 
with asthma (postbronchodilator).  
 
Healthy children 
(N = 41) 
Children with 
asthma 
(Postbronchodilator) 
(N = 30) 
 
Median IQR Median IQR z-stat 
Significance 
(MWU test) 
mIE50SLP 1.22 0.29 1.45 0.24 4.02 <0.001*** 
vIE50SLP 0.47 0.18 0.6 0.38 2.96 <0.01** 
mtI/tE 0.82 0.16 0.69 0.12 -3.09 <0.01** 
mtI/tTot 0.45 0.05 0.41 0.04 -3.09 <0.01** 
vtPTEFSLP/tE 0.18 0.1 0.19 0.12 0.65 0.51 
No. of Breaths 82 26.25 86 32 0.68 0.50 
(**Significant with P<0.01,*** Significant with P<0.001). 
 
 
Figure 5-2 Box plots showing mtI/tE(A), mtI/tTot(B), vtPTEFSLP/tE(C) in healthy children and in those 
with asthma (pre- and postbronchodilator).  
52 
 
The grey line indicates the median value, the rectangle spans the IQR, and the black whiskers 
indicate the minimum and maximum values (excluding the outliners indicated by the black 
circles). BD, bronchodilator; IQR, interquartile range; m, median; tE, expiratory time; tI, 
inspiratory time; tPTEFSLP, time to reach peak tidal expiratory thoraco-abdominal displacement 
rate; tTot, total breath time; v, variability (Hmeidi et al., 2017, p.9). 
Also, as it is shown in Table 5-5, CLES evaluation showed that SLP parameters which were 
significantly different between healthy children and children with asthma could differentiate 
between both groups with high sensitivity, particularly IE50 and its variability (CLES: 82.9% 
and 81.1%, respectively). In the same way, bronchodilator effects could be detected in children 
with asthma in most of the cases but not as accurate as the spirometry-obtained outcomes (FEV1 
and FEV1/FVC)  
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Table 5-5. CLES evaluation of SLP and spirometry-obtained breathing parameters. 
Hypothesis 
CLES 
(%) 
Interpretation 
Healthy versus children with asthma1 
mtI/tE: lower in asthma group 75.2 
In 75.2% of cases, mtI/tE was lower in 
asthma group 
mtI/tTot: lower in asthma 
group 
75.3 
In 75.3% of cases, mtI/tTot was lower in 
asthma group 
VtPTEF/tE: higher in asthma 
group 
65.5 
In 65.5% of cases, vtPTEF/tE was higher in 
asthma group 
mIE50SLP: higher in asthma 
group 
82.9 
In 82.9% of cases, mIE50SLP was higher in 
asthma group 
vIE50SLP: higher in asthma 
group 
81.1 
In 81.1% of cases, vIE50SLP was higher in 
asthma group 
Pre- versus post-BD2 (children with asthma) 
FEV1: increases after BD 100.0 FEV1 was increased in all patients after BD 
FEV1/FVC: increases after BD 86.7 
In 86.7% of casas, FEV1/FVC increased 
after BD 
mIE50SLP: reduced after BD 70.0 
In 70.0% of casas, mIE50SLP reduced after 
BD 
vIE50SLP: reduced after BD 73.3 
In 73.3% of casas, vIE50SLP reduced after 
BD 
 
Median and IQR values for parameters are denoted by the prefix m and v respectively. 
BD: bronchodilator; CLES: common language effect size; FEV1: forced expiratory volume in 1 
sec; FVC: forced vital capacity; IE50SLP: TA inspiratory displacement rate at 50% of inspiratory 
displacement divided by TA expiratory displacement rate at 50% of expiratory displacement; 
IQR: interquartile range; tE: expiratory time; tI: inspiratory time; tTot: total breath time; 
tPTEFSLP: time to reach peak tidal expiratory TA displacement rate. 
1Data are shown for parameters that significantly differed between healthy children and children 
with asthma (prebronchodilator) only (see Table 5-2). Note spirometry data were not available 
for healthy subjects and hence only effect sizes for SLP parameters are given. 
 
2Data are shown for parameters that significantly differed following bronchodilator 
administration in children with asthma only (See Table 5-3) ( *Significant with P<0.05, ** 
Significant with P<0.001). 
54 
 
Furthermore, a Spearman’s rank correlation was carried out between mIE50SLP and spirometry 
parameters in children with asthma (prebronchodilator). The correlations between mIE50SLP 
and both FEV1 (% predicted) and FEV1/FVC were (-0.49, P=0.0054) (Figure 5-3) and (-0.38, 
P=0.034), respectively. No correlation in these parameters was found after bronchodilation. The 
correlation between mIE50SLP and FEV1 (% predicted) stayed significant after bronchodilation 
in the responded asthmatic subgroup (i.e. exhibited ≥ 12% increase in FEV1%; P=0.016), but 
for those who did not respond was not significant (P=0.25). Finally, the correlation between 
mIE50SLP and FEV1/FVC was not significant post bronchodilation in any of the subgroups, 
responder (P=0.08) or non-responder (P=0.11). 
 
 
Figure 5-3. Correlation between mIE50SLP and FEV1 (% predicted) in children with asthma 
(prebronchodilator) 
 (Hmeidi et al., 2017, p.10) 
 
5.5  Discussion 
As noted by Weissman et al., 1984; Caretti et al., 1994; Laveneziana et al., 2015a, measuring 
tidal breathing has some restrictions which limit its use. This study aimed to investigate the use 
of SLP, as a non-invasive, non-contact technique for measuring tidal breathing, to differentiate 
children with asthma from healthy children, and to assess its sensitivity in detecting response 
to bronchodilation in the asthmatic group.  
From the results, it is shown that some SLP parameters can differentiate between healthy 
participants and children with asthma, particularly the inspiratory to expiratory TA 
displacement rate ratio (mIE50SLP) and its within-subject variability (vIE50SLP) which have 
distinguished healthy children from those with asthma and indicated a response to 
bronchodilation. This parameter is comparable to IE50 which defines the ratio of inspiratory to 
expiratory flow at 50% of tidal volume (H. Hmeidi et al., 2017). These two SLP parameters 
have shown promising results, being sensitive enough to detect a response to bronchodilation 
in a non-invasive assessment, however not as sensitive as spirometry measure (FEV1). 
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Previous studies have shown that during an acute asthma attack, there is an increase in airway 
resistance and indices of expiratory flow, such as FEV1, FEV1/FVC, peak expiratory flow and 
TEF50 decreases (Papiris et al., 2001). The reduction in TEF50 was shown in various studies 
with patients similar to the asthmatics in this study. 
For example, Tauber et al. (2003) in his study using a negative expiratory pressure technique, 
has shown that TEF50 is lower in asthmatic children visiting outpatient clinic for a routine 
check than healthy children. As IE50SLP is the ratio between TIF50SLP/TEF50SLP, an 
obstruction-related reduction in TEF50SLP will cause an increase in IE50SLP. Tauber in his study 
showed that the decrease in airway resistance post bronchodilation improved expiratory flow 
(Tauber et al., 2003). In our study, the increase in TEF50SLP after bronchodilation did not return 
it to normal. As a result, the drop in mIE50SLP did not bring it to the level found in healthy 
children. This might indicate incomplete airway obstruction reversibility. In addition, mIE50SLP 
was found to be higher in chronic obstructive pulmonary disease (COPD) patients compared to 
healthy subjects (Motamedi-Fakhr, Wilson and Iles, 2017). 
It is known that breathing patterns are not constant, allowing speech and tasks unrelated to gas 
exchanged to occur (Brack, Jubran and Tobin, 2002). In this study, IQR for all parameters was 
calculated for each SLP assessment, as a measure of within-subject variability, and showed that 
vIE50SLP was significantly higher in children with asthma than healthy children. It has been 
reported previously that obstructive lung disease such as asthma can affect the variability of 
tidal breathing. In a study by (Kuratomi et al., 1985), tidal volume variability was measured 
using electrical impedance pneumography in healthy adults and adults experiencing an 
exacerbation of asthma, and it was shown that the asthmatic group have a significantly higher 
tidal volume variability than the healthy group and that the variability was reduced to normal 
after treatment. However, in this study, vIE50SLP decreased after bronchodilation but did not 
come back to normal. Within-subject variability in vtPTEFSLP/tE was also higher in children 
with asthma before treatment than in controls. Even though vtPTEFSLP/tE did not change 
significantly after bronchodilation, there was no longer a significant difference between the 
asthmatics after bronchodilation and controls, indicating some decrease in within-subject 
variability. 
Furthermore, regional parameters did not show significant differences in this study. The relative 
contribution of the thorax to each breath (rCT) was similar in healthy children and patients with 
asthma, and no effect after bronchodilation was observed. This was also demonstrated by 
(Motamedi-Fakhr, Wilson and Iles, 2017), where no difference on rCT was detected  between 
COPD patients and healthy subjects using SLP. However, in a previous study on patients with 
COPD, a reduction in rCT after bronchodilation was reported (Laveneziana et al., 2015a). 
Different TA regions’ movement with respect to each other, is described by phase parameters. 
The synchronization between the abdomen and thorax during tidal breathing is often disturbed 
in children with acute asthma, when the movement of the abdomen supersedes the movement 
of the thorax. In this study, patients attended a routine outpatient clinic, and were not in an acute 
condition, and thus, they were not likely to show asynchrony. 
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In the next chapter, the effect of acute asthma exacerbation and treatment on SLP parameters is 
investigated, which include regional and temporal parameters such as rCT, TAA and left-right 
hemithoracic asynchrony.     
The use of SLP in the measurement of tidal breathing has several advantages over current 
methods for assessing tidal breathing (i.e. Pneumotachography and RIP), mainly the non-
invasive and the contactless nature of the test. The participant should remain as still as possible 
during the test to avoid any interference being introduced to the signal, even though previous 
work has shown that children as young as three years of age could be measured (Hmeidi et al., 
2015). Also, it should be known that some slight tracking errors which are non-breathing 
related, could be detected and excluded from the data. 
In this study, because many statistical comparisons were made, and there is a risk of some 
statistically significant result to appear by chance, the Bonferroni correction method was used. 
Dividing the P-Value by the number of comparisons results in P<0.002 (0.05/24). This method, 
however, assumes that all the parameters are independent, which is not the case in many SLP-
measured parameters and may, therefore, be very conservative. Some differences between these 
parameters have a physiological basis and supported by previous researches. CLES calculation 
further supported those findings. 
The use of spirometry was a prerequisite for recruitment in this study to confirm the existence 
of airway obstruction and its changes after treatment. Hence, younger subjects who might 
benefit the most from SLP were not included, because they are not able to perform spirometry. 
This cohort of children is considered in the next chapter.  
 
5.6  Conclusions 
This study has demonstrated that SLP which is a non-contact and non-invasive technique to 
measure tidal breathing, can (1) be successfully utilized in children as young as 7 years of age, 
and (2) distinguish between children with and without airway obstruction and detect responses 
to bronchodilator.  
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6 Tidal breathing parameters in Children 
recovering from acute asthma  
 
 
 
 
 
 
 
 
 
The work reported in this chapter has been published in Physiological Reports ISSN 
2051-817X, with the title “Tidal breathing parameters measured by structured light 
plethysmography in children aged 2-12 years recovering from acute asthma/wheeze 
compared with healthy children” by (Hmeidi et al., 2018). Permission was obtained 
from the publisher to reuse relevant aspects of this work in this thesis (i.e. figures, plots 
and tables). 
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6.1 Introduction 
An accurate assessment of lung function is crucial to effectively manage respiratory conditions 
such as asthma (Beydon et al., 2007; Wijngaart, Roukema and Merkus, 2015). 
Even though spirometry is considered the gold standard, it is often inappropriate to use in 
younger children because the test involves forced breathing manoeuvres which children might 
be unable to perform (Wijngaart, Roukema and Merkus, 2015). Measuring tidal breathing 
patterns is a different approach to assess breathing. Pneumotachography (PNT) and respiratory 
inductive plethysmography (RIP) are used for this purpose, and both can be utilized in children 
(J. H. Bates et al., 2000; Stick et al., 1992). The clinical use of those techniques is limited due 
to some practical drawbacks, such as individuals tending to change their breathing patterns due 
to the use of a mouthpiece in PNT, and the movement of the transducer bands in RIP can result 
in erroneous readings (Stick et al., 1992; Caretti et al., 1994; Laveneziana et al., 2015a). In 
literature, the quantified tidal breathing parameters were not consistent. Thus, there is a lack of 
agreement in identifying which are the important parameter(s) to be investigated in the presence 
of respiratory disease (Kuratomi et al., 1985; Brack, Jubran and Tobin, 2002; Schmalisch, 
Wilitzki and Wauer, 2005). 
This is an observational cohort study, which aimed to compare SLP-estimated parameters 
between: (1) healthy and acute asthma/wheeze participants (2-12 years); (2) pre and post 
intervention for the Asthma group; (3) younger children (aged 2–5 years), who cannot perform 
spirometry with older children (aged 6–12 years). 
 
6.2 Materials and Methods 
6.2.1  Participants  
Children (2–12 years) recovering from an acute exacerbation of asthma (wheezes in those 
without a formal asthma diagnosis) were recruited for this study. Children with this condition 
receive regularly inhaled bronchodilators with the repetition depending on the severity of the 
condition as a part of standard care. Within the first three days of admission, children were 
recruited as they were in the recovery phase of an attack, on a treatment frequency of 3-hourly 
or longer regular salbutamol. All children were considered clinically stable, based on the on-
duty clinician’s opinion, before taking part in the study. 
SLP-parameters from the asthma group were compared with those from a group of age-matched 
healthy children without a diagnosis of any respiratory condition. 
Children were excluded from the study if they had significant co-morbidity or chest wall 
abnormality, obstructive sleep apnea, a body mass index >40 kg/m2, any acute or chronic 
condition that restricted his/her ability to take part. Children were also excluded if they were 
not able to comply with the protocol.   
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6.2.2 Study design 
Once well enough, asthma/wheeze children underwent two five-minute SLP assessments. The 
first one was performed 5-10 minutes before the administration of bronchodilation, which was 
given routinely once clinicians determined its need. Children had received different numbers 
of bronchodilator treatments before this according to their condition. The second SLP 
assessment was performed 10-15 minutes post bronchodilation. Healthy children underwent 
one SLP assessment. A research nurse provided a distraction method (cartoon played on a tablet 
computer) in order to keep the subjects as still as possible. 
The study (ClinicalTrials.gov identifier: NCT02543333) was conducted in line with 
International Conference on Harmonisation Good Clinical Practice guidelines and was 
approved by the UK Health Research Authority National Research Ethics Service (reference 
number 11/EE/00/37). Parents or guardians provided written informed consent. 
 
6.2.3 SLP procedure and data analysis 
Tidal breathing was measured using an SLP device on the bedside. To ensure data were as 
artefact-free as possible, the criteria presented in chapter four were used to define and exclude 
artefacts.  
 
6.2.4 Statistical Analysis 
This study was conducted parallel to the stable asthma study. Thus, no power calculations were 
performed before this study because these are the first data reported using SLP in young 
children. prefix ‘m’ represents parameter’s magnitude and ‘v’ its within-subject variability. For 
each group parameter’s magnitude and variability are represented using median and IQR. 
A Mann-Whitney-U test was used to compare each ‘m’ and ‘v’ parameter in healthy children 
and those with acute asthma/wheeze (both before and after bronchodilator administration). A 
robust two-way ANOVA was utilised to test for significant interactions between these effects 
and age (Kloke and Mckean, 2012). 
To assess the effect of bronchodilator in asthma/wheeze group, a paired Wilcoxon signed-rank 
(WSR) was utilised. Mann-Whitney-U test of the differences (post – pre-bronchodilator) was 
used to compare these effects in younger and older children. Common Language Effect Size 
(CLES) was used to assess the ability of SLP parameters to differentiate between children with 
asthma/wheeze and healthy children. It was also used to evaluate the effect of bronchodilator 
for the parameters that have shown significant differences. “CLES is the probability that a score 
sampled from one distribution will be higher than a score from another distribution” 
(Björgvinsson and Kerr, 1995, p. 151). CLES is easily interpreted, and it is robust against the 
deviation from normality assumption. Thus, an important measure in clinical research 
(Björgvinsson and Kerr, 1995).   
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No corrections were made to p-values for the multiple tests done because this was an 
exploratory study. 
 
6.3 Results 
Thirty-nine children with acute asthma/wheeze (26 with a formal diagnosis of asthma, 13 with 
no formal diagnosis) in addition to 54 age-matched healthy controls were eligible for this study 
and provided valuable data for the analysis. 
Figure 6-1 and Table 6-1 show the similarity in demographics between the study groups. The 
success rate of SLP procedure was 87.8% which is defined as the number of measurements 
which have provided evaluable data divided by the total number of measurement done 
(137/156). 
The success rate according to age differed such that: in older participants (aged 6–12 years 
inclusive) was 93.7% (59/63), and in the younger pre-school participants (aged 2–5 years 
inclusive) was 83.9% (78/93). The excluded data was  because of their poor quality resulted 
from either excessive movement, light or creases in the t-shirt (See 4.3.3). 
Numerous parameters have shown significant differences between healthy controls and 
children recovering from an acute exacerbation of asthma/wheeze (before bronchodilator 
administration)  Table 6-5. 
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Table 6-2. Of the timing parameters, mRR was significantly higher in children with asthma (30 
vs. 23 brpm; p<0.001), while mtI (0.83 vs. 1.13 seconds), mtE (1.14 vs.1.48 seconds), and 
mtTot (2.00 vs. 2.60 seconds) were significantly lower (all p<0.001). Apart from vRR, the 
within-subject variability in all timing indices and ratios were significantly lower in children 
with asthma/wheeze than in healthy controls.  
Of the flow-based parameters, vtPTIFSLP/tI was significantly lower (0.16 vs. 0.21, p<0.001), 
whereas mIE50SLP was significantly higher in children with asthma/wheeze compared with 
healthy children (1.47 vs. 1.31, p=0.002) Figure 6-2. Both asynchrony parameters (mTAA and 
mHTA) were significantly higher in children with asthma/wheeze (mTAA: 40.16 vs. 11.88 
degrees; mHTA: 5.53 vs. 3.43 degrees; both p<0.001), as well as their variabilities (vTAA: 
24.08 vs. 13.53 degrees; vHTA, 6.82 vs. 4.58 degrees; both p<0.001) Figure 6-3. 
mTAA differed significantly between younger and older children with asthma/wheeze (2–5 vs 
6-12 years) (interaction p<0.001) Table 6-2 showing the age-related effect of asthma. In healthy 
children, there was a slight decrease in mTAA with age (12.6 to 11.4 degrees for younger and 
older children, respectively), while in children with asthma/wheeze, mTAA has shown more 
than 50% reduction from 52.2 in the younger children to 25.1 degrees in the older ones (Figure 
6-4). 
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Figure 6-1. Distribution of ages in both groups: (A) Healthy and (B) Acute asthma/wheeze 
(Hmeidi et al., 2018, p.4). 
 
Table 6-1. Participants demographics from both groups. Data are mean (standard deviation) unless 
otherwise specified. 
 
Healthy children 
(N = 54) 
Children with Acute 
asthma/wheeze 
(N = 39) 
Gender (male: female), n 33:21 26:13 
Age, years 6.1(2.9) 5.2(2.7) 
Age groups  
(2-5: 6-12 years), n 
26:28 24:15 
Height, cm 116.5(21.0) 114.1(18.3) 
 
None of the parameters’ magnitudes changed significantly after bronchodilation administration 
for overall asthma/wheeze group (Table 6-3). The within-subject variability of tPTEFSLP/tE was 
63 
 
the only parameter that has shown a change from 0.21 to 0.15  (p<0.001) Figure 6-2 (C). When 
assessed based on age, the effect of bronchodilation varied between the older and the younger 
cohorts for mrCT, mTAA and vTAA (interaction p <0.05). After bronchodilation, mrCT 
dropped significantly in the younger cohort (interaction p<0.05 and WSR p<0.05), but 
increased for most of the individuals in the older cohort (Figure 6-5 A). 
Bronchodilation effect was significantly different between the two cohorts for mTAA, such that 
it decreased in the younger children and increased in the older cohort, although the effects in 
both cohorts were not significantly different from zero (Figure 6-5 B). Likewise, vTAA has 
shown a significant decrease after bronchodilation in the younger cohort (p <0.05) but did not 
show any difference in the older children (Figure 6-5 C).  
Table 6-4 shows that all the parameters that were significantly different between healthy 
children and those with asthma/wheeze pre bronchodilation stayed so post bronchodilation. 
Based on CLES calculations, mtI and mTAA have shown the largest effect in differentiating 
between healthy children from those with acute asthma/wheeze Table 6-5. The same parameters 
have also shown the largest effect size in differentiating between both groups post 
bronchodilation (mtI: 83.4%; mTAA: 81.8%), as well as mRR and mtTot (both 80.2%). 
Furthermore, bronchodilation effect in children with acute asthma could be detected using 
within-subject variability of tPTEFSLP/tE (74.4% of cases) Table 6-5. 
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Table 6-2. SLP-estimated tidal breathing parameters in healthy children versus children with acute 
asthma/wheeze (before bronchodilator administration). 
 
 
Healthy 
children 
(N = 54) 
Children with 
acute 
asthma/wheeze 
(before 
bronchodilator) 
(N = 39) 
 
Median IQR Median IQR z-stat 
(MWU 
test) 
P-value 
Robust 
ANOVA) 
P-value 
Timing indices and ratios 
mRR (brpm) 23.00 5.35 30.00 7.71 -4.74 <0.001** 0.369 
vRR (brpm) 4.52 2.95 4.45 3.16 0.11 0.913 0.761 
mtI (sec) 1.13 0.30 0.83 0.19 5.44 <0.001** 0.569 
vtI (sec) 0.22 0.20 0.13 0.12 3.99 <0.001** 0.476 
mtE (sec) 1.48 0.40 1.14 0.43 4.10 <0.001** 0.888 
vtE (sec) 0.43 0.25 0.23 0.15 4.87 <0.001** 0.385 
mtTot (sec) 2.60 0.64 2.00 0.57 4.74 <0.001** 0.727 
vtTot (sec) 0.53 0.31 0.33 0.11 4.86 <0.001** 1.000 
mtI/tE 0.73 0.13 0.70 0.15 1.20 0.229 0.653 
vtI/tE 0.23 0.12 0.16 0.08 3.55 <0.001** 0.397 
mtI/tTot 0.42 0.04 0.41 0.05 1.20 0.229 0.652 
vtI/tTot 0.07 0.03 0.05 0.03 3.37 0.001* 0.248 
Flow-based parameters 
mtPTEFSLP/tE 0.34 0.11 0.38 0.18 -1.76 0.079 0.987 
vtPTEFSLP/tE 0.22 0.10 0.21 0.20 0.14 0.885 0.102 
mtPTIFSLP/tI 0.55 0.10 0.53 0.06 1.18 0.236 0.248 
vtPTIFSLP/tI 0.21 0.09 0.16 0.06 4.65 <0.001** 0.113 
mIE50SLP 1.31 0.30 1.47 0.40 -3.13 0.002* 0.335 
vIE50SLP 0.60 0.33 0.56 0.41 1.01 0.313 0.130 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 41.01 14.48 42.86 20.69 -0.77 0.439 0.876 
vrCT(%) 9.22 6.83 10.13 7.40 -0.60 0.551 0.271 
mHTA (deg.) 3.43 2.09 5.53 5.79 -4.47 <0.001** 0.566 
vHTA (deg.) 4.58 2.19 6.82 4.67 -3.64 <0.001** 0.550 
mTAA (deg.) 11.88 9.84 40.16 43.55 -5.41 <0.001** <0.001** 
vTAA (deg.) 13.53 12.97 24.08 14.71 -4.21 <0.001** 0.170 
No. of Breaths         81 27 103 35.5 -4.11 <0.001** 0.269 
Significantly different parameters are shown in bold italic (*Significant with P<0.01, ** Significant with 
P<0.001). 
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Figure 6-2. Comparison between SLP-estimated parameters in health and acute asthma pre and post-
bronchodilation administration. 
Two of the timing-based parameters [mtI (A), vtI (B)], and three flow-based parameters [vtPTEFSLP/tE 
(C), vtPTIFSLP/tI (D), and mIE50SLP (E)] differed between healthy children and those with 
asthma/wheeze both pre- and post-bronchodilator administration. The reduction in vtPTEFSLP/tE in the 
children with asthma following bronchodilator administration is also illustrated (C) (Hmeidi et al., 2018, 
p.6). 
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6.4 Discussion  
In this study, SLP-estimated tidal breathing parameters in children recovering from acute 
asthma/wheeze (2-12 years) were compared with healthy children of the same age. The effect 
of bronchodilator administration in the acute asthma group was also investigated, then a 
secondary analysis was carried out to investigate whether the effect of asthma/wheeze or the 
effect of bronchodilation varied between younger (aged 2–5 years) and older (aged 6–12 years) 
children. 
In the whole asthma group, median values of seven parameters, and the within-subject 
variability of eight parameters showed significant differences from healthy children. None of 
the median values changed after the administration of bronchodilation. However, a reduction 
in the within-subject variability of one flow-based parameter was observed. The response to 
bronchodilation in younger children was different than in the older children, with greater 
changes observed in regional parameters (TAA and rCT). 
In the whole group, median IE50SLP was higher in children with acute asthma/wheeze than those 
in the healthy group. Conventionally, the tidal breathing parameter IE50 is defined as the ratio 
of inspiratory to expiratory flow at 50% of tidal volume (TIF50/TEF50) (Stick, 1996). Previous 
studies have shown a reduction in tidal expiratory flow at 50% tidal volume (TEF50) in 
obstructive airways disorders such as asthma (Totapally et al., 1996; Papiris et al., 2002; Tauber 
et al., 2003). A drop in TEF50, without a change in TIF50, would increase the ratio between 
them (IE50) and could justify the higher median IE50SLP observed in this study. 
Higher IE50 has been reported in the previous study in children aged 7–16 years with stable 
asthma (H. Hmeidi et al., 2017) and in adults with COPD (Motamedi-Fakhr, Wilson and Iles, 
2017). IE50SLP did not change as a response to bronchodilation administration and stayed higher 
than in normal although they were in the recovery phase of their disease (considered clinically 
stable). Contrary to the findings in the previous study in children with stable asthma where 
IE50SLP dropped significantly following bronchodilation administration. In the previous study, 
children included were known to have abnormal forced expiratory volume in one second 
(FEV1), and that the reduction in IE50SLP after bronchodilation administration was linked with 
an increase in % predicted FEV1, showing a bronchodilator response. In this study, however, 
spirometry was not performed, and thus it was not known if FEV1 was low prior to 
bronchodilator treatment. Therefore, it could be that the observed increase in IE50SLP is 
indicative of the components of airflow obstruction which was not sensitive to bronchodilation, 
or simply no detectable bronchodilator response occurred. 
In the previous study, IE50SLP stayed significantly higher than normal after bronchodilation. 
The observation in this study might suggest that these children were still experiencing the effect 
of respiratory exacerbation even though they were considered in the recovery phase of there 
illness. 
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Figure 6-3. Asynchrony parameters mTAA (A), vTAA (B), mHTA (C), and vHTA (D) differences in 
healthy children compared with those with asthma/wheeze which remained after bronchodilator 
administration (Hmeidi et al., 2018, p.6). 
 
Figure 6-4. mTAA in healthy children and with those with asthma/ wheeze, classified by age groups  
(Hmeidi et al., 2018) 
In other studies, tidal breathing parameters in asthmatic children were returned towards normal 
after bronchodilation (Kuratomi et al., 1985; van der Ent et al., 1996). Comparing IE50SLP in 
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the same asthmatic children with and without an exacerbation and during recovery from an 
exacerbation would be of interest, in order to see whether this variable is sensitive enough to 
monitor disease activity. 
Asynchrony parameters’ magnitudes and their within-subject variability for TAA and rCT were 
significantly higher in the acute asthma/wheeze group than in healthy children. Even though 
some asynchrony was observed in healthy children (Sivan and Newth, 1990; Newth and 
Hammer, 2005), generally the thorax and abdomen move in synchrony when no obstructive 
disease exists. Conversely, the movement of the abdomen precedes that of the thorax with the 
increase in work of breathing that happens in children with acute asthma, causing a loss of this 
synchrony (Giordano et al., 2012). Within-subject variability in asynchrony parameters is 
higher in children with acute asthma (for thorax-abdomen and left-right hemi-thorax), which 
might suggest a compensatory mechanism such that spatial variability is presented into the 
system once temporal variability is decreased. 
In the stable asthma study, the within-subject variability of asynchrony was not observed when 
compared with healthy children (Hmeidi et al., 2017) ; however, children in that study were 
older, therefore, were likely to have reduced chest wall compliance, and thus, less tendency for 
regional variation. The observation in this study that the effect of asthma/wheeze on TAA was 
higher in younger children than in older cohort has further supported this effect of age. Asthma 
effect on HTA or on the within-subject variability in asynchrony parameters has not been 
previously reported. 
Unexpectedly, the variability observed in tPTIFSLP/tI was lower in the asthma group than in 
normal children, which contradicts with previously reported results.  For instance, studies have 
found that children with asthma have greater variability in airway resistance (Lall et al., 2007). 
This observation could be attributed to the frequent bronchodilator treatment given to asthmatic 
children in this study before the test intervention. The reduced variability in tPTEFSLP/tE as a 
response to bronchodilator treatment, which is in line with the reported airways resistance 
variations following bronchodilation in both asthmatics and controls (Lall et al., 2007). 
Similarly, a non-significant decrease in the variation of tPTEFSLP/tE was observed in the stable 
asthma study as a response to bronchodilation. Furthermore, the difference was seen between 
healthy and asthmatics (pre-bronchodilator) was no longer noticeable post-bronchodilator, 
indicating that a drop has happened (H. Hmeidi et al., 2017). No such drop was observed in the 
variability of IE50SLP following bronchodilation in children with acute asthma/wheeze. A 
reduction in the variability of airways resistance was higher than that of FEV1 as reported by 
(Lall et al., 2007). The variability of tPTEF/tE could similarly, be more sensitive to the effects 
of bronchodilator treatment than the variability of IE50 based on this study’s observations, 
which need to be further investigated. 
The effect of bronchodilator treatment was higher on mTAA and vTAA in younger children, 
who have shown a reduced and less variable asynchrony. Additionally, their breathing became 
more abdominal as shown by the reduction of mrCT. In the stable asthma study, these 
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observations were not evident in older children with stable asthma, indicating that it is an age-
related effect because of the differences in chest wall compliance. 
 
  
Figure 6-5. Changes in mrCT (A), mTAA (B) and vTAA (C) after bronchodilator administration in 
children with asthma/wheeze, classified by age group. 
Error bars indicate the 25th and 75th percentiles 
(Hmeidi et al., 2018, p.9). 
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Table 6-3. SLP-estimated tidal breathing parameters in children with acute asthma/wheeze before and 
after bronchodilator administration. 
 Children with 
acute 
asthma/wheeze 
(before 
bronchodilator) 
(N = 39) 
Children with 
acute 
asthma/wheeze 
(After 
bronchodilator) 
(N = 39) 
 
Median IQR Median IQR 
z-
stat 
(WRS test) 
P-value 
(MWU 
test) 
P-value 
Timing indices and ratios 
mRR (brpm) 30.00 7.71 31.03 8.25 -1.56 0.118 0.305 
vRR (brpm) 4.45 3.16 4.36 2.85 -0.47 0.635 0.146 
mtI (sec) 0.83 0.19 0.80 0.21 1.61 0.108 0.612 
vtI (sec) 0.13 0.12 0.13 0.11 0.50 0.619 0.828 
mtE (sec) 1.14 0.43 1.13 0.40 1.06 0.290 0.175 
vtE (sec) 0.23 0.15 0.25 0.15 -0.82 0.410 0.603 
mtTot (sec) 2.00 0.57 1.93 0.59 1.61 0.107 0.363 
vtTot (sec) 0.33 0.11 0.32 0.20 -0.30 0.763 0.419 
mtI/tE 0.70 0.15 0.70 0.14 1.03 0.301 0.665 
vtI/tE 0.16 0.08 0.14 0.06 1.35 0.176 0.283 
mtI/tTot 0.41 0.05 0.41 0.05 0.97 0.331 0.707 
vtI/tTot 0.05 0.03 0.05 0.02 1.3` 0.190 0.246 
Flow-based parameters 
mtPTEFSLP/tE 0.38 0.18 0.37 0.14 0.85 0.395 0.679 
vtPTEFSLP/tE 0.21 0.20 0.15 0.12 3.87 <0.001** 0.352 
mtPTIFSLP/tI 0.53 0.06 0.53 0.06 -1.24 0.213 0.564 
vtPTIFSLP/tI 0.16 0.06 0.17 0.08 0.10 0.922 0.658 
mIE50SLP 1.47 0.40 1.50 0.32 0.71 0.477 0.598 
vIE50SLP 0.56 0.41 0.52 0.37 1.84 0.065 0.309 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 42.86 20.69 39.47 19.85 1.95 0.051 0.041* 
vrCT(%) 10.13 7.40 8.98 4.58 1.45 0.147 0.051 
mHTA (deg.) 5.53 5.79 5.98 5.33 0.82 0.41 0.338 
vHTA (deg.) 6.82 4.67 6.82 5.09 0.03 0.978 0.449 
mTAA (deg.) 40.16 43.55 31.08 39.26 0.89 0.372 0.030* 
vTAA (deg.) 24.08 14.71 20.31 14.57 1.41 0.159 0.020* 
No. of Breaths         103 35.5 107 22.8 -1.68 0.094 0.862 
Significantly changed parameters are shown in bold italics italic (*Significant with P<0.05, ** 
Significant with P<0.001). 
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Patients with acute asthma/wheeze have higher RR than in healthy children in order to 
compensate for the decreased amount of air inhaled in each breath caused by the airway 
obstruction (Kesten et al., 1990). In this study, RR was higher in asthmatic children, tTot and 
its components tI and tE were shorter compared with those of healthy children. Except for RR, 
all timing indices and ratios have shown a reduced within-subject variability in children with 
acute asthma/wheeze, which is attributed to the faster RR, restricting variation. Healthy subjects 
naturally show some variability in tidal breathing parameters (Tobin et al., 1988), which was 
confirmed in this study. The tendency of normal breathing patterns to change permits the 
participation of respiratory system in other tasks besides gas exchange, such as speech and 
coughing (Brack, Jubran and Tobin, 2002). SLP measures a large number of consecutive 
breaths (mean ≥ 80 breaths per assessment in this study). Thus it is suitable to measure within-
subject variability. 
SLP is a contactless technique which does not require the use of equipment such as nose clips 
and face masks, which might affect tidal breathing (Gilbert et al., 1972), and requires minimal 
cooperation from the subject. This method requires individuals to stay still for five minutes, 
which is one of the limitations of this method. Consequently, in this study children with acute 
asthma were not assessed until they were clinically stable. It is possible, therefore, that the study 
might have missed changes in tidal breathing parameters happening during the exacerbation. 
Moreover, as these participants were in the NICU, they were exposed to high or more frequent 
dosages of bronchdialators. These treatments could have created a carry-over effect, which was 
sustained during SLP assessment. Consequently, after exposing participants to this study’s 
treatment, SLP’s ability to detect response may have been violated. 
The risk of some statistically significant results happening by chance, due to the multiple 
comparisons made in this study was taken into account (Hmeidi et al., 2018). The Bonferroni 
correction was not applied in this study as it assumes the independence between the 
comparisons, which is not the case here. Though CLES calculations have supported the initial 
statistical comparisons, and many of the observed changes in SLP parameters had a firm 
physiological origin or are confirmed by other studies (Laveneziana et al., 2015b; Motamedi-
Fakhr, Wilson and Iles, 2017). 
In this study, it is shown that SLP can be successfully utilized in children as young as two years 
recovering from acute asthma/wheeze. Furthermore, several SLP parameters, specifically 
IE50SLP, RR and asynchrony (both hemi-thoracic and thoraco-abdominal), with the within-
subject variability of multiple parameters were different in the acute asthma group. Thus, SLP 
could offer the clinician ways of distinguishing asthmatic children from their healthy 
counterparts, and also ways of monitoring recovery. 
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Table 6-4. SLP-estimated tidal breathing parameters in children with acute asthma/wheeze 
(after bronchodilator administration) versus healthy children. 
 
Healthy children 
(N = 54) 
Children with 
acute 
asthma/wheeze 
(After 
bronchodilator) 
(N = 39) 
 
Median IQR Median IQR z-stat 
MWU test 
P-value 
Robust 
ANOVA 
P-value 
Timing indices and ratios 
mRR (brpm) 23.00 5.35 31.03 8.25 -5.01 <0.001** 0.642 
mtI (sec) 1.13 0.30 0.8 0.21 5.67 <0.001** 1.000 
vtI (sec) 0.22 0.20 0.13 0.11 4.57 <0.001** 0.782 
mtE (sec) 1.48 0.40 1.13 0.40 4.17 <0.001** 0.814 
vtE (sec) 0.43 0.25 0.25 0.15 4.72 <0.001** 0.195 
mtTot (sec) 2.60 0.64 1.93 0.59 5.02 <0.001** 0.924 
vtTot (sec) 0.53 0.31 0.32 0.20 4.66 <0.001** 0.508 
vtI/tE 0.23 0.12 0.14 0.06 4.18 <0.001** 0.663 
vtI/tTot 0.07 0.03 0.05 0.02 4.09 <0.001** 0.321 
Flow-based parameters 
vtPTIFSLP/tI 0.21 0.09 0.17 0.08 4.26 <0.001** 0.083 
mIE50SLP 1.31 0.30 1.50 0.32 -3.26 0.001* 0.350 
Regional Parameters (Phase and relative contribution) 
mHTA (deg.) 3.43 2.09 5.98 5.33 -4.11 <0.001** 0.796 
vHTA (deg.) 4.58 2.19 6.82 5.09 -3.29 0.001** 0.767 
mTAA (deg.) 11.88 9.84 31.08 39.26 -5.21 <0.001** 0.054 
vTAA (deg.) 13.53 12.97 20.31 14.57 -3.34 0.001** 0.682 
No. of Breaths         81 27 107 22.8 -5.33 <0.001** 0.271 
Significantly different parameters are shown in bold italics italic (*Significant with P<0.01, ** 
Significant with P<0.001). 
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Table 6-5. CLES evaluation of SLP-estimated tidal breathing parameters. 
Hypothesis 
CLES 
(%) 
Interpretation 
Healthy versus children with asthma (before BD administration) 
mRR: High in asthma 
group 
78.5 
In 78.5% of cases, mRR was higher in asthma 
group 
mtI: lower in asthma 
group 
82.1 
In 82.1% of cases, mtI was lower in asthma 
group 
vtI: lower in asthma 
group 
73.2 
In 73.2% of cases, vtI was lower in asthma 
group 
mtE: lower in asthma 
group 
74.2 
In 74.2% of cases, mtE was lower in asthma 
group 
vtE: lower in asthma 
group 
79.2 
In 79.2% of cases, vtE was lower in asthma 
group 
mtTot: lower in asthma 
group 
78.5 
In 78.5% of cases, mtTot was lower in asthma 
group 
vtTot: lower in asthma 
group 
79.1 
In 79.1% of cases, vtTot was lower in asthma 
group 
vtI/tE: lower in asthma 
group 
71.7 
In 71.7% of cases, vtI/tE was lower in asthma 
group 
vtI/tTot: lower in asthma 
group 
70.6 
In 70.6% of cases, vtI/tTot was lower in 
asthma group 
vtPTIFSLP/tI: lower in 
asthma group 
78.4 
In 78.4% of cases, vtPTIFSLP/tI was lower in 
asthma group 
mIE50SLP: higher in 
asthma group 
69.1 
In 69.1% of cases, mIE50SLP was higher in 
asthma group 
mHTA: higher in asthma 
group 
77.3 
In 77.3% of cases, mHTA was higher in 
asthma group 
vHTA: higher in asthma 
group 
72.2 
In 72.2% of cases, vHTA was higher in 
asthma group 
mTAA: higher in asthma 
group 
83.0 
In 83.0% of cases, mTAA was higher in 
asthma group 
vTAA: higher in asthma 
group 
75.7 
In 75.7% of cases, vTAA was higher in 
asthma group 
Healthy versus children with asthma (after BD administration) 
mRR: High in asthma 
group 
80.2 
In 80.2% of cases, mRR was higher in asthma 
group 
mtI: lower in asthma 
group 
83.4 
In 83.4% of cases, mtI was lower in asthma 
group 
vtI: lower in asthma 
group 
76.5 
In 76.5% of cases, vtI was lower in asthma 
group 
mtE: lower in asthma 
group 
74.9 
In 74.9% of cases, mtE was lower in asthma 
group 
74 
 
vtE: lower in asthma 
group 
78.1 
In 78.1% of cases, vtE was lower in asthma 
group 
mtTot: lower in asthma 
group 
80.2 
In 80.2% of cases, mtTot was lower in asthma 
group 
vtTot: lower in asthma 
group 
77.9 
In 77.9% of cases, vtTot was lower in asthma 
group 
vtI/tE: lower in asthma 
group 
75.5 
In 75.5% of cases, vtI/tE was lower in asthma 
group 
vtI/tTot: lower in asthma 
group 
75.0 
In 75.0% of cases, vtI/tTot was lower in 
asthma group 
VtPTEFSLP/tE: lower in 
asthma group 
64.9 
In 64.9% of cases, VtPTEFSLP/tE was lower 
in asthma group 
VtPTIFSLP/tI: lower in 
asthma group 
76.0 
In 76.0% of cases, VtPTIFSLP/tI was lower in 
asthma group 
mIE50SLP: higher in 
asthma group 
69.9 
In 69.9% of cases, mIE50SLP was higher in 
asthma group 
mHTA: higher in asthma 
group 
75.1 
In 75.1% of cases, mHTA was higher in 
asthma group 
vHTA: higher in asthma 
group 
70.1 
In 70.1% of cases, vHTA was higher in 
asthma group 
mTAA: higher in asthma 
group 
81.8 
In 81.8% of cases, mTAA was higher in 
asthma group 
vTAA: higher in asthma 
group 
70.4 
In 70.4% of cases, vTAA was higher in 
asthma group 
Before vs. after BD administration (Children with asthma) 
vtPTEFSLP/tE: reduced 
after BD 
74.4 
In 74.4% of cases, vtPTEFSLP/tE decreased 
after BD 
 
 
SLP is a useful technique especially for pre-school children, due to the difficulties in assessing 
airflow obstruction (hence, provide an accurate asthma diagnosis) in this age group. The 
preliminary results in this study are promising and could support further investigation and 
improvements in this technique in order to introduce it into routine clinical practice. The effect 
of age on breathing patterns needs to be further investigated, SLP might introduce a method for 
assessing lung function in patients who cannot use traditional techniques such as spirometry. 
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7 Acute Viral Bronchiolitis (AVB) Study 
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7.1 Introduction 
Bronchiolitis is a lower respiratory tract infection, which affects infants usually in their first 
year of life (Ralston et al., 2014). In most cases, bronchiolitis results from a respiratory 
syncytial virus (RSV), and symptoms clear up without any treatment. However, some infants 
develop severe symptoms which make hospitalisation essential (Gajdos et al., 2010). In some 
cases, bronchiolitis can cause respiratory failure, and the assessment of respiratory muscle 
function might be clinically useful in these cases even though it has some limitations (Gaultier, 
1995). Since existing methods are designed to be used in adults, its use in infants is deemed to 
be inconvenient.  
Most advanced pulmonary function techniques for neonates and infants require sedation and 
highly trained technicians to perform the tests, which restricts their use to specialised research 
centres. Thus, the measurements of tidal breathing parameters have been proposed to be an 
alternative approach to simplify lung function testing in this group (Banovcin, Seidenberg and 
Von Der Hardt, 1995; Bates et al., 2000). 
Many studies have shown the usefulness of the analysis of tidal breathing (such as flow-volume 
loops) in assessing lung functions in infancy (Lodrup-Carlsen and Carlsen, 1993; Banovcin, 
Seidenberg and der Hardt, 1995; Carlsen et al., 1995; Frey and Merkus, 2010). In infants, tidal 
breathing yields more information than in adults, due to the small geometric dimensions of the 
tracheal tree. Therefore, tidal breathing in infancy is closer to maximal work of breathing, and 
any additive load during respiratory disease can bring the infant to a forced expiration breathing 
state (Seddon, Davis and Coates, 1996). Hence, tidal breathing can be very informative for 
diagnosing different pathologies (Lødrup, 2000). 
Gas exchange is usually used to assess the severity of AVB and the effectiveness of different 
treatments in children who develop respiratory failure and increased work of breathing (WOB) 
(Greenough, 2009). Remarkably, Limited research has been done investigating respiratory 
mechanics in infants with severe bronchiolitis under mechanical ventilation (Øymar, Skjerven 
and Mikalsen, 2014; Ralston et al., 2014). 
This study aims to investigate the use of SLP in the assessment of tidal breathing in infants with 
AVB. Tidal breathing parameters were examined whether they can differentiate between 
infants with AVB and healthy controls. In addition, changes in tidal breathing parameters 
between the day of admission and discharge were investigated in the AVB group. 
 
7.2 Materials and methods 
7.2.1 Participants  
Thirty-four infants diagnosed with AVB (12 female), aged 0-1 year were recruited on admission 
to the children’s assessment unit (CAU) or children’s intensive care unit. In the clinician’s 
opinion, all infants were clinically stable, without any immediate danger, to take part in the 
study. SLP-parameters from the AVB group on admission were compared with those from a 
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group of 22 healthy infants (16 female) recruited from the maternity department. In this context, 
healthy is defined as not having any signs of respiratory disease or need for extra oxygen. Four 
AVB infants were discharged on the same day, and the rest stayed in the hospital for at least 
two days for observation and were re-assessed using SLP on discharge. 
 Infants were excluded from the study if they had significant co-morbidity or chest wall 
abnormality, obstructive sleep apnoea, a body mass index >40 kg/m2, any acute or chronic 
condition that restricted his/her ability to participate, or they were unable to comply with the 
protocol.  
The study was approved by the UK Health Research Authority National Research Ethics 
Service (reference number 11/EE/00/37) and was performed at the Royal Stoke University 
Hospital (Stoke-on-Trent, UK), according to International Council for Harmonisation 
Guidelines for Good Clinical Practice. Parents or guardian provided written informed consent. 
 
7.2.2 Study design  
Infants with AVB underwent two SLP assessments; the first was performed on admission and 
the last on discharge. Healthy infants underwent one SLP assessment. Each assessment was 
planned to be for five minutes, but for practicality reasons it was not possible to record the full 
duration in all infants, as some infants moved or cried during the assessment. A distraction 
method (sleeping music) was used to keep the subjects as still as possible. 
 
7.2.3 SLP procedure and data analysis 
Tidal breathing was measured using an SLP device on the bedside, as previously described in 
chapter three. The 3D-reconstruction was played and checked to ensure that data were as 
artefact-free as possible. Visual assessment of the 3D surface is an important step to identify 
tracking errors such as errors caused by a lack of contrast in the projected grid for more details 
see 4.3.3. 
 
7.2.4 Statistical Analysis 
Power calculations were not performed before this study since this is the first data reported 
using SLP in infants and data on expected variability were not available. A Mann-Whitney-U 
test was used to compare each ‘m’ and ‘v’ parameter (4.3.2 for more details) in healthy infant 
and those with AVB. To assess the differences in clinical measures and tidal breathing 
parameters between admission and discharge a paired Wilcoxon signed-rank (WSR) was 
utilised. Common language effect size (CLES) was used to further assess the ability of SLP 
parameters, which have shown a significant difference to differentiate between the two groups 
and to detect recovery. No corrections were made to P-values for the multiple tests performed, 
as this was an exploratory study. 
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Figure 7-1. SLP assessment on an infant with AVB during sleeping. 
 
7.3 Results 
Thirty-four infants with AVB, in addition to 22 healthy controls were eligible for this study and 
provided valuable data for the analysis. Table 7-1 shows the demographics of both studied 
groups. The success rate of SLP procedure was 96.6% and was defined as the number of 
measurements which have provided usable data divided by the total number of measurements 
performed (86/89). The excluded measurement was because of its poor quality caused by either 
excessive movement or light.  
Many parameters have shown significant differences between healthy controls and infants with 
AVB (on the admission day) (Table 7-3). Of the timing parameters, none of the parameters’ 
magnitudes has shown a significant difference between infants with AVB and healthy controls. 
Apart from vtI/tE, the within-subject variability in all timing indices and ratios were 
significantly lower in infants with AVB than in healthy controls; vRR (9.97 vs. 17.33 brpm; 
p<0.001), vtI (0.13 vs. 0.22 sec; p<0.01), vtE (0.17 vs. 0.33 sec; p<0.001) and vtI/tTot (0.07 vs. 
0.11 sec; p=0.03). 
Of the flow-based parameters, vtPTEFSLP/tE, mIE50SLP and vIE50SLP were significantly lower 
in the AVB group compared with healthy infants (0.16 vs. 0.27, p = 0.02), (1.00 vs. 1.19, 
p=0.03) and (0.48 vs. 0.97, p<0.001), respectively. Finally, of the regional parameters, Thoraco-
79 
 
abdominal asynchrony (TAA) was significantly higher in infants with AVB than in healthy 
controls (mTAA: 62.13 vs. 16.17 degrees, p<0.01). 
Thirty infants with AVB were compared between admission and discharge as they were kept 
in hospital for observation, and four were discharged on the same day. None of the parameters’ 
magnitudes differed significantly between admission and discharge (Table 7-4). The within-
subject variability of IE50SLP was the only parameter that has increased as a result of the natural 
recovery of the condition from 0.48 to 0.62 (p=0.047). The increase that occurred was toward 
the normal value seen in healthy controls (0.97). 
 
Table 7-1. Participants demographics from both groups.  
 Healthy infants 
(N = 22) 
Children with AVB 
(N=34) 
Gender (male: female), n 6:16 22:12 
Age, weeks 8.60 (6.99) 19.29 (14.06) 
Length, cm 56.75 (1.20) 62.75 (8.99) 
Data are mean (standard deviation). 
 
 
Table 7-2. Comparison of clinical measures in infants with AVB (N=30) on admission and discharge. 
Heart Rate; Respiratory Rate; Oxygen saturation.  
 
Heart Rate 
(bpm) 
Median (IQR) 
Respiratory 
Rate (brpm) 
Median (IQR) 
SaO2 (%) 
Median (IQR) 
Admission day 146.5 (22) 44 (8) 96 (5) 
Discharge day 137.5 (18) 40 (6) 96 (2) 
p-value* 0.108 <0.01 0.753 
Significance* tested using Wilcoxon Signed rank-test. 
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 Table 7-3. Comparison of tidal breathing parameters measured with SLP between 
healthy children and infants with AVB (Admission).  
 
Healthy Infants 
(N = 22) 
Infants with AVB 
(Admission) 
(N = 34) 
 
Median IQR Median IQR z-stat 
Significance 
(MWU test) 
Timing indices and ratios 
mRR (brpm) 50.04 19.45 48.01 19.10 -0.48 0.63 
vRR (brpm) 17.33 10.24 9.97 5.87 4.47 <0.001** 
mtI (sec) 0.55 0.20 0.58 0.27 -0.64 0.52 
vtI (sec) 0.22 0.33 0.13 0.13 3.09 <0.01* 
mtE (sec) 0.62 0.27 0.62 0.30 0.65 0.52 
vtE (sec) 0.33 0.35 0.17 0.11 3.41 <0.001** 
mtTot (sec) 1.20 0.57 1.25 0.47 0.48 0.63 
vtTot (sec) 0.54 0.57 0.20 0.17 3.73 <0.01** 
mtI/tE 0.88 0.09 0.93 0.19 -1.89 0.06 
vtI/tE 0.43 0.45 0.29 0.31 1.48 0.14 
mtI/tTot 0.47 0.02 0.48 0.05 -1.89 0.06 
vtI/tTot 0.11 0.11 0.07 0.07 2.30 0.03* 
Flow-based parameters 
mtPTEFSLP/tE 0.41 0.08 0.45 0.35 -0.84 0.40 
vtPTEFSLP/tE 0.27 0.14 0.16 0.13 2.27 0.02* 
mtPTIFSLP/tI 0.47 0.10 0.47 0.16 -0.65 0.52 
vtPTIFSLP/tI 0.24 0.17 0.14 0.21 1.05 0.29 
mIE50SLP 1.19 0.25 1.00 0.48 2.17 0.03* 
vIE50SLP 0.97 0.64 0.48 0.38 3.70 <0.001** 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 62.59 18.74 57.39 37.24 -0.16 0.87 
vrCT(%) 17.06 9.00 17.49 13.26 -0.39 0.69 
mTAA (deg.) 16.17 30.87 62.13 97.54 -3.08 <0.01* 
vTAA (deg.) 29.44 26.87 27.13 29.31 0.60 0.55 
No. of Breaths 75 63 79 72 0.63 0.53 
(*Significant with P<0.05, ** Significant with P<0.001).  
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Table 7-4. Comparison of tidal breathing parameters measured with SLP in infants with AVB on 
admission and discharge.  
 Infants with AVB 
(Admission) 
(N = 30) 
Infants with AVB 
(Discharge) 
(N = 30) 
 
Median IQR Median IQR z-stat 
WSR test 
P-value 
Timing indices and ratios 
mRR (brpm) 48.01 19.10 48.65 15.21 -0.47 0.64 
vRR (brpm) 9.93 5.72 9.80 7.94 -0.52 0.60 
mtI (sec) 0.57 0.27 0.53 0.17 -1.708 0.09 
vtI (sec) 0.13 0.09 0.10 0.13 -0.05 0.96 
mtE (sec) 0.62 0.27 0.62 0.27 -0.42 0.67 
vtE (sec) 0.17 0.09 0.16 0.13 -0.62 0.54 
mtTot (sec) 1.25 0.47 1.23 0.37 -0.62 0.54 
vtTot (sec) 0.20 0.17 0.22 0.17 -0.54 0.59 
mtI/tE 0.93 0.19 0.89 0.24 -1.870 0.06 
vtI/tE 0.29 0.27 0.29 0.30 -0.05 0.96 
mtI/tTot 0.48 0.05 0.47 0.07 -1.85 0.06 
vtI/tTot 0.07 0.07 0.09 0.08 -0.55 0.59 
Flow-based parameters 
mtPTEFSLP/tE 0.45 0.37 0.41 0.23 -1.08 0.28 
vtPTEFSLP/tE 0.16 0.12 0.25 0.18 -1.80 -0.07 
mtPTIFSLP/tI 0.47 0.18 0.45 0.10 -0.94 0.35 
vtPTIFSLP/tI 0.14 0.21 0.15 0.19 -0.30 0.77 
mIE50SLP 0.96 0.45 1.06 0.30 -0.59 0.56 
vIE50SLP 0.48 0.38 0.62 0.49 -1.96 0.047* 
Regional Parameters (Phase and relative contribution) 
mrCT(%) 56.21 37.24 61.00 25.34 -0.50 0.61 
vrCT(%) 17.49 13.75 17.55 11.76 -0.44 0.66 
mTAA (deg.) 62.13 104.43 53.15 103.77 -0.52 0.60 
vTAA (deg.) 28.76 29.46 24.48 26.91 -0.40 0.69 
No. of Breaths         79 72 61.50 68 -0.23 0.82 
(*Significant with P<0.05).  
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Figure 7-2. vIE50SLP differed in healthy infants compared with those with AVB at admission and 
discharge. 
 
7.4 Discussion 
In this study, SLP-estimated tidal breathing parameters in infants recovering from acute viral 
bronchiolitis were compared with healthy infants. Differences in the parameters between 
admission and discharge were studied in the AVB group.  
Median values of two parameters and the within-subject variability of seven parameters have 
shown significant differences from healthy infants. As a part of the normal regulatory 
mechanism of breathing, the within-subject variability is expected to be higher in healthy 
infants. Because of the load on the respiratory system caused by airways obstruction in the AVB 
group, the system becomes more rigid resulting in a drop in the within-subject variability. This 
is in line with the findings of this study that the within-subject variability of IE50SLP has shown 
a significant increase on discharge.  
In our previous study comparing asthmatic children (7-16 years) with healthy controls, IE50SLP 
was significantly higher in the asthmatic group. Similarly, IE50SLP was higher in children with 
asthma/wheeze (2-12 years) compared to healthy controls. The increase in IE50SLP was 
attributed to the drop in TEF50SLP caused by airways obstruction. The physiology of 
bronchiolitis suggests lower airways obstruction caused by the secretion of mucus in the 
airways, and as such, its value was expected to be higher in infants with AVB. Median IE50SLP 
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was lower in infants with AVB than in the healthy infants, and the reduction is caused by a 
reduced TIF50SLP compared to TEF50SLP. This could be attributed to either (1) the higher effect 
of AVB on the inspiratory part than on the expiratory part of breathing or (2) the natural age-
related differences in IE50SLP components, knowing that patients with AVB were relatively 
older than their healthy counterparts 19.29 (14.06) vs. 8.60 (6.99). This contradiction with what 
was previously reported about IE50SLP changes in airways obstruction needs to be further 
investigated. 
TAA was significantly higher in the AVB group than in healthy infants. Some degree of 
thoraco-abdominal asynchrony was observed in healthy infants (Sivan and Newth, 1990; Newth 
and Hammer, 2005), but generally, thorax and abdomen move in synchrony in the absence of 
an airways obstruction. In AVB infants, the increased work of breathing caused by airways 
obstruction could disturb this synchronization (Giordano et al., 2012).  
The variability observed in tPTEF/tE was lower in infants with AVB than in healthy infants, 
which is in line with the results reported in previous studies on infants and children with airways 
obstruction (Morris and Lane, 1981; Lødrup, 2000; Latzin et al., 2009). 
In this study, vIE50SLP was the only parameter that was sensitive to recovery, but contrary to 
the finding in the stable asthma group, vIE50SLP has significantly increased toward normal value 
on discharge compared to admission. Even though, the value did not reach the normal level.  
CLES have shown that vIE50SLP have increased in 70.0 % of the cases on discharge. The 
recovery was confirmed by the drop of both heart rate and respiratory rate (P=0.01), and the 
stabilized SaO2 level. 
Although the Bonferroni correction was not applied in this study, CLES have supported the 
multiple comparisons performed. Furthermore, many of the observed differences and changes 
in SLP parameters were confirmed by previous studies. 
In this study, it is shown that SLP can be successfully utilised in infants (< 1 year), recovering 
from AVB. Numerous SLP parameters, specifically thoraco-abdominal asynchrony (TAA), 
with the within-subject variability of timing indices and ratios, were different in the AVB group 
and hence, could offer the clinicians ways of differentiating infants with AVB from their 
healthy counterparts, and also ways to monitor recovery. 
The preliminary results and the success rate in this study are promising and could support 
further investigations in infants with AVB prior the administration of Oxygen (and pre/post 
different interventions).  
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Table 7-5. CLES evaluation of SLP-estimated tidal breathing parameters which have shown significant 
differences. 
Hypothesis 
CLE
S (%) 
Interpretation 
Healthy versus infants with AVB (Admission) 
vRR: Higher in AVB group 85.7 85.7% of cases, mRR was higher in AVB group 
vtI: lower in AVB group 74.6 74.6% of cases, vtI was lower in AVB group 
vtE: lower in AVB group 77.1 77.1% of cases, vtE was lower in AVB group 
vtTot: lower in AVBgroup 79.8 79.8% of cases, vtTot was lower in AVB group 
vtI/tTot: lower in AVB group 67.9 67.9% of cases, vtI/tTot was lower in AVB group 
vtPTEFSLP/tE: lower in AVB 
group 
67.4 67.4% of cases, vtPTEFSLP/tE was lower in AVB group 
mIE50SLP: lower in AVB group 79.6 79.6% of cases, mIE50SLP was lower in AVB group 
vIE50SLP: lower in AVB group 68.2 68.2% of cases, vIE50SLP was lower in AVB group 
mTAA: higher in AVB group 74.6 74.6% of cases, mTAA was higher in AVB group 
Admission vs. discharge (infants with AVB) 
vIE50SLP: increased on discharge 70.0 In 70.0% of cases, vIE50SLP increased on discharge 
 
7.5 Conclusion  
SLP procedure can be successfully conducted in infants as young as one week of age, and that 
SLP-estimated tidal breathing parameters can differentiate between infants with AVB and 
healthy infants and can also identify recovery. Further research to confirm these observations 
needs to be conducted. It would be very interesting to demonstrate the use of SLP with AVB 
infants who are not clinically stable. However, upon arrival to the hospital, infants with AVB 
are in a critical medical condition that requires an immediate medical intervention to stabilise 
their condition. A study of this nature must be carefully designed to overcome this major ethical 
issue. 
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8 Investigating the effect of upper-body movements 
and coughs on SLP quantified parameters 
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8.1 Introduction 
Any signal produced from a medical or biological source is called a bio-signal, those signals 
could be at different levels from the molecular to the systemic or organ levels (Muthuswamy, 
2003). 
Bio-signals are considered as combinations of noise and signal of interest, one of the main goals 
of signal processing is to remove noise components and preserve the components of the signal 
of interest, a step called signal filtering (Blinowska and Zygierewicz, 2012).  
For example, an electroencephalogram (EEG) is the electrical activity in the human brain and 
is usually recorded from the scalp. The EEG signal may be contaminated by the electrical 
activity of muscles such as those around the eye or the heart (ECG) and the powerline 
interference (50-60 Hz). The main goal of signal processing is to selectively remove irrelevant 
information from the signals in order to make the information of interest more easily available 
and usable by a human or computer (Delgutte, 2007). More specifically, SLP uses reflected 
light to track the movement of TA region of patients, which requires them to be in a still position 
throughout the assessment. However, this is not always achievable due to either the duration of 
the assessment or the ability of a child to follow instructions. Thus, upper-body movements and 
coughs were commonly observed during an SLP assessment. 
In a typical biomedical application, signal processing consists of four steps: data acquisition, 
signal conditioning, feature extraction, and decision making.  
The goal of data acquisition is to record the signal in a form suitable for computer processing; 
the second step is signal conditioning, which aims mainly to remove extraneous components 
from the recorded signal. In the feature extraction stage, a number of parameters are quantified 
which describe the signal of interest. Finally, the hypothesis testing and decision making stage 
is of great importance in clinical applications as it may involve diagnosis decisions and medical 
interventions (Kayvan and Splinter, 2012). 
 
Figure 8-1. Biomedical signal processing steps: 
Data Acquisition, signal conditioning (filtering), feature extraction and finally hypothesis testing. 
Biomedical signals are used clinically for monitoring specific pathological or physiological 
states, which could be used for diagnosis or the assessment of a clinical intervention. 
 
Digital Signal Processing (DSP) offers numerous powerful tools which could be applicable for 
each specific type of noise. Therefore, the purpose of this chapter is to investigate the SLP 
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signal and the interferences that might be introduced to it, mainly upper-body movements and 
coughs. Some fundamental signal processing concepts are introduced, that can be utilised to 
understand the nature of the SLP signal and noise. This study aimed to propose an algorithm 
that can identify and remove those artefacts and improve SLP-parameters estimation. 
Prior to choosing the appropriate DSP method, we need to understand the frequency spectrum 
in relation to the signal-of-interest and noise. Such that, if the frequency spectra of signal-of-
interest and noise do not overlap, with enough frequency-separation between them, then 
filtering could be used to reduce the noise.  Another condition is the use of specific features, of 
either signal-of-interest or noise, to differentiate between them if their spectra overlap (Davis, 
2002).  
The most commonly observed artefacts during SLP signal data acquisition is upper-body 
movements. SLP cameras capture TA-wall movements, and patients are instructed to sit as still 
as possible during the data acquisition, but even a small upper-body movements might be 
detected by SLP and could affect SLP parameters estimation, this problem is more likely to 
happen in younger children who are the subjects of our studies. In addition, one of the main 
symptoms of asthma is a chronic cough, which might also occur during SLP data acquisition.  
In this study, one type of upper-body movement (forward-backwards from the camera) is 
studied. This type of movements was studied due to its direct impact on the SLP recording, in 
where the forward-backwards TA wall movement is the signal of interest during breathing. The 
limited duration of this study and the diversity of movements restricted further investigations 
of more complex movements. The chosen movement is not a comprehensive representation of 
the effect of upper-body movement on SLP signal, but it provides an idea about the specific 
features of this artefact and allows us to investigate possible methods to remove it. 
Different filtering techniques used in filtering biomedical signals are discussed in this chapter, 
and an experiment was designed to assess the  effect of those two types of artefact on SLP 
outcomes. The effect was assessed by quantifying the agreement between tidal breathing 
parameters measured using a simultaneous SLP and Pneumotachograph (PNT) recordings, 
considering PNT signal as the gold standard in measuring tidal breathing parameters. 
Frequency components of breathing and artefacts were investigated using continuous wavelet 
transformation (CWT). CWT has shown a clear overlap in frequency spectra between breathing 
and upper-body movements. Thus, spectral subtraction method was used in an attempt to 
remove upper-body movements without affecting the breathing signal. However, as coughs are 
considered rejected breaths, they were removed from the time series. The removal was done 
using a statistical approach (which will be discussed later in this chapter), whilst taking into 
considerations coughs’ specific features, such as a high amplitude or short duration. In addition, 
removal of both coughs and upper-body movements was assessed to test the removal’s effect 
on the estimated parameters.  
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By viewing the video of the 3D-reconstructed surface, movements or coughs could usually be 
identified as sudden deviations. This approach cannot be used in clinical settings, where quick 
diagnostic or therapeutic decisions are needed. 
This study aimed to: (1) identify the optimal SLP recording time in an ideal SLP session-still 
position, (2) investigate the effect of upper-body movements and coughs on SLP-estimated tidal 
breathing parameters, and (3) assess the effect of using different techniques in removing these 
artefacts on the estimated parameters. 
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8.2 Digital Filters 
Digital filters are widely used in the studies of major systems of the body such as electrograms 
of hearing, blood pressure and flow, and nerve action potentials (Challis and Kitney, 1982) 
Digital filters are used to achieve two main goals: either separating combined signals or 
restoring distorted signals (Smith, 1997). The properties of these filters and their uses are 
described briefly in this section. 
Signal separation is required when the signal is combined with another signal or artefact, such 
as the signal acquired from a device measuring ECG of an infant in the mother’s uterus, the 
signal will be contaminated with the heartbeat of the mother, filtering is used in this case to 
separate the two signals. Whereas signal restoration is used when the captured signal is 
distorted, such as the deblurring of an ultrasound image acquired with an unstable probe. 
Filter characteristics for every linear filter are shown in Figure 8-2; those parameters can best 
describe its properties; impulse response, step response and frequency response. The most 
straightforward way to apply a digital filter is by using the convolution between the input signal 
and the digital filter's impulse response (Smith, 1997). 
The step response shows how the information characterised in the time domain is being changed 
by the system, while the frequency response shows how information characterised in the 
frequency domain is being changed. There is a trade-off between the time domain and 
frequency domain performances, where if a good performance in the time domain is required, 
a poor performance in the frequency domain will be obtained, and vice versa. Hence, designing 
a digital filter is an application dependent (Smith, 1997). 
 
  
90 
 
 
Figure 8-2. Filter characteristics.  
(a) Linear filter’s  impulse response, (b) step response which is the discrete integration of the impulse 
response, (c) Linear frequency response which is the Fast Fourier Transform (FFT) of the impulse 
response, (d) Frequency response in decibels. The linear scale is best at showing the passband ripple 
and roll-off, while the decibel scale is best for showing the stopband attenuation (Smith, 1997).  
 
8.2.1 Frequency Domain Parameters 
In frequency-domain filters, the main goal is to let some frequencies pass through unchanged 
while stopping other frequencies (Smith, 1997). Figure 8-3 shows the four commonly used 
frequency responses with the main parameters which determine the performance of the filter in 
the frequency domain. Firstly, the passband denotes the frequencies which are accepted, the 
stopband refers to the frequencies which are rejected, and the transition band is the band that 
connects them. The cut-off frequency is the frequency between the passband and the transition 
band, it is usually defined as the frequency where the amplitude is reduced to 70.7%, and finally, 
the roll-off describes the width of the transition band (Smith, 1997). 
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Figure 8-3. The Four common filter types (frequency responses). 
(a) low-pass,(b) high-pass, (c) band-pass, and (d) band-reject (Smith, 1997) (permission obtained from 
the author). 
To obtain good filter performance, the passband should be free of ripples to pass the frequencies 
in that band unchanged. Moreover, the stopband should have a good attenuation, to sufficiently 
stop the frequencies in that band. Furthermore, if the passed and the stopped frequencies are 
close, a fast roll-off is needed or in other words a narrow transition band (Smith, 1997). 
 
8.3 Discrete Fourier Transform (DFT) 
Discrete Fourier transform is the transform which is used to transform a discrete input signal 
into its sinusoidal components. Usually, input signals which enter DFT are in the time domain 
as they are sampled at even periods of time, it can also refer to any discrete signal to be analysed. 
There are mainly two types of DFT transforms, real and complex transforms. Numerous ways 
to calculate the DFT exist, with the Fast Fourier Transform (FFT) algorithm being the most 
effective for calculating the complex DFT (Smith, 1997).  
In real DFT, an N point input signal is decomposed into two N/2+1 point signals in the 
frequency domain, N is any positive integer of power 2, i.e., 128, 256, 512, etc. The two signals 
in the frequency domain are the real and the imaginary parts, which represent the amplitudes of 
the cosine and sine waves, respectively (Smith, 1997). In the complex DFT, two N point time 
domain signals are transformed into two N point frequency domain signals. Each domain 
contains a real and an imaginary part. 
In order to calculate the real DFT for an N point signal using the complex transform (e.g. FFT 
algorithm), first, the N point signal is filled into the time domain’s real part of the Complex 
DFT, and the imaginary part samples are set to zero. The output of the complex DFT is real and 
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imaginary signals in the frequency domain, each containing N points. The real DFT is the 
samples from 0 to N/2 of those signals. 
 
 
Figure 8-4. Real and complex DFT. 
In Real DFT an N point time domain signal is transformed into N/2+1 point signals in the frequency 
domain, whereas the complex DFT creates two N point signals in the frequency domain from two N 
point time domain signals. Changing from time-Domain to frequency-Domain is referred to as 
Forward DFT, while the transformation from Frequency-Domain to time-Domain is called Inverse 
DFT (Smith, 1997). 
The information in both time and the frequency domains are identical but represented in 
different forms, so that the data can be looked at in different ways. This has the advantage that 
some signal-related information which is not revealed in the time domain, could be easily 
discovered in the frequency domain.  
Fourier transform is the conventional analytical tool used for frequency domain analysis. 
However, Fourier transform assumes the stationarity of the signal (which means that its 
frequency content is not changing with time); thus, it is not an adequate method to analyse non-
stationary physiological signals, as FFT does not provide any time resolution. To overcome this 
shortcoming in Fourier transform, Short-Time Fourier transform (STFT), was introduced  
wherein a time series is windowed into smaller parts of fixed length, then the Fourier transform 
is calculated for each smaller part, this allows the reveal of time information about the spectral 
content of the signal (Polikar, 1994). 
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STFT allowed for the analysis of signals with time-varying spectra. However, it cannot be used 
to determine activities at different time scales because of the fixed window size in its definition. 
Wavelet transformation is a multi-scaled signal analysis tool, which was developed to overcome 
this deficiency in STFT. SLP signals, like most biomedical signals, are non-stationary. 
Moreover, transient changes which may interfere with SLP signals such as upper-body 
movements and coughing can happen at any time during data acquisition; this requires a solid 
tool to be able to represent those changes and reveal time-amplitude information. Thus, wavelet 
transformation was employed here to analyse SLP signals, for a better understanding of the 
signal and the artefacts. 
 
8.4 Wavelet Transformation 
8.4.1 Introduction 
Wavelet transformation is a linear process in which a signal is analysed into a different 
resolution components (Sahambi, Tandon and Bhatt, 1997). Wavelet analysis has been 
developed in the past decades as a robust tool for the multiscale representation of signals. This 
technique has the advantage over the traditional Fourier techniques by the way it represent the 
information content of signals (Unser and Aldroubi, 1996). 
Wavelet transformation possesses the capability of providing information on both the time and 
frequency simultaneously, hence portraying the time-frequency representation of the signal,  
which make it a convenient tool for analysing non-stationary signals (Polikar, 1994). 
Physiological signals contain non-stationary features such as drifting, abrupt changes, and 
starting and ending of events, those features are sometimes of big importance to understand 
(Shoeb and Clifford, 2006; Sorkhabi, 2014); hence, wavelet could give information on a 
specific spectral component occurring at any interval. This can be of particular interest in 
biomedical applications, for instance, EEG measures the time lapse between a stimulus to the 
brain and the response to it. Hence, the knowledge on time intervals of occurrence of a specific 
frequency can help in acquiring more information from the EEG. Wavelet transforms help in 
gaining this knowledge. 
Wavelet analysis incorporates a multi-resolution analysis of the signal (Liu, 2010). This concept 
analyses different frequencies with different resolutions. The multi-resolution analysis is 
formulated to yield good time resolution and poor frequency resolution in the case of high 
frequencies and provide good frequency resolution and poor time resolution in the event of low 
frequencies. This concept is highly appropriate in practical scenarios which are characterized 
by the occurrence of high frequencies for short durations and the existence of low frequencies 
for long time periods. 
In this chapter, a brief explanation of wavelets and the main equations to clarify the concept are 
given. More about the mathematics behind the concept can be found in (Burrus, Gopinath and 
Guo, 1998). 
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8.4.2 Continuous-time Wavelet Transformation (CWT) 
Similar to STFT, continuous wavelet transform uses a window function to obtain signal 
segments. In CWT the window is called a wavelet function but rather than being only translated 
over the input signal, it is also scaled (dilated and contracted), which allows capturing different 
time scale events (Polikar, 1994; Shoeb and Clifford, 2006). Equation 8-1 shows the 
continuous-time wavelet transform of signal 𝑥(𝑡): 
𝐶(𝑠, 𝜏) = ∫ 𝑥(𝑡)𝜓𝑠,𝜏
∞
−∞
𝑑𝑡 
Equation 8-1 
 
Where: 
𝜓𝑠,𝜏(𝑡) =
1
√𝑠
𝜓 (
𝑡 − 𝜏
𝑠
) 
Equation 8-2 
    
The analysis function  𝜓 , also called the mother wavelet is moved in time by 𝜏, and scaled by 
𝑠 , then correlated with the input signal 𝑥(𝑡). A scalogram is created which describes the 
strength of correlations between 𝑥(𝑡) and 𝑠 scaled  𝜓 at a specific time 𝜏, this correlation 
quantifies the degree of similarity between 𝑥(𝑡) and 𝜓 over time. 
𝜏 is related to the location of the window, as it is shifted throughout the signal, while 𝑠 is a scale 
parameter and is related to frequency. The multiplication of 
1
√𝑠
 is for energy normalization 
purposes. 
Wavelet transformation has solved the resolution problem encountered in STFT, by changing 
the time and frequency resolutions at different scales. This is achieved by contracting and 
dilating the mother wavelet which reveals short and long time-scale events Figure 8-5 shows 
that short time-scale events such as spikes are emphasised in the upper end of the plot, whereas 
the long time-scale events such as a baseline oscillation are emphasised in the bottom end of 
the plot (Shoeb and Clifford, 2006). This offers the potential of time-localizing the prompt 
changes in the SLP signal caused by the artefacts. 
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Figure 8-5. Constructing a Scalogram in CWT. 
Signal’s activities can be revealed at different times and scales, by plotting the correlation-change 
between the input signal and the mother wavelet over time (Shoeb and Clifford, 2006, p.10). 
 
 
Figure 8-6. Time-Frequency plane of the Continuous Wavelet transform. 
There is a trade-off between time and frequency resolutions in cwt; x and y-axes refer to the time and 
frequency resolutions, respectively. It is to be noted that though the rectangles differ in the dimensions, 
they have the same area. This denotes that if the time resolution is high, the frequency resolution is 
proportionally low and vice versa. 
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8.5 Spectral Subtraction 
Spectral subtraction is one of the oldest algorithms that has been used for the enhancement of 
speech signals (Upadhyay and Karmakar, 2015). In this method, the spectrum of noise is 
estimated from the noisy signal during the intervals where speech is absent and only noise exists 
and then is subtracted from the spectrum of the noisy signal (Upadhyay and Karmakar, 2015). 
Spectral subtraction algorithms have been commonly used for reducing additive noise in speech 
signals, with the assumption that the noise is stationary, such that its spectrum does not change 
significantly with time (Boll, 1979; Vaseghi, 2000). 
Additive noise causes an increase in the mean and the variance of the magnitude spectrum of 
the signal; spectral subtraction can eliminate the increase in the mean but not the increase in the 
variance (Vaseghi, 2000). 
 
8.5.1 Spectral Subtraction Principle  
If a noisy signal 𝑦(𝑚) is made up of a clean speech 𝑥(𝑚) and statistically independent additive 
noise 𝑛(𝑚) : 
 
𝑦(𝑚) = 𝑥(𝑚) + 𝑛(𝑚) Equation 8-3 
 
The main two assumptions here are that the additive noise has a zero mean and does not 
correlate with the clean signal. The speech signal is non-stationary as it changes its spectral 
content with time. Therefore it is usually processed on a frame basis.  
The short-time Fourier transform (STFT) of the previous equation is: 
 
𝑌(𝑓, 𝑘) = 𝑋(𝑓, 𝑘) + 𝑁(𝑓, 𝑘) Equation 8-4 
 
Where 𝑘 is the number of frames. By dropping 𝑘 for simplicity and finding the power spectrum 
of 𝑦(𝑚): 
 
|𝑌(𝑓)|2 =  |𝑋(𝑓)|2 + |𝑁(𝑓)|2 Equation 8-5 
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Thus, the clean speech power spectrum could be estimated by subtracting the power spectrum 
of the estimated noise from the power spectrum of the noisy signal. 
 
|𝑋(𝑓)|2 = |𝑌(𝑓)|2 − |𝑁(𝑓)|2 Equation 8-6 
 
Where the power spectrum of noise is estimated by averaging the periods of the noisy signal 
when the speech was absent. In order to reconstruct the clean signal, phase information is 
required, and the phase information of the noisy signal is usually used for this purpose 
(Upadhyay and Karmakar, 2015). Finally, the inverse Fourier transform is applied to estimate 
the clean waveform in the time domain, by using the addition and overlapping of |𝑋(𝑓)|2  (Boll, 
1979; Vaseghi, 2000). 
 
 
Figure 8-7. A block diagram representation of spectral subtraction 
One of the limitations in spectral subtraction is that its performance highly depends on the 
estimation of noise, such that an inaccurate estimation of noise may distort the speech signal 
(Upadhyay and Karmakar, 2015).  
In this study, the noise spectrum is available and derived from upper-body movement signal 
recorded by Vicon. Assuming that body movement is statistically independent and additive to 
the SLP signal, spectral subtraction could be a suitable technique to remove the upper-body 
movement from breathing in an SLP recording. 
 
8.6 Abnormalities-Removal Algorithm 
This section will discuss the statistical approach implemented to remove upper-body 
movements and coughs from SLP signals. An algorithm has been developed to identify 
abnormal breaths using a statistical approach. After identifying breath-cycles as trough-peak-
trough, the algorithm quantifies the rising and the falling edges’ amplitudes and durations for 
each cycle. Any cycle with a rising or a falling edge of less than 0.2 is excluded from the median 
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calculation. 0.2 was chosen as a threshold for two reasons:  firstly, it has been observed that the 
level of breathing peak-to-peak amplitude is almost five times higher than this value. Hence, 
this small peak is likely to represent a ripple. Secondly, this step was done to make sure that the 
median calculation is not influenced by peak-to-peak amplitudes of the ripples before using the 
median value as a reference for breath selection.  
The whole breath-cycle will be considered as rejected if either the rising or the falling edge is 
above a max-amplitude threshold, or below a min-amplitude threshold. Similarly, the cycle will 
also be rejected if the duration of either the rising or the falling edge is above a max_duration 
threshold or below a min_duration threshold. 
Duration threshold values as: 
min_duration = 0.5* Median value of rising/falling edges’ durations. 
max_duration= 1.5 * Median value of rising/falling edges’ durations. 
 
Amplitude threshold values: 
min_amplitude = 0.5 * Median value of rising/falling edges’ amplitudes. 
max_amplitude = 1.5 * Median value of rising/falling edges’ amplitudes. 
If the duration of the rising or the falling edge is below the min_duration threshold, it is unlikely 
to represent a breath and might represent a fast event instead such as a ripple or a cough. 
Moreover, if duration exceeded a max_duration, it represents slow events such as a slow body-
movements or a very slow breath, in all the previous cases the cycle is unlikely to represent a 
tidal breath. 
If the amplitude of the rising or the falling edge is also below the min_amplitude threshold, it 
is unlikely to represent a breath and might represent a ripple instead. Moreover, if it exceeds 
max_amplitude, it might represent a body-movements or a deep breath. 
If any of the previous conditions is met, the cycle is unlikely to represent a tidal breathing cycle. 
Therefore, the complete cycle will be removed from the time series. The signal will then be 
attached to the next cycle by placing the troughs on each other accounting for the difference in 
the y-amplitude between the two breaths. 
The abnormalities-removal algorithm was applied on SLPMov, and the sensitivity of the 
algorithm in detecting and removing upper-body movements was calculated. The agreement 
between Tidal breathing parameters measured by SLP and PNT was assessed before and after 
applying the algorithm. Movements, if detected, are removed because they do not represent a 
pure tidal breath. 
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The algorithm was also applied on SLPCough, and the sensitivity of the algorithm in detecting 
and removing coughs was evaluated. Differences between tidal breathing parameters estimated 
from SLPStill and SLPCough were calculated before and after applying the algorithm. Coughs, if 
detected, are removed because they do not represent a tidal breath. 
 
8.7 Methodology 
8.7.1 Study Participants and design 
In this study, 14 participants (7M:7F) aged 18- 60 with no history of respiratory diseases were 
recruited. Participants were excluded if they had a cold or any other viral infection, chest 
surgery within the past month or an acute disease-process likely to interfere with data 
acquisition. 
The study was approved by the Keele University Ethical Review Panel (ERP), (Ref number: 
ERP1303), and was performed in the Turing lab/Colin Reeves at Keele University. 
 
8.7.2 Study Devices and Procedures  
8.7.2.1 Pneumotachometer (PNT) 
Pneumotachometer (Viasys Masterscope CT; Viasys Healthcare GmbH, Hӧchberg, Germany) 
is a device that measures airflow, by converting the airflow passing through its mouthpiece into 
a relative pressure-difference either side of a pressure transducer. A flow signal is produced, 
and a volume signal is also quantified by integrating the flow signal with respect to time. Viasys 
Masterscope was used, with a sampling rate of 100 Hz, flow range 0 to ±20 L/Sec, and flow 
accuracy of 2%. A 3-L syringe was used for the calibration prior to the arrival of every subject, 
ambient temperature, pressure and humidity were recorded. 
8.7.2.2 Vicon Motion Capture System 
The Vicon (Vicon Ltd, Oxford) system is a motion capturing system, which consists of multiple 
high-resolution cameras fixed at different locations around a capture volume. Each camera has 
a ring of light emitting diodes (LEDs) fitted around the lens. The LEDs project infrared light 
into the capturing volume, and the light reflected from retroreflective markers attached to a 
subject is detected by the lens to identify their exact locations. 
The Vicon system is used clinically to examine human body-parts movement, by attaching a 
number of reflective markers on specific body parts, and tracking marker positions in real time. 
Positions of the markers in 3-dimensions are then used to quantify its: velocity, acceleration 
and jerk with high accuracy. Vicon is considered the gold standard in movement analysis. 
The markers were placed on a specific (bony) visible locations Figure 8-8. The placement of 
the markers was based on the assumption that the bony parts of the shoulders (front and back) 
and the C7 do not move with the movement of TA wall during breathing. This assumption was 
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confirmed by quantifying distances variations between (front - back, left - right shoulder) 
markers, which have shown to be within one millimetre that was considered negligible 
(compared to TA wall movement during tidal breathing). Thus, we assumed the rigidity of 
upper-thorax, and we dealt with the segment of five markers as one unit.  
 
 
Figure 8-8. Markers placement on the subject’s shoulder and C7 
 
8.7.2.3 SLP (Thora-3Di™, PneumaCare, Ltd., Cambridgeshire, UK). 
For each assessment, tidal breathing was recorded for five minutes using an SLP device. 
 
8.7.3 Study divisions  
This study was divided into three investigations, special conditions of each investigation will 
be discussed individually. However, certain conditions were shared by all three, which are: 
Every subject was asked to put on a close-fitting white T-shirt, and to sit in a high-backed chair 
with arms as far back in the seat as possible. Five reflective markers were attached on top of 
the t-shirt at Front Right Shoulder (FRSH), Back Right Shoulder (BRSH), Front Left Shoulder 
(FLSH), Back Left Shoulder (BLSH) and C7.  PNT was suspended from the ceiling, stabilised 
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and positioned at a height that allows the participant to place the mouthpiece in their mouths 
comfortably, gravity-eliminated position Figure 8-9. This method of positioning was done to 
avoid blocking the SLP grid. A nose-clip was used to block the subject’s nose. 
SLP machine was positioned one metre away from the subject, the height and angle of SLP 
head were adjusted such that the optical axis of the cameras were perpendicular to the subject’s 
chest wall. The projected light was aligned to cover the Thoracoabdominal (TA) area of the 
subject, with the cross point of the projected light placed at the base of the xiphisternum. The 
area above a hypothetical horizontal line at xiphisternum level is identified as the thorax and 
below it as the abdomen.  
As a part of normal operating conditions for SLP, room lights were switched off to allow a 
better grid visualisation by the SLP cameras. PNT and SLP recorded tidal breathing, and Vicon 
recorded upper-body movements all at the same time for five minutes. 
 
 
Figure 8-9.  Study setup. The subject is sitting as far back in a high-backed chair as possible with his 
arms on the chair arms. The PNT suspended from the ceiling to avoid blocking SLP-grid. 
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8.7.3.1  Sitting still and breathing 
In this part of the study, participants were instructed to sit as still as possible and breathe 
naturally. 
 
8.7.3.2 Breathing with Upper-body movements 
In this part of the study; participants were asked to sit still and breathe and were instructed to 
move their upper-extremity forward-backwards once a minute at different speeds. The 
movements were introduced to mimic the real upper-extremity movements which might occur 
during an SLP recording. 
 
8.7.3.3 Breathing with Coughing 
Participants were asked to sit still and were instructed to cough once every one minute at 
different strengths and to try to keep the coughs as natural as possible. Coughs were introduced 
to mimic the real coughs which might occur during an SLP recording. 
 
8.8 Study Aims 
This study had three investigations; each has a specific purpose contributing toward the overall 
aim of the study, as follows:   
The first trial aimed to identify the optimal recording time to obtain the least differences 
between SLP and PNT parameters. The agreement between the estimated parameters from both 
devices was then assessed. 
The second trial aimed to assess the effect of upper-body movements on the agreement between 
the estimated parameters. Different approaches to remove upper-body movements from the 
SLP signal were investigated. 
The third trial aimed to assess the effect of coughs on the estimated parameters. The effect of 
removing coughs on parameters estimation was assessed.  
 
8.9 Software and Data Analysis  
8.9.1 Pre-processing 
PNT volume-derived signal was exported for each subject using Jscope software (Viasys 
Healthcare GmbH). Pneumaview-3D™ software (PneumaCare Ltd) was used to export TA wall 
displacement-signals.  
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Due to the difference of sampling frequencies between both devices (PNT: 100 Hz; SLP: 30 
Hz), SLP signals were resampled to match the sampling rate of the PNT signals. This was done 
using a piecewise cubic Hermite interpolating polynomial. This interpolation was used 
previously by Motamedi‐Fakhr et al., 2017, because it minimally affects the morphology of the 
signal (i.e. shape-preserving) (Kahaner et al., 1989). The algorithm explained in 4.3.3 was used 
for breaths. 
Continuous wavelet transformation (cwt) was used to investigate frequency components of 
breathing, movements and coughs. Spectral subtraction and abnormalities-removal algorithms 
were applied in a trial to remove upper-body movements and coughs.  
 
8.9.2 Calculation of Tidal Breathing Parameters 
Inspiratory start times, expiratory start times, and expiratory end times were indicated. Each 
trough in the traces (PNT, and SLP) is considered as inspiratory start time (which in turn is 
considered the end time of the previous expiratory period), and each peak is considered as 
expiratory start time Figure 8-10. This method of identifying respiratory cycles is beneficial for 
calculating timing indices (Motamedi‐Fakhr et al., 2017).  
Following (Stocks, 1996) definitions, the parameters were calculated as follows:
 
Figure 8-10. Tidal volume signal (PNT), with the peaks and troughs localized. 
Inspiratory, expiratory start times and expiratory end times identified. 
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tI = Expiratory start time – Inspiratory start time 
tE = Expiratory End time – Expiratory start time 
tTot = tI+ tE 
RR = 60/tTot 
IE50 = TIF50/TEF50 
More details about the calculations of the parameters, is discussed in Chapter Four. 
 
8.9.3 Statistical Analysis  
8.9.3.1 Sitting still and breathing 
Median of each tidal breathing parameter was calculated from both SLP and PNT signals using 
a total signal length of 10, 20, 30, 40 and 47 Breaths. Means of differences and Confidence 
intervals were quantified at each breath count, to find the period which offers the lowest mean 
difference and the narrowest CI range. The upper and lower confidence intervals were 
calculated as: 
Mean of differences ± 1.96* (standard deviation / Sqrt (sample size) for each parameter. 
For the chosen breath count, a Bland-Altman plot (Bland and Altman, 1986) was used to assess 
the agreement between tidal breathing parameters measured by SLP and PNT. Upper-limit of 
agreement (ULOA) and the Lower-limit of agreement (LLOA) are evaluated as mean of 
differences ±1.96(SD). Since PNT is considered as a gold standard for measuring those tidal 
breathing parameters, the x-axis in the Bland-Altman plot represented the PNT values. Bland-
Altman plot contained 14 points for each parameter such that a point for each subject. 
Percentage differences were also calculated for each parameter: (XSLP- XPNT)/XPNT, and X is 
any of the tidal breathing parameters. 
 
8.9.3.2 Breathing with upper-body movements 
Bland-Altman plots (Bland and Altman, 1986) were used to assess the agreement between the 
parameters after the introduction of upper-body movement (SLPMov and PNTMov). Changes in 
the estimated parameters in both devices were also quantified to assess the effect of upper-body 
movements on parameters estimation. 
Mean of differences between SLP and PNT, ULOA and LLOA were used to assess spectral 
subtraction and abnormalities removal performances. 
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8.9.3.3 Breathing with Coughing 
Differences in the parameters between SLPStill and SLPCough were quantified, and then the 
parameters were quantified from SLPCough after coughs removal and compared with SLPStill. 
 
8.9.4 Results 
14 subjects (7M:7F) were recruited, with an age range of 19-49 years; mean (SD) 29.9 (9.55) 
years. 
 
Table 8-1. Participants demographics;  
Data for each subject: age, height, weight and gender; F: female; M: male. 
Subject number Age (yrs.) Height (cm) weight (Kg) Gender 
Sub_01 36 164.5 67 M 
Sub_02 28 176.5 77.5 M 
Sub_03 49 168.5 85 M 
Sub_04 26 178 82.8 M 
Sub_05 31 164.5 62 F 
Sub_06 47 178 92 M 
Sub_07 19 179 89 M 
Sub_08 20 172 64.2 F 
Sub_09 33 169 62 F 
Sub_10 36 162 68 M 
Sub_11 26 165 71 F 
Sub_12 26 170 57 F 
Sub_13 20 168 66 F 
Sub_14 21 162 74 F 
Total (Mean:SD) 29.9 (9.55) 169.79 (6.05) 72.68 (10.98) 7M:7F 
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Figure 8-11. Continuous wavelet transformation of a PNT signal recorded from Subject_03 in 
Sitting still session. 
The grey area marked with the dashed-line shows the area where edge effects become significant 
 
Figure 8-12. Continuous wavelet transformation of a SLP signal recorded simultaneously from 
Subject_03 in Sitting still session. 
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8.9.4.1 The agreement between SLPStill and PNTStill 
Respiratory Rate (RR) 
Respiratory rate median values range between 8.73 – 20.69 brpm. Figure 8-13 shows means 
of differences and CIs at different breath numbers. Means of differences ranged between 
0.036 – 0.103 brpm with the smallest RR mean difference of 0.036 brpm obtained at 10 
breaths period. 
 
Figure 8-13. Mean differences between RRSLP and RRPNT and CIs at 10, 20, 30, 40 and 47 breaths. 
 
Inspiratory Time (tI) 
Inspiratory time (tI) median values range between 1.29 – 2.84 sec. Figure 8-14 shows mean 
differences and CIs at different breath numbers. Mean of differences ranged between 0.065 
– 0.079 sec with the smallest tI mean difference of 0.065 sec obtained at 10 breaths period. 
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Figure 8-14. Mean differences between tISLP and tIPNT and CIs at 10, 20, 30, 40 and 47 breaths. 
 
Expiratory Time (tE) 
Expiratory time (tE) median values range between 1.62 – 4.18 sec. Figure 8-15 shows mean 
differences and CIs at different breath numbers. Means of differences ranged between 0.036 
– 0.064 sec with the smallest tE mean difference of 0.036 sec obtained at 20 breaths period. 
 
Figure 8-15. Mean differences between tESLP and tEPNT and CIs at 10, 20, 30, 40 and 47 breaths. 
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Total Breath Time (tTot) 
Total Breath time (tTot) median values range between 2.9 – 6.87 sec. Figure 8-16 shows 
mean differences and CIs at different breath numbers. Means of differences ranged between 
0.013 – 0.043 sec with the smallest tTot mean difference of 0.013 sec obtained at 20 breaths 
period. 
 
Figure 8-16. Mean differences between tTotSLP and tTotPNT and CIs at 10, 20, 30, 40 and 47breaths. 
 
Inspiratory/Expiratory Time Ratio (tI/tE) 
Inspiratory /expiratory time (tI/tE) median values range between 0.501 – 0.841. Figure 8-17 
shows mean differences and CIs at different breath numbers. Mean of differences ranged 
between 0.041 – 0.045 with the smallest tI/tE mean difference of 0.041 obtained at 10 and 
20 breaths period. 
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Figure 8-17. Mean differences between tI/tESLP and tI/tEPNT and CIs at 10, 20, 30, 40 and 47 breaths. 
Duty Cycle (tI/tTot) 
Duty cycle (tI/tTot) median values range between 0.334 – 0.457. Figure 8-18 shows mean 
differences and CIs at different breath numbers. Mean of differences ranged between 0.015 
– 0.016 with the smallest tI/tTot mean difference of 0.015 obtained at 10, 20 and 47 breaths 
period. 
 
Figure 8-18. Mean differences between tI/tTotSLP and tI/tTotPNT and CIs at 10, 20, 30, 40 and 47 
breaths 
111 
 
IE50 
IE50 median values range between 0.791 – 1.754. Figure 8-19 shows mean differences and 
CIs at different breath numbers. Mean of differences ranged between 0.005 – 0.072 with the 
smallest IE50 mean difference of 0.005 obtained at 40 breaths period. 
Table 8-2 presents the absolute and percentage differences and 95% LOAs at 40 breaths. 
The agreement between PNT and SLP is assessed using the LOAs and the mean of 
differences.  
 
Figure 8-19 Mean differences between IE50SLP and IE50PNT and CIs at 10, 20, 30, 40 and 47 breaths. 
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Table 8-2 Absolute and Percentage differences between tidal breathing parameters measured 
simultaneously by SLP and PNT at 40 breaths. 
Tidal breathing 
parameters 
Absolute  differences 
(over 40 breaths) 
Percentage differences 
(over 40 breaths) 
RR(brpm) -0.10 [-0.48, 0.27] -0.84 [-3.61, 1.94] 
tI (sec) 0.08 [-0.05, 0.20] 4.93[-2.89, 11.67] 
tE (sec) -0.06 [-0.2, 0.07] -2.57 [-7.43, 2.28] 
tTot (sec) 0.04 [-0.1, 0.18] 0.86 [-1.99, 3.71] 
tI/tE 0.04 [-0.03, 0.12] 6.91 [-4.91, 18.74] 
tI/tTot 0.02 [-0.01, 0.04] 4.03 [-2.86, 10.91] 
IE50 0.01 [-0.20, 0.21] 0.67 [-15.76, 17.09] 
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8.9.4.2 The effect of upper-body movements on derived tidal breathing parameters 
SLP is a contactless measure of breathing signals, in which signals are acquired by 
measuring the movement of the TA wall during breathing. Upper-body movements could be 
captured during breathing measurements, which could deteriorate the quality of the signal 
(Motamedi-Fakhr, Wilson and Iles, 2017),  and might provide the clinician with unrealistic 
breathing parameters. Figure 8-20 represents SLP, and PNT signals measured 
simultaneously, upper body-movements affect both signals, and it is clear that the SLP signal 
is more sensitive to this artefact. The agreement of the parameters between SLP and PNT 
was quantified at still and movement, then the differences in the parameters between 
movement and still were calculated for both devices Table 8-3. 
 
Figure 8-20. The effect of upper-body movement on SLP and PNT signals measured simultaneous. 
The effect of the movements on SLP is much bigger than on the PNT signal. 
Continuous wavelet transformation was used to investigate frequency contents of the signals. 
Figure 8-21 and Figure 8-22 show the time-frequency plane of still SLP and PNT signals 
respectively, the bright colour extending at all times in both figures represent the frequency 
range of breathing 0.3 to 0.4 Hz.  
Figure 8-23 shows the effects of upper-body movements on SLP frequency content, the five 
spikes that occupy the frequency range from 0.3 to 6 Hz represent upper-body movements’ 
frequency content. Figure 8-24 shows that the effect of the movement on PNT frequency 
content was barely noticeable. Hence, there is an overlap in frequency-bands between the 
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signal of interest and the interference in the SLP signal. Figure 8-25 shows the wavelet 
transformation of a Vicon signal which represents frequency components of upper-body 
movement for that specific subject.  
The continuous wavelet transform is an efficient technique for detecting transient 
components and sudden changes (Leonard et al., 2006). Therefore, it was used to identify 
and localise the intermittent components of upper-body movements. 
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Table 8-3. The agreement between PNT and SLP in both study conditions.  
The first row represents the mean of differences and LOAs in still condition and the second in movement. LOA is measured as Mean (Diff) ± 1.96(SD). 
Study 
Condition 
The 
difference 
(SLP - PNT) 
Tidal Breathing Parameters 
RR (brpm) tE (sec) tI (sec) tTot (sec) tI/tE tI/tTot IE50 
Still 
Mean -0.05 -0.01 0.02 0.03 0.03 0.01 0.07 
LOAs [-0.69, 0.60] [-0.22, 0.19] [-0.14, 0.19] [-0.17, 0.22] [-0.06, 0.13] [-0.02, 0.04] [-0.22, 0.36] 
Movement 
Mean 0.27 -0.05 -0.01 -0.08 0.00 0.00 0.03 
LOAs [-0.64, 1.17] [-0.23, 0.13] [-0.14, 0.12] [-0.33, 0.17] [-0.11, 0.11] [-0.03, 0.03] [-0.28, 0.34] 
 
 
Table 8-4. Changes in the estimated parameters between both study conditions observed from both machines.  
The first row represents the mean of differences and LOAs in SLP, and the second in PNT. LOA is measured as Mean (Diff) ± 1.96(SD). 
Machine 
type 
Difference 
(Mov – Still) 
Tidal Breathing Parameters 
RR (brpm) tE (sec) tI (sec) tTot (sec) tI/tE tI/tTot IE50 
SLP 
Mean 1.98 -0.38 -0.18 -0.59 0.03 0.01 -0.08 
LOAs [-3.88, 7.84] [-1.54, 0.78] [-1.00, 0.64] [-2.42, 1.24] [-0.10, 0.15] [-0.03, 0.05] [-0.59, 0.43] 
PNT 
Mean 1.67 -0.34 -0.15 -0.48 0.05 0.02 -0.04 
LOAs [-4.35, 7.69] [-1.49, 0.81] [-1.01, 0.72] [-2.37, 1.41] [-0.13, 0.23] [-0.04, 0.07] [-0.63, 0.55] 
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Figure 8-21. Continuous wavelet representation of a still SLP signal for Sub_01. 
 
 
Figure 8-22. Continuous wavelet representation of a still PNT signal for Sub_01 
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Figure 8-23. Continuous wavelet representation of SLP-signal with five upper-body movements for 
Sub_01. 
 
Figure 8-24. Continuous wavelet representation of a PNT-signal with five upper-body movements 
for Sub_01. 
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Figure 8-25. Continuous wavelet representation of the Vicon signal with the five body movements 
sub_01 
Spectral subtraction was employed in an attempt to remove upper-body movements from 
SLP signals, by subtracting the frequency contents of upper -body movements (Vicon), from 
the frequency content of SLP for each subject. Figure 8-26 shows the result of applying 
spectral subtraction on an SLP signal (blue), using the reference noise recorded by Vicon 
(green). The red trace shows the filtered signal; movement peaks were significantly 
suppressed using this approach with a minimal effect on the breathing parts of the signal. 
However, the reduced peaks did not reach a normal-breathing level, and some of them 
created a high-frequency oscillation in the place of the movement. 
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Figure 8-26. Spectral subtraction outcome for Sub_06.  
Top, blue is the SLP signal with upper-body movements interferences; red is the signal post-spectral 
subtraction. Upper-body movements are highlighted in a black box. 
The performance of spectral subtraction filtering approach was assessed using the agreement 
between tidal breathing parameters measured by SLP (Pre and Post-filtering) and PNTMov. 
Abnormalities removal algorithm was applied to remove upper-body movements and any 
other abnormal breath cycles as explained earlier on page 97. The algorithm successfully 
identified all upper-body movements as they have higher amplitudes than breathing peaks. 
Table 8-6 shows the agreement between tidal breathing parameters measured by SLP and 
PNT at still, movement, post spectral subtraction and post movement removal. 
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Figure 8-27. Upper-body movements identification and removal from SLP signal (Sub_10) using 
abnormalities removal algorithm. 
On top a raw PNT signal which shows the minimal effect of upper-body movements on the gold 
standard; in the middle, an SLP signal with movement-peaks identified and set to zero, and on the 
bottom, the identified peaks are removed, and the trace is attached at the cutting locations. 
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Table 8-5. The sensitivity and specificity of the abnormalities-removal algorithm in detecting upper-
body movements for subjects Sub_01-14. 
Subject Number   
 Sensitivity (%) Specificity (%) 
Sub_01 100 92 
Sub_02 100 97 
Sub_03 100 95 
Sub_04 100 89 
Sub_05 100 99 
Sub_06 100 85 
Sub_07 100 95 
Sub_08 100 91 
Sub_09 100 96 
Sub_10 100 87 
Sub_11 100 97 
Sub_12 100 100 
Sub_13 100 88 
Sub_14 100 100 
Average 100 94 
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Table 8-6. The agreement between tidal breathing parameters measured by PNT and SLP at still, movement, post spectral subtraction and post movement 
removal.  
Values are mean [LOA]. 
Tidal Breathing Parameters 
 Absolute Differences between tidal breathing parameters measured by PNT and 
SLP at Still, movement ,post spectral subtraction and post abnormalities removal 
algorithm 
Still Movement Post spectral sub Post mov removal 
RR (brpm) -0.05 [-0.69, 0.60] 0.27 [-0.64, 1.17] 0.92 [-1.03, 2.86] -0.02 [-0.49, 0.46] 
tE (sec) -0.01 [-0.22, 0.19] -0.05 [-0.23, 0.13] -0.22 [-0.73, 0.30] -0.01 [-0.15, 0.13] 
tI (sec) 0.02 [-0.14, 0.19] -0.01 [-0.14, 0.12] -0.06 [-0.27, 0.16] 0.01 [-0.10, 0.11] 
tTot (sec) 0.03 [-0.17, 0.22] -0.08 [-0.33, 0.17] -0.26 [-0.93, 0.40] -0.01 [-0.13, 0.12] 
tI/tE 0.03 [-0.06, 0.13] 0.00 [-0.11, 0.11] 0.02 [-0.12, 0.17] -0.01 [-0.10, 0.08] 
tI/tTot 0.01 [-0.02, 0.04] 0.00 [-0.03, 0.03] 0.01 [-0.04, 0.05] 0.00 [-0.03, 0.03] 
IE50 0.07 [-0.22, 0.36] 0.03 [-0.28, 0.34] -0.03 [-0.37, 0.31] 0.06 [-0.22, 0.33] 
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8.9.4.3 The Effect of coughing on SLP-derived tidal breathing parameters 
Figure 8-28 represents raw PNT and SLP signals measured simultaneously, the effect of the 
five-coughs on both traces is comparable. Differences between tidal breathing parameters 
estimated from SLPStill and SLPCough were quantified in Table 8-8. 
 
 
Figure 8-28. A comparison between PNT and SLP signals for one subject, both traces were normalized 
to facilitate visual comparison. 
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Figure 8-29. Continuous wavelet representation of SLP signal with five coughs from Sub_01. 
 
 
Figure 8-30. Continuous wavelet representation of a PNT signal with five coughs from Sub_01. 
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Figure 8-31. Coughs identification and removal from SLP signal using abnormalities-removal 
algorithm. On top a raw PNT signal which show the effect of coughs on the gold standard; in the middle 
SLP signal with the coughs identified; and on the bottom the identified peaks are removed, and the trace 
is attached at the cutting locations (identified by blue circles). 
Table 8-7. The sensitivity of abnormalities-removal algorithm in detecting coughs. 
Subject Number Sensitivity (%) Specificity (%) 
   
Sub_01 100 98 
Sub_02 100 89 
Sub_03 100 94 
Sub_04 100 96 
Sub_05 100 96 
Sub_06 100 77 
Sub_07 100 90 
Sub_08 100 96 
Sub_09 100 96 
Sub_10 80 91 
Sub_12 80 100 
Sub_13 80 95 
Sub_14 100 100 
Average 95 94 
 
126 
 
Table 8-8. Differences in tidal breathing parameters measured by SLPStill and SLPCough. 
Tidal 
Breathing 
Parameter 
Still Coughing Differences 
 Mean SD Mean SD Mean SD 
RR (brpm) 13.86 2.79 14.83 2.40 0.97 -0.39 
tE (sec) 2.59 0.59 2.36 0.46 -0.23 -0.13 
tI (sec) 1.88 0.32 1.75 0.29 -0.13 -0.03 
tTot (sec) 4.49 0.87 4.15 0.71 -0.34 -0.16 
tI/tE 0.75 0.07 0.77 0.09 0.02 0.02 
tI/tTot 0.43 0.02 0.43 0.03 0.00 0.01 
IE50 1.51 0.26 1.55 0.35 0.04 0.09 
 
Table 8-9. Differences in tidal breathing parameters measured by SLPStill and SLPCough post the removal 
of coughs using the abnormalities-removal algorithm. 
Tidal 
Breathing 
Parameter 
Still Post-Cough removal Differences 
 Mean SD Mean SD Mean SD 
RR (brpm) 13.86 2.79 14.77 2.44 0.91 -0.35 
tE (sec) 2.59 0.59 2.39 0.48 -0.2 -0.11 
tI (sec) 1.88 0.32 1.77 0.30 -0.11 -0.02 
tTot (sec) 4.49 0.87 4.18 0.74 -0.31 -0.13 
tI/tE 0.75 0.07 0.77 0.09 0.02 0.02 
tI/tTot 0.43 0.02 0.43 0.03 0.00 0.01 
IE50 1.51 0.26 1.55 0.37 0.04 0.11 
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Figure 8-32. Power spectrums of an SLP signal before and after coughs removal. 
A part of the power of high frequencies is removed after removing the coughs. 
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8.10  Discussion 
8.10.1  Sitting Still and Breathing  
Measuring respiratory functions (i.e. flow and volume) can be performed by many techniques; 
however, Pneumotachograph is considered the gold standard via widespread use, among 
researchers and clinicians (Stick, 1996). SLP measures the displacement of the TA wall, which 
is a different approach for measuring tidal breathing parameters. Therefore, differences between 
PNT and SLP are expected (Motamedi‐Fakhr et al., 2017). In this study, we have assessed the 
agreement between tidal breathing parameters measured simultaneously by PNT and SLP.  
In the first part of this study, errors of measurement were quantified at 10, 20, 30, 40 and 47 
breaths count. All subjects breathed a minimum of 47 breaths. Hence, it was the maximum 
value that could be chosen while not excluding any subjects. Errors were defined as the absolute 
means of differences between parameters from PNT and SLP and were quantified for each 
parameter. The optimal recording period for each parameter was then defined as the breath 
count associated with the minimum absolute difference between both devices. For each 
participant, the median value for each parameter over 10, 20, 30, 40, 47 breaths was calculated 
to quantify its magnitude. 
Figure 8-13, Figure 8-14, Figure 8-17 and Figure 8-18 illustrate that the 10-breath period was 
sufficient to obtain the least error between PNT and SLP for: RR (CI ranging: 0.036 - 0.103 
brpm), tI (ranging: 0.065 - 0.079 sec), tI/tE (ranging: 0.041 - 0.045) and tI/tTot (ranging: 0.015 
- 0.016) respectively.  
However, Figure 8-15 and Figure 8-16 show that more breaths (20-breath period) were required 
to get the least errors for both: tE (CI range: 0.036 - 0.064 sec) and tTot (CI range: 0.013 - 0.043 
sec) respectively. Finally, Figure 8-19 shows that even more breaths (40-breath period) were 
needed to obtain the minimum error for IE50 (ranging: 0.005 – 0.072). 
From that we can conclude that in order to obtain the least error for all the tidal breathing 
parameters investigated, the 40-breath period should be recorded. The Absolute and percentage 
differences between tidal breathing parameters measured by PNT and SLP were then quantified 
at 40-breaths (which correspond on average to one minute for infants, and two minutes for 
children). 
According to (Smith and Mackay, 2011) and (Parker et al., 2016), differences in RR within two 
brpm are considered clinically insignificant. For this study we considered this threshold to 
report similarity or agreement between RRSLP and RRPNT. Table 8-2 shows the absolute and 
percentage differences between PNT and SLP in measuring RR at 40-breath period. Absolute 
difference and LOAs -0.10 [-0.48, 0.27], were within the clinically acceptable limit. Based on 
this, we concluded that RRSLP and RRPNT are in agreement, which is in line with the results 
shown in a previous study by (Motamedi‐Fakhr et al., 2017).  
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There are no recognised clinically acceptable limits for some parameters such as tTot 
(Motamedi‐Fakhr et al., 2017), but knowing the mathematical relation between RR and tTot 
and their corresponding LOAs we could infer some information.  
LOAs of the absolute difference in quantifying tTot ranged between (-0.1 to 0.18 sec), and by 
knowing that we have previously concluded that RRSLP and RRPNT are in agreement at the 40-
breath period. Therefore, we could anticipate that tTotSLP  and tTotPNT also agree over that range. 
From a more precise view, low-pass filtering with 0.5 Hz cut-off is frequently used to smooth 
respiratory traces (Chervin, Malhotra and Burns, 2008; Walter and Vaughn, 2013), this kind of 
filtering can move the inspiratory and expiratory markers by up to 0.5 sec, which could indicate 
that such a difference is considered clinically insignificant. This might support our finding since 
LOAs range (-0.1 to 0.18) fall within this clinically acceptable limit. Similarly, the LOAs for tI 
and tE can be considered in the agreement between SLP and PNT as they all fall within that 
range of ±0.5 sec.  
LOAs of the absolute difference in calculating tI/tE were within ±0.12 and up to 18.74% 
percentage difference. In the agreement study conducted by (Motamedi‐Fakhr et al., 2017) over 
45-sec recording, a disagreement in quantifying tI/tE over 20% was considered significant. 
However, the agreement was assumed to be an application dependent. Both LOAs in this study 
were within the reported limit. From another view, mechanical ventilation studies usually 
require choosing inspiration to expiration (I:E) ratios, in order to enhance patient’s ventilation. 
tI/tE is obtained by taking the ratio between two integers; such as 1:2 or 1:4 which are 
commonly used settings in these studies. Hence it is unlikely that an error of 0.12 in quantifying 
tI/tE is clinically significant. Therefore, we have concluded that tI/tESLP and tI/tEPNT are in 
agreement.  
Differences in quantifying Duty cycle (tI/tTot) have shown a narrower LOAs range than in tI/tE 
-0.01 and 0.04 in terms of absolute difference, which is not known if it is clinically significant. 
In a previous study to validate RIP against PNT in sleeping infants, it was stated that LOAs of 
the difference in quantifying tI/tTot ranged between -0.016 and 0.064 (Stick et al., 1992). The 
LOA for our comparison was a little narrower with the mean difference close to zero, suggesting 
a higher agreement.  
IE50 showed a relatively higher disagreement compared to the timing indices, this could be 
reasoned to the fact that IE50 describes the shape of the flow-volume loop from PNT signal, 
and the TA displacement - TA displacement rate loop from SLP signal. In (Motamedi‐Fakhr et 
al., 2017) validation study absolute and percentage mean differences over a 45-sec scan were 
0.05 and 4.85 respectively, in their study they have anticipated that an improvement in the 
agreement could be obtained by increasing the capturing period. In this study, 40-breath period 
was analysed, and the mean and percentage differences in quantifying IE50 were: 0.01 and 0.67 
respectively, which confirms their assumption. In their study, A 95% LOA ranging from -0.15 
to 0.25 was considered relatively narrow, which was not highly affected by a longer capturing 
period in this study -0.2 to 0.21. 
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In the first part of the study, measurement errors were quantified at different breath counts 10, 
20, 30, 40 and 47. 40-breath period was selected as an optimal recording period as it has 
provided the smallest absolute error between parameters measured by PNT and SLP. In the 
second part of this section, the agreement between tidal breathing parameters measured by both 
devices was assessed at 40-breath period using the mean of differences and 95% LOA. From 
the previous discussion and by adopting the same assumptions by (Motamedi‐Fakhr et al., 
2017), that percentage difference of 10% or less is considered clinically insignificant; we might 
conclude that: RR, tI, tE, tTot and tI/tTot were in agreement between SLP and PNT. tI/tE and 
IE50 differed by more than 10% between both devices, but the differences were lower than 
what have been reported by (Motamedi‐Fakhr et al., 2017), this confirms their assumption; that 
an improvement in the agreement might be achieved by a longer capturing period. 
LOAs using mean and SD could also not be representative of the true ones since most of the 
distributions of differences were not normally distributed. LOA ranges determined in this way 
are likely to be higher and should not show a false disagreement (Bland and Altman, 1999). 
 
8.10.2 The Effect of Upper-Body Movements on the Derived Tidal Breathing Parameters 
In the previous part of the study, we have examined the agreements between tidal breathing 
parameters quantified from SLPStill and PNTStill in simultaneous measurements. We have shown 
that including 40 breaths in the analysis offered the best agreement between the parameters if 
all the parameters including IE50 are considered. A much shorter recording period is required 
if IE50 is not to be included. The main challenge when scanning young children is their 
excessive movement; this movement might affect some tidal breathing parameters according to 
Motamedi-Fakhr, Wilson and Iles, (2017). In children, respiratory signal is one of the most 
difficult to establish due to movement artefacts (Almazaydeh et al., 2013), therefore 
understanding the effect of upper-body movement on tidal breathing parameters is crucial. 
Children may be uncooperative, easily distracted and in motion. Moreover, children are less 
tolerant to monitoring machines. Assessing signals in such cases can be quite challenging, and 
the readings obtained can be misleading (Leonard et al., 2006). Incorrect readings could be 
dangerous in that patients could be given the wrong medications or medical procedures. 
Therefore, in this part of the study, we have examined the effect of upper-body movements on 
tidal breathing parameters, by introducing five upper body-movements during five minutes of 
SLP-recording. The effect of five pre-defined, artificial upper-body movements on both SLP 
and PNT signals was assessed by measuring the agreements between tidal breathing parameters 
measured by SLP and PNT in still and movement and by quantifying changes in parameters 
from each device between still and movement. 
From Table 8-3, the agreement between PNT and SLP was affected slightly by the introduction 
of five-upper body movements. Means of differences and ranges of LOAs have shown an 
increase for both RR and tTot, an increase in the mean difference for tE and the range of LOAs 
for IE50 were observed. Smaller changes in the agreement were detected in tI, tI/tE and tI/tTot. 
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However, the changes in the agreements for all the estimated parameters remained within the 
clinically acceptable limits explained in the previous section. 
 
Table 8-4 represents the changes in the parameters observed from both devices after the 
introduction of upper-body movements. The results show that the changes were comparable 
between PNT and SLP. Means of difference and LOAs ranges indicate that SLP was more 
influenced than PNT by this kind of artefact, which can be confirmed by purely viewing both 
traces on Figure 8-20. The observed increase in RR in both devices could be attributed to an 
increase in subjects’ breathing rate as a reason of movement, and not only to the effect of 
movements on the estimated parameters. 
For each participant, the median value for each parameter over the 5-min assessment was 
calculated to quantify its magnitude. The number of breaths included in the calculation varied 
between participants and ranged between 53 and 93 breaths. SLP-derived parameters were more 
likely to be influenced by upper-body movements than PNT.  
Median was used to calculate parameters’ magnitudes as it is a robust measure against outliers. 
However, the agreement between PNT and SLP derived parameters was slightly affected. This 
could be attributed to the artificial and exaggerated nature of the introduced movements 
(subjects were instructed to perform them), with higher peak-to-peak amplitudes than breathing 
peak-to-peak amplitudes. 
Median is the value which separates the data into two halves after ranking them from lower to 
higher values. Hence, it is a robust measure to outliers, which could explain the small reduction 
in the agreement between SLP and PNT derived parameters. The agreement might be affected 
further if a higher number of upper-body movements is introduced to the SLP signal, as they 
will introduce more extreme points in each parameter’s series and might have a larger effect on 
parameters’ magnitudes. 
From the previous discussion, five upper body-movements could be considered as outliers 
relative to the total number of breaths analysed. Moreover, these artefacts are not likely to 
significantly affect parameters estimation, because of the way those parameters were calculated. 
SLP and PNT signals with movement artefact were further investigated using the continuous 
wavelet transformation (CWT), in order to identify the added frequency components on both 
signals. CWT was used because of its ability to reveal the time-frequency information of the 
signal. Figure 8-21and Figure 8-22 show the time-frequency domain of a still SLP and PNT 
recordings respectively, frequencies at 0.2-0.3 Hz exist at all times which are the dominant 
frequencies of breathing. Figure 8-23 and Figure 8-24 respectively, show the added frequencies 
on SLP and PNT signals due to five-upper body movements. Movement-effect could be seen 
clearly on the time-frequency representation of the SLP signal but not on the PNT signal, the 
added frequencies on the SLP extended from 0.2 to 6 Hz at the times when body-movements 
132 
 
occurred. Figure 8-25 shows the wavelet transformation of the reference noise (body-rocking) 
recorded simultaneously using Vicon, which was used to confirm that the identified added 
frequencies in Figure 8-23 are due to body-movements.  
It was not possible to completely separate movement signal from the breathing signal using 
various techniques such as band-pass filtering or wavelet filtering, due to the overlap in the 
frequency contents of breathing and body movements at the times of movement. Applying any 
of those filtering approaches to remove body-movement have affected breathing parts. 
Therefore, spectral subtraction method was employed in a trial to use Vicon reference-noise 
signal in the filtering process.  
Spectral subtraction successfully suppressed big parts of upper-body movements while 
minimally affected breathing signal. Movement peaks were reduced differently using this 
approach, few of them were reduced to breathing-peaks level Figure 8-26. Table 8-6 shows the 
increase in parameters’ mean differences and LOAs ranges between SLP and PNT as a result 
of applying spectral subtraction. This could be attributed to the creation of new peaks (high- 
frequency ripples) in the place of movement peaks, which might have introduced more 
abnormal values. Hence, affected SLP parameters estimation and the agreement as a result. 
Furthermore, the reference noise signal might have contained some breathing components 
Figure 8-25 which could have further affected the outcomes of this filtering approach. 
Table 8-6 shows the results obtained by applying the abnormalities-removal algorithm, means 
of differences and LOAs show an improvement in the agreement for most of the parameters. 
This statistical approach has shown superior performance over Spectral subtraction to recover 
the agreement between SLP and PNT. Rejecting peaks with abnormal amplitudes or timing was 
more effective and has slightly improved the robustness of parameters calculation. Furthermore, 
the Abnormalities-removal algorithm could identify and remove movements with high 
sensitivity without requiring a reference noise signal (which is not usually available in clinical 
settings). 
As a summary, the introduced movements could be completely removed from the analysis using 
a statistical approach by applying the abnormalities-removal algorithm. This approach simply 
excludes any peak with an abnormal rising or falling amplitude (high or low) relative to the 
median rising or falling amplitudes of the entire trace, or an abnormal rising or falling duration 
(long or short) relative to the median rising or falling durations of the entire trace.  
Five artificial upper-body movements were introduced to the signal and did not significantly 
affect the agreement between the parameters measured by SLP and PNT. Even though, this 
approach has successfully restored this slight effect of body movements on the agreement and 
thus improved the robustness of parameters calculation.  
Movement removal algorithm was highly successful in identifying and removing peaks 
corresponding to upper-body movements. If a movement has an amplitude that falls within the 
amplitude range of breathing, the algorithm will use the duration (speed) of that peak to identify 
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it and vice versa. The sensitivity and specificity of the algorithm were 100% and 94% 
respectively; this shows that some real breaths that might be longer/shorter (or larger/ smaller) 
were excluded. The effect of removing abnormal real breaths is expected to be minimal since 
those values will be considered as outliers and removing them will have a small effect on the 
parameters. Hence, removing a real breath will be better than not removing a movement. In this 
study, movements were artificial, and of high amplitudes, the algorithm needs to be further 
assessed with more natural and complicated upper-body movements.  
 
8.10.3 The Effect of Coughing on SLP-Derived Parameters 
In the previous part of the study, we have shown that upper-body movements do not 
significantly affect SLP-estimated parameters. Furthermore, removing the peaks corresponding 
to the movements is advantageous in restoring the agreement between parameters measured 
simultaneously by SLP and PNT. One of the other challenges when scanning children with 
breathing disorders is coughing; therefore, understanding the effect of coughing on the 
estimated parameters is crucial. 
In this part of the study, we have asked the participants to perform five coughs and to try keeping 
them as natural as possible, at a rate of one cough per minute. Figure 8-28 shows that the effect 
of the five coughs on both PNT and SLP signals is comparable. Thus, there was no point in 
assessing the agreement between tidal breathing parameters measured by both devices in this 
case. 
SLP and PNT signals with coughs were further investigated using the continuous wavelet 
transformation (cwt), in order to identify the added frequency components on both signals. 
Added frequencies on both signals spread from 0.3 to 6 Hz, with the highest powers at the 
frequencies below 1 Hz Figure 8-29 and Figure 8-30. It was not possible to completely separate 
coughs from breathing signal using various filtering techniques such as band-pass filtering or 
wavelet filtering, due to the overlap in the frequency contents of breathing and coughing.  
SLP-estimated parameters were compared between both sessions: still and with coughing, to 
quantify the effect of coughs on the parameters. Table 8-8 shows the differences between the 
means of the parameters at still and cough. Small differences were observed in almost all the 
parameters except tI/tTot which stayed the same. This could be attributed to the robustness of 
the algorithm used to calculate the parameters against outliers, as it uses the median value to 
quantify parameters’ magnitudes. 
Coughs should be considered as rejected breaths as they do not represent a normal tidal 
breathing cycle. Coughs have few features that distinguish them from tidal breathing; firstly, a 
high amplitude and secondly a shorter duration, both of those features could be identified using 
the abnormalities-removal algorithm. Figure 8-31 presents the identification and removal of 
coughs from one SLP signal; it shows the ability of the algorithm to detect the five coughs and 
remove them from the trace. 
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Table 8-7 shows the high sensitivity and specificity of the algorithm in detecting coughs 95% 
and 94% respectively. This confirms that most of the coughs were detected and removed. Few 
real breaths were removed because of their abnormal amplitude or duration, which is not 
expected to highly affect parameters estimation (as they were considered as outliers).  
Table 8-9 represents the differences between the means of the parameters at still and coughs 
post coughs removal. There were clear drops in the differences in RR, tE, tI and tTot (mean and 
SD). Differences in tI/tE, tI/tTot and IE50 stayed the same. 
Power spectrum in Figure 8-32 shows the removal of a part of the power of higher frequencies 
after removing the five coughs from an SLP signal.  
As a summary; differences in tidal breathing parameters were observed between SLPStill and 
SLPCough. Those differences could be caused by the introduction of the coughs or the normal 
difference (variability) between the two sessions. The application of abnormalities-removal 
algorithm has identified and removed most of the coughs and resulted in a drop in the 
differences for most of the parameters. A difference in RR, for example, stayed 0.91 brpm, 
which may indicate that this difference could have been caused by an increase in the breathing 
rate of the subjects as a result of coughing. 
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9 General Discussion 
This thesis was informed by four main studies, all of which evaluated the reliability of SLP for 
measuring tidal breathing parameters. The purpose of this chapter is, therefore, to consolidate 
the results and discussions from individual chapters, relating to the aforementioned studies, into 
a summative conclusion and final discussion. 
An accurate assessment of lung function is crucial for effective management of respiratory 
conditions (Beydon et al., 2007; Wijngaart, Roukema and Merkus, 2015). Spirometry, 
conventionally used for the assessment of lung function, typically requires the patient to have 
a level of compliance and understanding when undertaking the assessment. Hence, it is often 
not appropriate for young children (Wijngaart, Roukema and Merkus, 2015). Alternative 
approaches include the use of PNT or RIP for the measurement of tidal breathing patterns. Their 
clinical usefulness for application in children is however limited, due to the testing equipment 
used, e.g. use of a mouthpiece in PNT can cause changes to breathing patterns, and slippage of 
the band can result in erroneous readings in RIP (Weissman et al., 1984; Stick et al., 1992; 
Caretti et al., 1994; Laveneziana et al., 2015a). SLP was therefore identified as a possible 
modality for overcoming these limitations, as it is a light-based, non-contact technique which 
allows a detailed assessment of tidal breathing patterns over successive breaths. SLP can be 
performed in either seated or supine positions and requires minimal subject cooperation. This 
is arguably a more suitable method for young children and infants. However, before SLP can 
be implemented clinically, it is important to ensure that the measures taken accurately reflect 
the patient's true lung function, as these measures may be used to diagnose respiratory 
conditions, monitor disease progression and responses to pharmacological interventions.  
Therefore, the primary step in determining the reliability of SLP required an evaluation of SLP 
for lung function monitoring in a paediatric population. The first study therefore, investigated 
the use of SLP in assessing tidal breathing in school-age children (7-16 years). In order to 
identify if SLP could detect differences in lung function between normative and pathological 
populations, children with asthma were compared with healthy children in this study. 
Additionally, the effect of bronchodilator administration on both spirometry and SLP-estimated 
parameters in the asthmatic group were investigated. Our results showed that SLP could 
differentiate between school-age children with and without asthma and may detect responses to 
bronchodilation. The most informative parameter was IE50SLP (IE50SLP, quantified as 
TIF50SLP/TEF50SLP), which was significantly higher in children with stable asthma compared 
to healthy controls of a similar age. As previously discussed, in asthma, the airways are 
narrowed due to the inflammation in the airway walls and constriction of smooth muscles 
surrounding them. This narrowing in the diameter becomes clear when exhalation occurs as 
exhalation causes further narrowing in these obstructed airways. Hence, a reduction in 
TEF50SLP was observed, which leads to an increased IE50 value in the asthmatic group. 
This result is in line with the findings observed by (Papiris et al., 2002; Tauber et al., 2003). A 
high success rate for the procedure was shown in this age group, and hence, it was concluded 
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that SLP could be successfully utilised in school-age children (aged 7-16 years) and that it is 
sensitive enough to detect airways obstruction in the asthmatic group. All the above points 
suggest several relative clinical applicability advantages for SLP. Using SLP comes with 
several conveniences over spirometry. First, SLP is a non-invasive technique, and its minimal 
subjects’ cooperation requirements make it more convenient for young children. In addition, 
the contactless nature of its procedure reduces the risk of cross-infection. Finally, the simplicity 
of the procedure and minimal training requirements, compared to spirometry, gives a superior 
clinical preference. In short, using spirometry accurately would require several factors to be 
considered: intensive training for the clinician, cooperation from the participant and in-session 
coaching and instructing to ensure that the child is cooperating correctly.  All these features 
might give precedence to using SLP as a quick monitoring tool to assess lung functions of 
children in none-specialised health services, such as schools and GP practices.  
Following this study, it was identified that further research was required before recommending 
the use of SLP in younger children, with or without respiratory pathology. Therefore, another 
study on children (2-12 years) recovering from acute asthma/wheeze was carried out. It was 
demonstrated that SLP could be performed successfully in children as young as two years of 
age. Many SLP parameters have differentiated between acute asthmatics and their healthy 
counterparts, specifically, IE50SLP and chest versus abdominal asynchrony TAASLP. The 
increased IE50SLP value in the acute asthma group is in line with the observations seen in older 
children with airways obstruction. However, IE50SLP stayed higher than normal after 
bronchodilation administration, which suggests no response to treatment, even though children 
were in the recovery phase of their disease. This contradicted the findings in the first study 
related to stable asthma, where IE50SLP dropped significantly after bronchodilation 
administration. TAASLP was also higher in children with acute asthma, which was expected 
because of the increased work of breathing they experience, resulting in a loss of 
thoracoabdominal synchrony (Lødrup, 2000; Giordano et al., 2012). The within-subject 
variability in TAA was higher in children with acute asthma suggesting a compensatory 
mechanism in which spatial variability is introduced into the system when temporal variability 
is reduced. Within-subject variability of asynchrony was not observed in the first study, which 
might be attributed to the reduced chest wall compliance in older children, and hence, less 
tendency for regional variation. One parameter vTPTEF/tESLP of the SLP was able to detect a 
response to bronchodilator administration in this study. SLP has shown a unique value in the 
preschool age group, where traditional airflow obstruction assessments are challenging. This 
may be useful for providing an accurate asthma diagnosis within this age group. Although the 
success rate of spirometry in preschool children was reported differently between studies 
(Aurora et al., 2004), in a feasibility study by Kampschmidt et al. (2016), success rates of 45%, 
65% and 87% for three, four and five years old, respectively was reported. The preliminary 
results reported in this study and the associated high success rate of 87% (93.7% for 6-12 years 
and   83.9% for 2-5 years), may support further investigations to assess the age-effect on 
breathing patterns. These points might suggest the use of SLP in obtaining objective clinical 
measures of lung function, specifically in pre-school children. This is because in this population 
obtaining accurate lung function measurements is challenging using conventional techniques. 
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Moreover, SLP can be used clinically to assess the natural recovery of asthma or the effect of 
different interventions. Further study on the technique and the data analysis methods is required 
before introducing SLP into routine clinical practice.  
After showing the high success rate in children with airways obstruction above two years of 
age, the next study was carried out to check the feasibility of SLP in infants recovering from 
acute viral bronchiolitis (0-1 year). SLP-estimated tidal breathing parameters in the AVB group 
were compared with those in healthy infants. Differences in the parameters between admission 
and discharge in the AVB group were also investigated. In this study, even though a high 
success rate of the procedure was shown, excessive movement of infants did not allow a full 
five-minute scan to be obtained. However, this study showed that three SLP parameters, 
specifically, IE50SLP, vIE50SLP and TAASLP were able to differentiate between healthy infants 
and those with AVB. IE50SLP was significantly lower in the AVB group, which contradicts our 
findings from the previous two studies on older children with asthma, where IE50SLP was 
significantly higher compared to healthy children. TAASLP was significantly higher in the AVB 
group compared to the healthy group, which is in line with what is reported in study two, that 
a loss of thoraco-abdominal synchrony is caused by the increased work of breathing resulted 
from airway obstruction. 
The reduced value of vIE50SLP on admission and its increase on discharge toward the value 
seen in the healthy group was expected. This is in line with the previously reported results 
stating that an increased load on the respiratory system caused by the obstruction make it more 
rigid, hence reduces its within-subject variability. As a result of the natural recovery of the 
condition, the load on the respiratory system decreases and this, in turn, will reduce its rigidity 
leading to an increase in within-subject variability. 
SLP has been proposed as a method for overcoming limitations associated with other methods 
used to obtain breathing measures. However, it is apparent that an optimal recording condition 
for SLP requires the child to remain still throughout, as upper-body movements would interfere 
with the signal. Five minutes of still recording (requested by the manufacturer) is a long period 
which is sometimes challenging to obtain in children. Therefore, the optimal recording time to 
obtain the minimum differences between SLP and PNT parameters was investigated. A total 
of 40 breaths, two minutes for a child and one minute for an infant, was found to be sufficient 
for meeting this condition. The agreement between parameters, measured by both devices at 
that duration, was found to fall within the clinically acceptable limits and the agreements were 
consistent with the finding observed by Motamedi-Fakhr et al. (2017). 
In the previous studies, other sources of interference stemming from coughing and upper-body 
movement especially in the younger age group were observed during data acquisition. The 
effect of these movement artefact sources on SLP-estimated tidal breathing parameters had not 
been previously studied. Hence, the next study was carried out in order to quantify and evaluate 
the effect of these artefact sources on SLP measures. In the final study, upper-body movements 
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and coughs were introduced to the SLP signals in two separate lab settings, to investigate their 
effect on SLP and PNT simultaneous recordings.  
The five-artificial upper-body movements, introduced to SLP recording, minimally affected the 
agreement between PNT and SLP.  In addition, any changes in the parameters from both 
devices were comparable. These results have shown the stability of the algorithm, as it uses the 
robust median to calculate the parameter from successive breaths. The added movements would 
have introduced outliers to each parameter sequence but would have only minimally affected 
the parameter estimation. The study has also shown the overlap in frequency contents between 
upper-body movements and breathing, which made it challenging to separate movement signal 
from breathing using ordinary filtering techniques. A statistical approach for removing upper-
body movements from the trace was used and demonstrated superior performance in improving 
the agreement between SLP and PNT over the spectral subtraction method. Spectral subtraction 
algorithm requires recording of the interference using an external system (Vicon) as a reference 
signal, which is not usually available in clinical settings. 
For artefact stemming from coughs, these episodes were considered as rejected breaths because 
they did not represent tidal breathing cycles. Furthermore, they showed an overlap in frequency 
content with the breathing signal. The application of a statistical approach successfully 
identified and removed coughs, reducing the differences between SLPStill and SLPCough for most 
of the studied parameters. 
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9.1 Limitations 
The studies carried out in this research shows the possible advantages of using SLP to display 
the difference in respiratory disease compared to normal control data as well as showing 
changes as recovery from illness happen. However, the clinical usefulness of this method 
remains to be proven. If SLP succeeded in offering additional clinically meaningful information 
to help to improve our diagnosis and management, its adaptation in a clinical setting would be 
justified.  
In preschool children, although SLP was successful in obtaining objective measurements of 
lung function, their link to certain pathological or physiological changes need to be further 
investigated. It is worth mentioning that, even though SLP has shown differences between 
health and disease in this group, it was not backed up by a gold standard method, spirometry, 
which is not used clinically in this age group at present. 
It is also important to point out that the effects of upper-body movements and coughs were 
investigated. However, these were from healthy adults and were artificial. This might not 
represent the natural coughs and body movements encountered in diseased children in the actual 
clinical setting. Further study to assess the effectiveness of abnormality-removal algorithm on 
detecting and removing these artefacts in this age group is therefore needed. 
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10 Conclusion and Future Work 
My research focused on finding a suitable technique to assess lung function, as there is a need 
for accurate assessment that is convenient for the patient and suitable for younger ages. The 
difficulties in lung function assessment in children are well established and have been described 
in this thesis.  
Tidal breathing was considered as an alternative approach to forced manoeuvres for measuring 
breathing, but the clinical non-practicality of the measuring devices used for this purpose have 
limited its use. SLP is a novel technique to measure tidal breathing which would arguably solve 
the shortcoming of the previous techniques and provide a new approach for assessing lung 
function in children. 
The main findings of this thesis are that SLP can be considered a reliable measure for assessing 
lung function in children aged 0 to 17 years, with each of the three studies showing development 
in the assessment in terms of the ages of the children. The target was to allow a non-invasive 
method for children as young as few weeks old, ensuring that data collected is accurate and 
provide data for children that have been presented with normal lung function as well as those 
with affected lung function, specifically stable asthma, acute asthma/wheeze and acute viral 
bronchiolitis. 
 The first study showed that IE50SLP was able to detect airways obstruction and identify 
responses to bronchodilator in children with stable asthma (6-17 years). In this study, I 
determined the reality of SLP in quantifying lung functions; the children were tested with both 
spirometry and SLP to establish a comparison between the techniques, with spirometry being a 
suitable technique to show lung obstruction and the effect of the treatment used. SLP was used 
here to check the feasibility of SLP in those children and to check if the parameters are sensitive 
enough to classify between asthmatics and healthy patients.   
The second study showed that IE50SLP and asynchrony parameters, along with the within-
subject variability of multiple parameters differentiated between children with acute asthma (2-
12 years) and their healthy counterparts and had detected recovery. In this study, SLP has shown 
usefulness in preschool children where assessment of airflow obstruction is challenging.  
The third study showed again that IE50SLP and TAASLP, along with the within-subject 
variability of multiple parameters could be used to differentiate between infants with AVB and 
healthy infants; vIE50SLP may also be used to detect recovery.  This study is a feasibility study 
that shows that even younger children can be scanned using SLP. The main progression within 
each of these tests is the age groups of the patients, with the first a larger older range of 7-16 
years old, the second a more focused age group of 2-12 years old and the third most specific 
for those under 2 years of age. 
These preliminary results look promising and support further study and refinement of the 
technique and data analysis methods with an aim toward introducing it to routine clinical 
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practice. Further study to evaluate the effects of age on breathing patterns is also required; SLP 
may represent a method for assessing lung function in patient populations in whom traditional 
techniques such as spirometry cannot be conveniently used. 
A more detailed investigation of thoracoabdominal asynchrony (TAA) parameter could be 
useful, by quantifying the inspiratory and expiratory TAA separately. This separation can 
provide a detailed information about the phase when asynchrony between thoracic and 
abdomen become apparent, which might help clinicians in supporting their diagnosis based on 
the physiological basis of each condition.  
In addition, a larger study would help in determining the diagnostic ability of SLP in children 
with asthma. More investigations are also required on infants with AVB, as the findings in this 
cohort contradicted our hypothesis about obstruction. Furthermore, different respiratory and 
neuromascular conditions in younger population could be investigated using SLP, which might 
help clinicians in monitoring and managing theese condition. 
SLP could be a promising technique in conditions that involve chest wall deformities 
particularly in children, and to monitor the changes in breathing after a surgical intervention, 
more researches in this area are recommended.   
In Adults, SLP might be a promising technique in elderly and severely ill patients (such as 
patients in the ICU) as a quick scanning tool to assess their lung functions when their 
cooperation cannot be achieved. 
Whilst the sources of artefact were identified, these could be overcome by implementing a 
statistical approach to remove them from the analysis rather than trying to filter them out of SLP 
signal, as those artefacts overlap in frequency with breathing. Further investigation on the 
abnormalities-removal algorithm is required to assess its robustness in detecting more complex 
upper-body movements (child's movement in real clinical setting). Furthermore, SLP data could 
have been filtered using different approaches if the displacement of every single square of the 
projected light was provided. Upper-body movements could be then identified by looking at 
the movement of the squares in each corner of the grid and compare their movements with 
respect to each other. This could help in identifying different nature of movements and can 
possibly be used in adaptively removing this movement from the raw data. 
Researches on the potential use of SLP in continuous monitoring could be conducted especially 
with young infants with sleeping apnoea, who will be lying in a supine position, and SLP might 
help in further understanding the changes in their breathing patterns at different sleeping stages. 
The feasibility of SLP in those infant need to be investigated, accounting for the possibility that 
infants might frequently change their sleeping position.  
In summary, SLP may offer a new approach to assess lung function in children, especially pre-
school children, where conventional techniques such as spirometry are not usually obtainable.  
Due to its ease of use and limited requirement of training, such technique can be used in health 
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centres, within schools or other institutions to bring about a quick assessment of lung function 
of the patient. The study shows that SLP can be used for children, and not only in adults, it is 
sensitive to obstruction and matches data used in spirometry for older children. 
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12 Appendices 
 
Appendix - A  Matlab codes  
 
• Code used for Spectral subtraction 
 
This code was used to clean the SLP signal using spectral subtraction, 
% For the original code see link:  
% https://gist.github.com/jameslyons/554325efb2c05da15b31 
% Copyright 2013 James Lyons , MIT License (MIT) 
  
function [S_out]=spectral_sub(S_in,I_in,Fs) 
  
NFFT = 1024; 
WINLEN = 10; %frame length in seconds 
WINSTEP = 0.5; % frame step in seconds 
  
% converting the noisy signal to frames and getting its spectral 
frames = frame_sig(S_in, WINLEN*Fs, WINSTEP*Fs, @hamming); 
cspec = fft(frames,NFFT,2); % complex spectrum 
pspec = abs(cspec).^2; % power spectrum of noisy signal 
phase = angle(cspec); 
  
  
% converting the noise to frames and getting its spectral 
noise_frames = frame_sig(I_in, WINLEN*Fs, WINSTEP*Fs, @hamming); 
noise_cspec = fft(noise_frames,NFFT,2); % complex spectrum 
noise_pspec = abs(noise_cspec).^2; % power spectrum of noisy signal 
noise_phase = angle(noise_cspec); 
  
  
clean_spec = pspec - noise_pspec; 
clean_spec(clean_spec < 0) = 0; % negative power spectrum is not allowed 
  
  
reconstructed_frames = ifft(sqrt(clean_spec).*exp(i * phase),NFFT,2); 
reconstructed_frames = real(reconstructed_frames(:,1:WINLEN*Fs)); % sometimes small 
complex residuals stay behind 
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S_out = 
deframe_sig(reconstructed_frames,length(S_in),WINLEN*Fs,WINSTEP*Fs,@hamming); 
 
Return 
 
% For the original code see link:  
% https://github.com/jameslyons/spl_featgen 
% Copyright 2013 James Lyons, MIT License (MIT) 
  
function win_frames = frame_sig(signal, frame_len, frame_step, winfunc) 
%function win_frames = frame_sig(signal, frame_len, frame_step, wintype) 
% takes a 1 by N signal, and breaks it up into frames. Each frame starts 
% frame_step samples after the start of the previous frame. Each frame is 
% windowed by wintype. 
% - to specify window, use e.g. @hamming, @(x)chebwin(x,30), @(x)ones(x,1), etc. 
if size(signal,1) ~= 1 
    signal = signal'; 
end 
  
signal_len = length(signal); 
if signal_len <= frame_len  % if very short frame, pad it to frame_len 
    num_frames = 1; 
else 
    num_frames = 1 + ceil((signal_len - frame_len)/frame_step); 
end 
padded_len = (num_frames-1)*frame_step + frame_len; 
% make sure signal is exactly divisible into N frames 
pad_signal = [signal, zeros(1,padded_len - signal_len)]; 
  
  
% build array of indices 
indices = repmat(1:frame_len, num_frames, 1) + ... 
    repmat((0: frame_step: num_frames*frame_step-1)', 1, frame_len); 
frames = pad_signal(indices); 
  
win = repmat(winfunc(frame_len)', size(frames, 1), 1); 
% apply window 
win_frames = frames .* win; 
% For the original code see link:  
% https://github.com/jameslyons/spl_featgen 
% Copyright 2013 James Lyons , MIT License (MIT) 
  
function rec_signal = deframe_sig(frames, signal_len, frame_len, frame_step, winfunc) 
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%rec_signal = deframe_sig(frames, signal_len, frame_len, frame_step, wintype) 
% frames - a N by frame_len matrix of frames 
% signal_len - the length of the original unframed signal (if unknown, use []) 
% frame_len, frame_step - should be same as used by frame_sig (framing function) 
% winfunc - the same used when framing, this is undone before overlap-add 
  
  
num_frames = size(frames,1); 
indices = repmat(1:frame_len, num_frames, 1) + ... 
          repmat((0: frame_step: num_frames*frame_step-1)', 1, frame_len);  
padded_len = num_frames*frame_step + frame_len; 
  
if isempty(signal_len) 
    signal_len = padded_len; 
end 
  
rec_signal = zeros(1,padded_len); 
window_correction = zeros(1,padded_len); 
%wsyn = 0.5-0.5*cos((2*pi*((0:frame_len-1)+0.5))/frame_len); 
  
win = winfunc(frame_len)'; 
  
for i = 1:num_frames 
    window_correction(indices(i,:)) = window_correction(indices(i,:)) + win + eps; 
     
    rec_signal(indices(i,:)) = rec_signal(indices(i,:)) + frames(i,:); 
end 
  
rec_signal = rec_signal./window_correction; 
rec_signal = rec_signal(1:signal_len); % discard any padded samples 
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• Code for abnormalities-removal algorithm 
% function 
[S_clean,S_zero,loc,rloc_zero,rloc_clean,y_rising,y_falling,t_rising,t_falling]=remove_abnor
mal(S_in,min_ratio,max_ratio,min_t_ratio,max_t_ratio,PK_TH) 
% S_in:     The input signal with abnormalities  
% min_ratio: Minimums ratio (with respect to median) of accepted 
% rising or falling (difference in y value) in the signal  
% max_ratio: Maximum ratio (with respect to median) of accepted 
% rising or falling (difference in y value) in the signal  
% min_t_ratio: Minimums time ratio (with respect to median) of accepted 
% rising or falling in the signal  
% max_t_ratio: maximums time ratio (with respect to median) of accepted 
% rising or falling in the signal  
% PK_TH: minimum value of the peaks that are included in median 
% calculations 
% S_clean:  The abnormalities are deleted, and the signal level is adjusted 
%           to be matched at the deletion point 
% S_zero:   The abnormalities are replaced with zero 
% loc:      minima-location matrix 
% rloc_zero: Rejected locations for S_zero matrix 
% rloc_clean: Rejected locations for S_clean matrix 
% y_rising: The value of y-difference (rising) 
% y_falling: The value of y-difference (falling) 
% t_rising: The value of t-difference in samples (rising) 
% t_falling: The value of t-difference in samples (falling) 
% Date:     01 June 2018 
% Author:   Hamzah Hmeidi (h.hmeidi@keele.ac.uk) 
  
function 
[S_clean,S_zero,loc,rloc_zero,rloc_clean,y_rising,y_falling,t_rising,t_falling]=remove_abnor
mal(S_in,min_ratio,max_ratio,min_t_ratio,max_t_ratio,PK_TH) 
  
% finding the minima by finding the maxima of the negative signal 
[minimas,loc] = findpeaks(-S_in); 
  
% storting location matrix 
loc=sort(loc); 
  
min_count = length(loc); % the number of minimas 
  
  
% Finding the the y-difference for the rising period and failing period 
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y_rising  = zeros(1,min_count-1); 
y_falling = zeros(1,min_count-1); 
  
% Finding the the t-difference (in samples) for the rising period and failing period 
t_rising  = zeros(1,min_count-1); 
t_falling = zeros(1,min_count-1); 
  
for index = 1:(min_count - 1) 
  
    % The current and the next minima 
    loc1 = loc(index); 
    loc2 = loc(index+1); 
  
    % Finding the value of the peak between the two minima 
    [pk,lc] = findpeaks(S_in(loc1:loc2)); 
     
    y_rising (index) = pk - S_in(loc1); 
    y_falling(index) = pk - S_in(loc2); 
     
    % Finding the number of samples from first minima to the peak 
    t_rising (index) = lc; 
    % Finding the number of samples from the peak to the second minima 
    t_falling(index) = (loc2-loc1) - lc;  
end 
  
  
% finding the median of y_rising and y_faling 
  
% exculuding peaks which has small values 
rising_med = median(y_rising(y_rising>PK_TH)); 
falling_med = median(y_falling(y_falling>PK_TH)); 
  
min_r = rising_med * min_ratio; % minimum accepted rising y difference 
max_r = rising_med * max_ratio; % maximum accepted rising y difference 
  
min_f = falling_med * min_ratio; % minimum accepted falling y difference 
max_f = falling_med * max_ratio; % maximum accepted falling y difference 
  
  
% finding the median of t_rising and t_falling 
% execluding the time of the peaks that has small values 
% notice that y_rising and y_falling are used to find those peaks 
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rising_t_med = median(t_rising(y_rising>PK_TH)); 
falling_t_med = median(t_falling(y_falling>PK_TH)); 
  
min_t_r = rising_t_med * min_t_ratio; % minimum accepted rising times 
max_t_r = rising_t_med * max_t_ratio; % maximum accepted rising times 
  
min_t_f = falling_t_med * min_t_ratio; % minimum accepted falling times 
max_t_f = falling_t_med * max_t_ratio; % maximum accepted falling times 
  
  
% The index of rejected minima location 
rejected_loc_index = zeros(1,min_count-1);  
  
% Finding the location of rejected breathing units (rising and falling) 
for index  = 1:(min_count-1) 
    if y_rising(index) < min_r | y_rising(index) > max_r 
        rejected_loc_index(index) = index; 
    elseif y_falling(index) < min_f | y_falling(index) > max_f 
        rejected_loc_index(index) = index; 
    elseif t_rising(index) < min_t_r | t_rising(index) > max_t_r 
        rejected_loc_index(index) = index; 
    elseif t_falling(index) < min_t_f | t_falling(index) > max_t_f 
        rejected_loc_index(index) = index; 
    end 
end 
  
% removing zeros values from rejected_loc_index 
rejected_loc_index(rejected_loc_index==0) = []; 
  
rloc_zero  = loc(rejected_loc_index); 
  
LN = length(rejected_loc_index); 
  
% Setting rejected breathing units to 0 
S_zero = S_in; 
for index = 1:LN 
    % The start and end of the rejected breathing unit 
    reject_start = loc(rejected_loc_index(index)); 
    reject_end = loc(rejected_loc_index(index)+1) -1; 
  
    S_zero(reject_start:reject_end) = 0; 
end 
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% Deleting the rejected breathing units 
S_clean = S_in; 
for index = LN:-1:1 
    % The start and end of the rejected breathing unit 
    reject_start = loc(rejected_loc_index(index)); 
    reject_end = loc(rejected_loc_index(index)+1) -1; 
     
    % Deleting the rejected breathing unit 
    S_clean(reject_start:reject_end) = []; 
     
    % If part of the signal is still remaining after deletion point 
    if reject_start < length(S_clean) 
        % If delection point is not the first point in the signal 
        if reject_start > 1 
            % Finding the difference between the deletion point and the 
            % point before it 
            y_diff = S_clean(reject_start) - S_clean(reject_start-1); 
  
            % Adjusting the level of the signal after deletion point 
            S_clean(reject_start:end) = S_clean(reject_start:end) - y_diff; 
        end 
    end 
     
    % Adjusting the location matrix to match S_clean 
    % Finding the difference in locations 
    loc_diff = reject_end-reject_start+1; 
    loc(rejected_loc_index(index)+1:end) = loc(rejected_loc_index(index)+1:end) - loc_diff; 
end 
  
  
rloc_clean = loc(rejected_loc_index); 
  
% Removing duplicate values in rloc_clean 
rloc_clean = unique(rloc_clean); 
  
  
return 
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Appendix - B  Clinical Studies Demographic 
 
12.1 Healthy Subjects 
ID Gender Age Height Weight BMI 
HHN01 M 9 138.3 30 15.68472 
HHN02 M 9 138.5 32.9 17.15127 
HHN03 M 7 115 21.6 16.3327 
HHN04 M 10 144 43 20.73688 
HHN08 F 8 141 33 16.59876 
HHN09 M 11 135.5 33 17.97361 
HHN12 F 8 130.6 36 21.1065 
HHN14 M 7 142 28 13.88613 
HHN15 M 4 111 20 16.23245 
HHN16 M 5 110.5 20 16.37968 
HHN17 F 3 98.3 14 14.48842 
HHN18 M 10 137 32 17.04939 
HHN20 F 7 118 20 14.36369 
HHN22 F 7 124.7 31.7 20.38573 
HHN23 F 7 126.8 28.05 17.44594 
HHN24 F 8 125.2 25.4 16.20411 
HHN25 M 8 133 26.1 14.75493 
HHN26 F 11 155 47 19.56296 
HHN28 M 8 125.3 24.15 15.38208 
HHN31 F 10 136.6 31 16.61347 
HHN34 F 5 113.6 27.3 21.15466 
HHN36 M 11 153.3 35.85 15.25474 
HHN39 M 7 126.5 28.7 17.93498 
HHN40 F 5 110.5 18.9 15.4788 
HHN41 F 5 116.7 21.52 15.80158 
HHN43 F 10 152.8 37.62 16.11284 
HHN44 F 12 153.2 43.1 18.36368 
HHN45 M 5 114.5 20.9 15.94172 
HHN46 M 12 148.8 37.8 17.07206 
HHN47 M 2 91.1 15.18 18.2909 
HHN50 M 10 144.7 50.38 24.06141 
HHN57 F 7 126.5 28.1 17.56003 
Healthy 001 F 4 101 17 16.66503 
Healthy 003 M 5 102 15 14.41753 
Healthy 004 M 3 94 15 16.97601 
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Healthy 007 F 6 111 20 16.23245 
Healthy 008 F 3 96 17 18.44618 
Healthy 009 F 4 101 16 15.68474 
Healthy 011 M 5 97 18 19.13062 
Healthy 012 M 6 110 27 22.31405 
Healthy 013 M 4 97 19 20.19343 
Healthy 014 M 4 90 18 22.22222 
Healthy 015 M 4 97 17 18.06781 
Healthy 016 M 2 76 14 24.23823 
Healthy 018 M 3 104 19 17.56657 
Healthy 019 M 2 95 14 15.51247 
Healthy 020 M 4 97 19 20.19343 
Healthy 021 M 2 95 17 18.83657 
Healthy 022 M 3 100 18 18 
Healthy 023 F 3 88 17 21.95248 
Healthy 024 M 2 82 15 22.30815 
Healthy 025 M 6 118 23 16.51824 
Healthy 026 F 6 115 23 17.3913 
Healthy 027 M 2 86 14 18.92915 
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12.2 Acute Asthma: 
ID Gender Age Height Weight BMI 
HHA01 M 5 109.9 18 14.90312 
HHA02 M 5 112.7 19 14.95911 
HHA03 F 11 143 34.54 16.8908 
HHA04 M 6 117.2 22 16.01649 
HHA07 F 3 100.6 15.5 15.31566 
HHA08 M 4 103.5 16.2 15.12287 
HHA09 F 6 126 33 20.78609 
HHA10 M 3 102.7 14.4 13.6528 
HHA11 M 5 112 19.8 15.78444 
HHA13 M 3 154 37 15.60128 
HHA16 M 8 
 
25.5 
 
HHA17 F 3 95.7 14.3 15.61393 
HHA21 F 6 109 18.8 15.82358 
HHA22 M 8 138 
 
0 
HHA23 F 4 103 17.36 16.36346 
HHA24 M 9 142 30 14.878 
HHA27 F 12 139 35.4 18.32203 
HHA29 M 7 128.3 24.3 14.76226 
HHA30 M 3 97.7 15 15.71456 
HHA31 F 8 121.5 25.26 17.11121 
HHA33 M 5 117.8 23 16.57438 
HHA34 F 3 94.8 13.36 14.86585 
HHA35 M 2 85.7 11.88 16.17539 
HHA36 M 8 
 
31.2 
 
HHA38 M 3 98.9 14.58 14.90613 
HHA39 F 5 111.6 20.4 16.37954 
HHA42 F 8 127.2 26.5 16.37841 
HHA43 M 9 142.4 38.2 18.83837 
HHA44 F 4 108 20.14 17.2668 
HHA45 M 2 91.2 12.7 15.26912 
HHA46 M 2 
 
15.2 
 
HHA48 M 2 96.9 13.4 14.27109 
HHA49 M 2 93.85 16.58 18.82418 
HHA51 M 2 86.7 13.76 18.30544 
HHA52 M 4 103.3 14.36 13.45717 
HHA53 F 5 107.9 17.9 15.37482 
HHA55 M 4 107.2 16 13.92292 
HHA56 M 10 144.1 34.46 16.59538 
HHA58 M 6 122.8 20.85 13.82641 
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12.3 Stable asthma: 
 
ID Gender Age Weight Heigth 
HHS01 F 11 65.5 162 
HHS02 F 8 20 119.4 
HHS03 F 8 24.9 130.8 
HHS04 F 9 29.8 133.2 
HHS05 F 13 64.7 153.9 
HHS06 M 12 29.8 133.2 
HHS07 F 8 29.8 129.6 
HHS08 M 13 62.5 165.4 
HHS09 F 10 30.1 129.9 
HHS10 M 13 45.7 151.4 
HHS11 M 10 34.1 135.6 
HHS12 F 13 56.15 160.2 
HHS13 M 11 54.8 160.1 
HHS14 F 12 45.8 150.9 
HHS15 F 13 41.65 150.4 
HHS16 F 13 56.8 173.7 
HHS17 M 11 44 143.2 
HHS18 M 4 15.1 97.1 
HHS19 M 7 24.8 129 
HHS20 M 13 73.85 159.8 
HHS21 F 11 51.8 138.6 
HHS22 M 13 40.25 155.2 
HHS23 M 7 22.2 118.5 
HHS24 M 8 28.8 128.4 
HHS25 F 9 30 133.7 
HHS26 M 13 49.2 158 
HHS27 M 15 60.7 177.3 
HHS28 F 9 33.95 128.7 
HHS29 F 9 24.4 128.9 
HHS30 M 9 27.8 131.3 
HHS31 M 9 34.5 151.4 
HHS32 M 16 61.4 181.4 
HHS33 M 12 50.2 149.9 
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Appendix - C  Bland-Altman Agreement Plots 
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Ethical Approvals: 
 
Asthma studies in chapters five and six 
Studies (ClinicalTrials.gov identifier: NCT02543333) were conducted in line with the 
International Conference on Harmonisation Good Clinical Practice guidelines and 
were approved by the UK Health Research Authority National Research Ethics Service 
(reference number 11/EE/00/37).  
https://clinicaltrials.gov/ct2/show/NCT02543333?term=structured+light+plethysmography&c
ond=Asthma&rank=1 
 
 
Acute Viral Bronchiolitis (AVB) study in Chapter seven 
This study (ClinicalTrials.gov identifier: NCT02881632) was conducted in line with the 
International Conference on Harmonisation Good Clinical Practice guidelines and 
was approved by the UK Health Research Authority National Research Ethics Service 
(reference number 11/EE/00/37).  
https://clinicaltrials.gov/ct2/show/NCT02881632?term=structured+light 
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Ref: ERP1303 24th November 2016 
Hamzah Hmeidi 
Institute for Science and Technology in Medicine 
Guy Hilton Research Centre 
Thornburrow Drive 
Stoke On Trent 
ST4 7QB 
Dear Hamzah, 
Re: Improvement of the reliability of Structured Light Plethysmography measurements 
Thank you for submitting your revised application for review. 
I am pleased to inform you that your application has been approved by the Ethics 
Review Panel. The following documents have been reviewed and approved by the panel 
as follows: 
 
If the fieldwork goes beyond the date stated in your application, 28th December 2016, or 
there are any other amendments to your study you must submit an 'application to amend 
study' form to the ERP administrator at research.erps@keele.ac.uk stating ERP1 in the 
subject line of the email. This form is available via 
http://www.keele.ac.uk/researchsupport/researchethics/ 
 
Document(s) Version Number Date 
Study Poster 4 16-11-2016 
Consent Form 4 16-11-2016 
Information Sheet 4 16-11-2016 
Health Screening Questionnaire 4 16-11-2016 
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If you have any queries, please do not hesitate to contact me via the ERP administrator on 
research.erps@keele.ac.uk stating ERP1 in the subject line of the e-mail. 
 
Dr Jackie Waterfield Chair - Ethical Review Panel 
CC RI 
Manager 
Supervisor 
 
Directorate of Engagement & Partnerships 
T: +44(0)1782 734467 
Keele University, Staffordshire ST5 5BG, UK 
www.keele.ac.uk +44(0)1782 732000 
 
Yours sincerely 
 
